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Abstract
African swine fever virus (ASFV) is a large DNA virus that assembles in 
viral faetories loeated elose to the mierotubule organising centre. This study has 
investigated the meehanisms by whieh ASFV reaches the cell surface from these 
perinuclear assembly sites. The first step in this transport is dependent on intact 
microtubules and involves the motor protein conventional kinesin. This plus-end 
motor is reeruited to virus factories and to individual eytoplasmie virions. Consistent 
with a role for eonventional kinesin during ASFV egress, over-expression of the 
cargo-binding domain of the kinesin light ehain, which acts as a dominant negative 
protein, severely inhibits movement of viruses to the plasma membrane. Preliminary 
binding studies show that p73, the main eapsid protein, may bind the cargo binding 
domain of kinesin light ehain in vitro. p73 may therefore recruit conventional kinesin 
to ASFV partieles. Once delivered to the periphery of the cell, virions were found 
associated with mierofllaments, possibly using eortical actin fibres as tracks. Once at 
the plasma membrane, partieles induee the formation of long aetin projeetions that 
morphologieally and strueturally resemble filopodia. A seeond generation of 
particles was capable of moving within these filopodia-like structures in a bi­
directional manner.
Altogether, these data suggest that ASFV transport from assembly sites to the 
plasma membrane involves at least four mechanisms: microtubule-based motility, 
transport along eortical actin filaments, aetin polymerisation from the plasma 
membrane and bi-directional movement along pre-existing projeetions.
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1 Introduction
1.1 African swine fever virus
African swine fever virus (ASFV) is a double stranded DNA virus that infects 
members of the family Suidae, such as the African warthogs (Phacochoerus 
aethiopicus) and bushpigs (Potamochoerus porcus). Ticks of the genus 
Ornithodoros, which parasitize warthogs, are also infected by ASFV and may act as 
vectors for its transmission (Mellor and Wilkinson, 1985; Wardley et al., 1983). 
ASFV is enzootic in the southern half of Africa where it causes a persistent and 
asymptomatic infection in its natural hosts (Wilkinson, 1989). Infection of domestic 
pigs causes a fatal haemorrhagic disease for which there is no treatment or vaccine. 
After adaptation in vitro, ASFV multiplies in several established cell lines from pigs 
and other animal species, such as monkeys, but naturally ASFV shows tropism for 
swine macrophages and vascular endothelial cells.
1.1.1 Taxonomic position
ASFV is the only member of the Asfarviridae family, which is derived from 
the term African swine fever and related viruses (Dixon et al., 2000). ASFV 
assembles in specific regions of the cytoplasm, designated virus assembly centres or 
viral factories, a property shared with poxviruses, iridoviruses and phycodnaviruses. 
A comparative analysis of the proteins encoded by these viruses revealed that they 
share a set of homologous genes that unite them to the exclusion of all other known 
viruses and cellular life forms (Iyer et al., 2001). These genes encode a helicase, a 
DNA packaging ATPase, a transcription factor for late gene expression, a capsid
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protein and a myristoylated virion membrane protein. Phylogenetic analyses 
performed with these shared genes suggests that all these viruses may have evolved 
from a single ancestral virus and that they constitute an evolutionary unit (Iyer et al., 
2001).
This group of viruses has been called “nucleocytoplasmic large DNA viruses” 
or NCLDV. As a group they infect terrestrial, aquatic and marine life but many are 
poorly characterised. The phycodnaviruses, for example, grow in diverse algae (Van 
Etten and Meints, 1999). DNA sequence analyses of the 330 kilobase pairs (kbp) 
linear genome of the prototypical phycodnavirus, Paramecium bursaria chlorella 
virus (PBCV-1), suggested that it encodes 376 proteins (Van Etten and Meints, 
1999), but the function of many remains unclear. Similarly, the Iridoviridae family 
comprises four genera of large icosahedral viruses infecting both vertebrates and 
invertebrates. Vertebrate iridoviruses infect fishes, amphibians and reptiles and those 
infecting invertebrates are found in insects. Most of the known biology of 
iridoviruses comes from a limited amount of work with frog virus 3 (FV3). The best 
characterised members of the NCLDV group are the family of poxviruses, that 
comprises a large group of enveloped viruses infecting vertebrates 
(Chordopoxviruses subfamily) or insects (Entomopoxviruses subfamily) (Moss,
1996). The chordopoxvirus subfamily includes Vaccinia virus (W ), the best known 
poxvirus.
Last year, a very large icosahedral double-stranded DNA virus infecting 
amoebae was discovered in a water tank in England (La Scola et al., 2003). This 
virus has been named Mimivirus and it defines the Mimiviridae family. The 800 kbp 
Mimivirus genome contains 21 genes that encode clear homologs to proteins of 
poxviruses, iridoviruses and phycodnaviruses. Some of the Mimivirus genes also
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exhibit lower similarities to ASFV genes (La Scola et a l, 2003). Therefore, 
Mimiviridae would be a new family in the evolutionary group composed by 
poxviruses, iridoviruses, phycodnaviruses and ASFV (La Scola et a l, 2003).
After the poxviridae, ASFV is the best characterised virus of the NCLDV 
group and a description of what is known of ASFV follows.
1.1.2 The disease
1.1.2.1 Discoverv
African swine fever (ASF) was first detected after the introduction of 
European domestic pigs into Africa. The first cases were described in 1910 in Kenya 
and the viral origin of the disease was established in 1921. ASFV made its first 
appearance in Europe in 1957 with an outbreak in Portugal (Wilkinson, 1989). It then 
spread to Spain and became established in the Iberian Peninsula. In the early 1970’s, 
ASF appeared in France, Italy and Cuba. Later, coinciding with frequent outbreaks in 
Portugal and Spain, the disease was detected in Malta, Sardinia, Brazil, Haiti and the 
Dominican Republic. The latest appearances of the disease outside its endemic area 
occurred in Belgium in 1985 and in the Netherlands in 1986 (Wilkinson, 1989). In 
most cases, ASF was eradicated at high costs through slaughter.
1.1.2.2 Pathogenesis
The original reports of ASF in Africa described an acute haemorrhagic 
disease with 100% mortality. After an incubation period of 4 to 10 days, sick animals 
showed high fever and died one to three days later. Since the virus became 
established in Spain, a more extensive range of syndromes has evolved, including
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sub-acute disease, from which pigs may recover after undergoing a brief period of 
illness. Once pigs have been infected, ASFV replicates locally in monocytes and 
macrophages and is then distributed throughout the body via the blood stream. High 
titres of the virus are present in all organs and tissues during acute infections 
(Wilkinson, 1989).
1.1.3 Genomic structure and organisation
The ASFV genome is a linear double-stranded DNA molecule of 170 to 190 
kbp, depending on the isolate. It has a conserved central region of about 125 kbp 
(Blasco et al., 1989). The ends of the genome are covalently closed by 37-base-long 
hairpin loops, that, like those of poxvirus DNA, are composed of incompletely paired 
A and T residues (Gonzalez et al., 1986). Another characteristic of the ASFV 
genome is the presence of 2.1 kbp-long terminal inverted repeats that are identical at 
both genome ends and resemble in structure those of poxviruses (de la Vega et al., 
1994).
The genome of the Badajoz 1971 Vero-adapted strain of ASFV (Ba71v) has 
been entirely sequenced (Yanez et al., 1995). It is 170,101 nucleotides long and 
contains 151 major open reading frames (ORFs). Major ORFs are those that encode a 
minimum of 60 amino-acids and do not significantly overlap with larger ORFs. 72 of 
the ORFs read rightwards and 79 of the ORFs read leftwards (Yanez et a l, 1995). 
Structural and/or functional information is available on 113 viral proteins. ASFV 
encodes 26 putative membrane proteins (Yanez et a l, 1995). One of these is the non- 
structural protein p30, that is expressed as early as 2 hours post-infection (hpi) 
(Afonso et a l, 1992). Although its function is unknown, immunodetection of p30 is
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often used as a marker of infection. ASFV is the only DNA virus that encodes 
polyproteins. Polyprotein processing as a mechanism of gene expression was thought 
to be restricted to positive-strand RNA viruses and retroviruses (Simon-Mateo et al., 
1993). Two polyprotein precursors, pp220 and pp62 give rise to several major 
components of the virus particle after proteolytic processing (Andres et al., 2002a). 
ASFV also encodes enzymes that are involved in nucleic acid metabolism such as 
nucleotide metabolism, nucleic acid modifications, DNA replication, repair and 
transcription and RNA modifications (Yanez et al., 1995). ASFV produces proteins 
involved in protein modifications, such as an ubiquitin-conjugating enzyme, a 
serine/threonine protein kinase and a prenyltransferase (Alejo et al., 1997; Baylis et 
a l, 1993; Hingamp et a l, 1992). ASFV also encodes proteins that share homology 
with cellular proteins and have the potential to interfere with the host immune 
response to the viral infection. To avoid cytokine action, ASFV expresses an IkB- 
like protein that inhibits the activity of the nuclear factor NFkB, which controls the 
expression of cytokine genes involved in the inflammatory and immune response 
(Powell et a l, 1996; Tait et a l, 2000). ASFV has also developed a mechanism to 
block the action of cytotoxic T-lymphocytes on virus-infected cells. ASFV encodes a 
homologue of the T-cell adhesion molecule CD2, a plasma membrane protein that 
mediates the interaction between the lymphocytes and the infected cells. ASFV CD2 
could block this interaction by sequestering the CD2 ligand in the infected cells 
(Rodriguez et a l, 1993a). To inhibit the induction of apoptosis during the infection 
cycle, ASFV encodes homologues of the cellular proto-oncogene Bcl-2 and of the 
inhibitor of apoptosis protein (Chacon et a l,  1995; Neilan et a l, 1993a).
Thirty-four to 50 proteins with molecular mass ranging from 10 to 150 kilo 
Dalton (kDa) have been detected in purified extracellular virions (Carrascosa et a l,
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1985; Esteves et al., 1986). About ten of these proteins participate in virion structure 
(Carrascosa et al., 1985) and some of them will be described in section 1.1.4.4.
1.1.4 The replication cvcle of ASFV
1.1.4.1 Attachment and entrv into cells
The attachment of ASFV to cells in culture is probably mediated by specific 
receptors, but they have yet to be identified (Alcami et al., 1989). The structural 
protein p l2  is involved in mediating the attachment of ASFV particles to these 
specific receptors (Carrascosa et al., 1991). This small highly conserved 12 kDa 
protein contains a putative transmembrane domain in its central region and is located 
in the outer envelope of extracellular particles (Alcami et al., 1992; Angulo et al., 
1993b). Incubation of cells with purified p l2  prevents ASFV infection, 
demonstrating that ASFV attachment mediated through the receptor recognised by 
pl2  is the major receptor-mediated event preceding a productive infection (Angulo et 
al., 1993a).
ASFV infectivity is inhibited in chloroquine-treated cells and the virus is 
retained in large vacuoles of lysosomal appearance, suggesting that ASFV 
penetration occurs by a mechanism of adsorptive endocytosis (Geraldes and 
Valdeira, 1985). Later, virions are present in secondary lysosomes, where they lose 
their outer envelope and their capsid (Valdeira and Geraldes, 1985). A compact 
nucleoprotein complex is then delivered into the cytosol (Valdeira et al., 1998) and is 
thought to travel towards its replication site on mierotubules (Heath et al., 2001).
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1.1.4.2 Viral factory morphogenesis
ASFV replication and assembly take place in the cytoplasm at specialised 
perinuclear sites called viral factories. Viral factories tend to exclude cellular 
materials and are surrounded with cytoskeletal elements (Carvalho et al., 1988; 
Nunes et al., 1975). Poxviruses, phycodnavirus and iridoviruses assemble similarly 
(Moss, 1996; Van Etten and Meints, 1999; Williams, 1996).
The recruitment of viral components into virus assembly sites is not well 
understood. Virus factories may form passively as a consequence of the localised 
accumulation of large quantities of viral protein during infection. Cells usually 
respond to the production of high levels of misfolded proteins by transporting them 
along mierotubules to perinuclear sites called aggresomes (Johnston et al., 1998). 
Aggresomes and viral factories share many properties: both are located near the 
mierotubule organising centre and require an intact microtubular network for 
assembly (Heath et al., 2001). Both are surrounded by a vimentin cage, cellular 
chaperones, proteasomes and mitochondria (Heath et al, 2001). Given that viral 
factories resemble aggresomes, it is possible that a cellular response originally 
designed to reduce the toxicity of misfolded proteins aggregates is exploited by 
ASFV and related viruses, such as poxviruses, phycodnavirus and iridoviruses, to 
concentrate structural proteins at the viral assembly sites (Heath et al., 2001). A 
diagram illustrating the formation of ASFV factories is given in figure 1.1.
1.1.4.3 Genome replication
DNA replication occurs in viral factories, at around 8 hours post-infection. In 
vitro experiments have shown that the host-cell nucleus is not required for ASFV 
DNA replication (Caeiro et al., 1990). Several viral proteins are probably involved in
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the DNA replication, such as a DNA polymerase, a DNA ligase and a type II 
topoisomerase (Garcia-Beato et a l, 1992; Rodriguez et a l, 1993b; Yanez and 
Vinuela, 1993).
1.1.4.4 Transcription
ASFV gene expression is regulated in a cascade fashion: the factors involved 
in the transcription of each class of gene are synthesised during the expression of the 
previous temporal class. Three classes of mRNA are produced: early, intermediate 
and late. In common with poxviruses, ASFV particles contain all the enzymatic 
machinery required for the synthesis and modification of early mRNA. These 
activities include an RNA polymerase, a poly A polymerase and a capping enzyme 
(Kuznar et a l, 1980; Salas et a l, 1981). The virions also contain a protein kinase 
activity and a nucleic-acid dependent ATPase (Baylis et a l, 1993; Kuznar et a l, 
1981). The RNA synthesised by the virion-associated RNA polymerase resemble 
those of eukaryotic cells and poxviruses in that they bear methylated cap structures at 
their 5’ ends and poly-A tails at their 3’ ends (Salas et a l, 1981). Early viral proteins 
are required for transcription of intermediate genes (Rodriguez et a l, 1996b). The 
intermediate mRNA class is then synthesised after the initiation of viral DNA 
replication but before the expression of late genes. Two ASFV genes give rise to 
intermediate mRNA. The first encodes a protein resembling cellular TFIIs 
transcription factors (Rodriguez et a l, 1992), whilst the second has no significant 
similarities to any proteins in the databases (Yanez et a l, 1995). ASFV late genes are 
transcribed after the initiation of viral DNA replication and at a later time than 
intermediate genes.
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Figure 1.1. Assembly of ASFV factory resemble aggresome formation.
After penetration into cells, ASF virions are uncoated and the virion cores are 
released into the cytoplasm. The virion cores are transported along 
mierotubules to the MTOC, in a manner reminiscent of large protein 
aggregates transport. ASFV factories, like aggresomes, are surrounded by 
vimentin cages, mitochondria, proteasomes and cellular chaperones (Heath et 
al, 2001).
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Individual genes are tightly regulated (Almazan et al., 1992; Almazan et al., 
1993; Yanez et al., 1995), resulting in transcripts of a defined length, and are 
initiated a short distance upstream of the corresponding ORFs. To date, no ASFV 
promoters have been identified. However, signals for the 3’ end formation of early 
mRNAs are present as a run of 7 or more consecutive thymidylate residues termed a 
7T motif (Almazan et al., 1992; Almazan et al., 1993). 7T motifs are usually 
downstream of the stop codon or within the following ORF if it has the opposite 
transcriptional orientation (Yanez et al., 1995). 7T motifs are similar to T5NT 
sequences in the vaccinia virus genome, which act as termination signals in that 
system (Yuen and Moss, 1986). At present, the role of 7T motifs contained within 
the coding strands of 33 of the major ORFs of ASFV is unknown.
1.1.4.5 Virion structure and morphogenesis
ASFV morphogenesis is a complex process that occurs in perinuclear viral 
factories described above. Electron microscopy reveals that viral factories contain 
membrane-like structures, an ordered series of assembly intermediates displaying 
one to six sides of a hexagon and fully assembled nucleocapsids as 200 nm diameter 
hexagons (Fig. 1.2) (Andres et al., 1998; Rouiller et al., 1998). Close inspection of 
fully assembled virions identifies concentric layers of different electron densities. 
The electron-dense central layer represents the DNA-containing nucleoid. The viral 
DNA is surrounded by a thick protein layer, called the core shell or matrix. The core 
is encased in a double inner lipid envelope and an icosahedral capsid (Andres et a l, 
1998; Rouiller et a l, 1998). The proposed structure of an ASFV particle is shown in 
figure 1.3.
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%Figure 1.2. Electron micrographs of ASFV viral factories. ASFV 
factories contain fully assembled particles, which appear as electron- 
dense hexagons (white arrow). They also contain membrane-like 
structures (black arrow) and assembly intermediates (red arrow). The 
image has been kindly provided by Paul Monaghan, lAH, Pirbright, 
UK. Scale bar, 500 nm.
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Figure 1.3. The ASF virion. An electron micrograph of an ASF virion 
is shown and overlayed with features highlighting the various 
structural components of the fully assembled viral particles. Particles 
are composed of an electron-dense central layer that represents the 
DNA-containing nucleoid. The viral DNA is surrounded by a thick 
protein layer, the core shell or matrix. The eore is encased in a double 
inner lipid envelope and an icosahedral capsid. Extracellular virions 
are enveloped by an outer membrane derived from the plasma 
membrane. The localisations of the main structural proteins are 
indieated.
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Immuno-electron microscopy and subcellular fractionation have suggested 
that the membranes present in ASFV factories originate from the endoplasmic 
reticulum (ER) (Andres et ah, 1998; Rouiller et ah, 1998). The recruitment of these 
ER-derived membranes into viral factories might involve microtubules and the 
ASFV membrane protein pJ13L (Heath et ah, 2001; Rodriguez et ah, 2004). The 
membranes of assembly intermediates are in continuity with these cellular 
membranes, suggesting that these membranes may serve as a scaffold for particle 
assembly. Loop structures are detectable at the ends of open intermediate 
membranes, demonstrating that ASFV inner double envelope derived from cisternal 
structures and not from single-layered membranes.
ASFV assembly is initiated by the recruitment of the major capsid protein 
p73 to one face of the ER cistemae (Cobbold et ah, 1996). Within 120 minutes of 
synthesis, 50% of the cytosolic pool of p73 accumulates on ER membranes as large 
complexes (Cobbold and Wileman, 1998). Interactions between p73 and other viral 
proteins targeted to the ER membranes may trigger the bending of the membrane, 
producing an ordered series of one- to six-sided structural intermediates and 
eventually icosahedral particles (Andres et ah, 1998; Rouiller et ah, 1998). At the 
same time, the core shell assembles underneath the concave face of the cistemae. 
Before the particle is closing, viral DNA and nucleoproteins are engulfed and 
condensed into particles (Andres et ah, 1997).
About ten proteins participate in virion stmcture (Carrascosa et ah, 1985). 
Two proteins with demonstrated DNA binding capacity are thought to be located in 
the nucleoid: p5AR and pK78R (Borca et ah, 1996; Munoz et ah, 1993). The inner 
core shell or matrix is composed of six proteins that are generated by the cleavage of
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the polyproteins p220 and pp62. pp220 cleavage produces p i50, p37, p34 and pl4 
(Simon-Mateo et ah, 1993). pp62 gives rise to pl5 and p35 (Simon-Mateo et ah,
1997). pp220 and pp62 cleavage products represent 25% of the total protein mass of 
the viral particle (Andres et ah, 2002b). Both polyproteins are expressed late in 
infection and are post-translationally processed by the viral cysteine proteinase 
pS273R (Andres et ah, 2001a). pJ13L, also called p54, is a transmembrane protein 
that localises on the inner membrane (Brookes et ah, 1998). The capsid is mainly 
composed of protein p73 (see below), which amounts to one third of the virus protein 
mass (Garcia-Escudero et ah, 1998). pE120R localises at the surface of intracellular 
virions and interacts with the main capsid protein p73 (Andres et ah, 2001b). Two 
proteins each possessing a transmembrane region are thought to localise in the outer 
envelope of the extracellular virion: p22 and p l2  (Yanez et ah, 1995). The locations 
of these proteins are shown in figure 1.3.
1.1.4.5.1 Structural protein d73
The B646L gene product is a protein with a predicted molecular mass of 73 
kDa, named p73. p73 is the main ASFV capsid protein and shares some sequence 
similarities with the major capsid protein of iridoviruses (Iyer et ah, 2001; Lopez- 
Otin et ah, 1990). p73 undergoes a rapid conformational change very soon after 
synthesis. A specialised chaperone, encoded by ASFV and named capsid associated 
protein 80 (CAP80), facilitates p73 folding by masking domains susceptible to 
aggregation (Cobbold et ah, 2001). CAP80 transiently associates with newly- 
synthesised unfolded p73 and dissociates before the conformationally mature p73 is 
assembled into virions.
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1.1.4.5.2 Structural protein pJl 3L
The J13L gene encodes a 183 amino-acid protein with a putative 
transmembrane domain close to its N terminus (Sun et al., 1995). pJ13L is a late 
protein, which size varies between 24 and 28 kDa in different virus isolates 
(Rodriguez et al., 1996a). This heterogeneity in size is explained by the variability of 
the number of repeats of a 15 nucleotide-long sequence (Rodriguez et al, 1994). 
Immuno-electron microscopy has shown that pJ13L localises on the ER-derived 
membranous structures within the virus factory, as well as in both intra- and extra­
cellular particles (Brookes et al., 1998; Rodriguez et al., 1994). Consistent with this, 
pJ13L has been shown to target ER membranes when expressed by transfection 
(Rodriguez et al., 2004). Inactivation of the J13L gene arrests virus morphogenesis at 
an early stage (Rodriguez et al., 2004). pJ13L has also been identified as a direct 
binding partner of the light chain of the microtubule motor dynein (Alonso et al., 
2001). Taken together, these studies suggest that pJ13L mediates the transport of ER 
cistemae to assembly sites, along microtubules via binding to cytoplasmic dynein 
(Rodriguez et al., 2004).
1.1.4.5.3 Stmctural protein p5AR
p5AR (also called pA104R) is a late protein that associates with the virion 
nucleoid (Borca et al., 1996). p5AR binds in vitro to both single and double stranded 
DNA in an apparently sequence independent fashion. The amino-acid sequence of 
5AR between residues 55 to 76 matches the sequence signature pattem for the family 
of bacterial histone-like proteins (Neilan et a l, 1993b). Histone-like proteins are 
small DNA-binding proteins involved in DNA packaging. They also affect 
transcription rates, site-specific recombination and initiation of DNA replication
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(Drlica and Rouviere-Yaniv, 1987). p5AR might therefore be involved in virion 
DNA packaging or in regulation of viral gene expression (Neilan et al., 1993b).
1.1.4.5.4 Structural protein pE120R
The E120R gene product is a protein of predicted molecular mass of 13.6 
kDa, named pE120R. pE120R is expressed as different molecular weight forms late 
after infection (Andres et al., 2001b; Martinez-Pomares et al., 1997). The protein 
lacks significant similarities with other proteins (Yanez et al., 1995). Early work 
showed that pE120R binds DNA in vitro, suggesting a potential role in DNA 
replication or assembly of the nucleoid core (Martinez-Pomares et al., 1997). 
However, by using a recombinant ASFV in which E120R gene expression was 
regulated by the E. coli lac repressor-operator system, it was demonstrated that 
pE120R plays a role in ASFV dissemination from assembly sites to the cell periphery 
(Andres et al., 2001b). When pE120R expression was reduced, ASFV particles 
assembled normally but were confined in assembly sites (Andres et al., 2001b). 
Consistent with its role in ASFV transport, pE120R localises at the surface of 
intracellular virions and interacts with the main capsid protein p73 (Andres et a l, 
2001b).
1.1.4.6 Release
Virions acquire their outer envelope by budding through the plasma 
membrane (Arzuza et a l, 1992). Their release gives rise to infectious extracellular 
enveloped particles.
The mechanisms by which ASFV reaches the plasma membrane from its site 
of assembly are unknown. Considering the evolutionary link between ASFV and
30
poxviruses (Iyer et al., 2001), and the fact that they both assemble in perinuclear 
factories, they might use similar mechanisms to traverse the cytoplasm towards the 
plasma membrane. The well-characterised poxvirus vaccinia virus (W )  uses 
microtubules to exit viral factories and reach the cell surface (Hollinshead et al., 
2001; Rietdorf et al., 2001; Sanderson et a l, 2000; Ward and Moss, 2001). Once 
delivered to the plasma membrane, W  exploits actin polymerisation to be propelled 
away from infected cells (Rietdorf et a l, 2001). It is possible that ASFV could also 
use cytoskeleton elements for transportation to the cell periphery. The focus of my 
PhD thesis is to understand the mechanisms used by ASFV to travel from assembly 
sites to the cell periphery, and an overview of the cytoskeleton network therefore 
follows. Consistent with a role of microtubules during ASFV egress, early studies 
have shown that ASFV particles associate in vitro with microtubules (de Matos and 
Carvalho, 1993).
1.2 An overview of the cytoskeleton network and intracellular 
transport
Intracellular transport in eukaryotic cells is dependent on two types of 
motility system, one based on microtubules and the other one on actin filaments. 
Microtubules and actin filaments are polar dynamic structures: one end is capable of 
rapid growth (the plus end) while the other end (the minus end) tends to lose subunits 
if not stabilised. Microtubules provide an extensive polarised network throughout the 
cytoplasm while actin filaments are most highly concentrated in the cell cortex 
underneath the plasma membrane. The microtubule network is thought to be used for
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long-range transport of cellular components whereas the actin network is proposed to 
be used for short-range transport (Langford, 1995). Molecular motors carry cargoes 
directionally along these cytoskeleton tracks (Vale, 2003).
1.2.1 The microtubule network
Microtubules are essential for the movement of cellular organelles in the 
cytoplasm during interphase and for chromosome segregation during cell division. 
To perform these specific fonctions, a cell must control the assembly and orientation 
of its microtubule cytoskeleton (Kirschner and Mitchison, 1986). Microtubules 
assemble by polymerisation of oc/p-tubulin heterodimer. Tubulin is a GTPase and the 
energy that drives microtubule assembly comes from GTP hydrolysis. The head to 
tail association of a/p-tubulin heterodimers results in linear protofilaments. Within 
the microtubule, 13 protofilaments associate laterally to form a cylindrical structure 
that measures 25 nm in diameter (Nogales, 2000). The uniform orientation of tubulin 
heterodimers in the microtubule lattice confers a polarity that is crucial in the 
functions of the microtubule cytoskeleton. a/p-tubulin heterodimers add more 
rapidly to the plus end than to the minus end, which is stabilised in a perinuclear 
organising centre. This organising centre, known as the centrosome in animal cells, is 
able to nucleate and organise micro tubules (Dammermann et a l, 2003; Zimmerman 
et a l, 1999). The centrosome, typically located in one side of the nucleus in 
interphase, is formed by a matrix of filaments made of several a-helical coiled-coil 
proteins, such as pericentrin, together with hundreds of ring shaped structures 
containing another isoform of tubulin, y-tubulin (Zimmerman et a l, 1999). Each y- 
tubulin ring serves as nucléation site for the growth of one microtubule filament.
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Functional abrogation or depletion of y-tubulin or pericentrin disrupts centrosome 
assembly and creates structural defect in microtubule asters (Zimmerman et a l,
1999). After nucléation, microtubules grow out with their plus ends leading in the 
cytoplasm. Thus, the distribution of the microtubule cytoskeleton is largely 
determined by the location of the centrosome.
Cells can re-arrange the distribution of microtubules by regulating 
microtubule stability. During the polymerisation of microtubules, the plus end 
switches between phases of slow growth and rapid shrinkage (Sammak and Borisy, 
1988). This behaviour is called dynamic instability and is regulated by microtubule- 
binding proteins (Howard and Hyman, 2003; Kinoshita et a l, 2002). These include 
microtubule associated proteins (MAPs), which bind all along the microtubule 
lattice. MAPs increase the growth rate and prevent microtubules shrinkage. Little is 
known about their mechanisms of action. Other microtubule-binding proteins, such 
as CLIP-70, specifically target microtubule plus-end and act as microtubule capping 
proteins (Diamantopoulos et a l, 1999; Perez et a l, 1999).
1.2.2 Actin filaments
The actin cytoskeleton is the supportive framework of the three-dimensional 
structure of eukaryotic cells. It provides the forces that enable the cell to adopt a 
variety of shapes and to undertake directed movements. The actin network is assisted 
in its functions by a large number of proteins known as actin binding proteins or 
actin associated proteins.
Actin exists in two forms, monomeric (G-actin), which is soluble in the 
cytosol and filamentous (F-actin). Filamentous refers to thin, flexible, helically 
arranged polymers of actin that may be up to hundreds of micrometers in length.
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Assembly is such that actin filaments are asymmetric, with 2 structurally distinct 
ends. ATP-bound monomers polymerise onto the plus end (barbed end) of the 
filament at up to 10 times the rate at which they polymerise onto the minus end 
(pointed end). A large pool of filamentous actin is in dynamic equilibrium with the 
pool of monomeric actin. The pool of monomeric actin is largely sequestered by 
actin monomer-binding proteins, principally thymosin and profilin. Addition or 
dissociation of monomers from filaments can be blocked by proteins that bind 
specifically to a filament end (capping proteins). Filaments can be broken into 
shorter ones by severing proteins. Thus, modulation of actin monomer-binding 
proteins, capping proteins and severing proteins enables the cell to regulate the rate 
of actin assembly or dissociation in localised regions of the cell (Condeelis, 2001).
Arp2/3 is a seven-protein complex that, when activated, nucleates de novo 
actin polymerisation. Arp2/3 is activated by the Wiskott-Aldrich syndrome protein 
(WASP) family complex, which consists of haematopoietic cell-specific WASP, 
ubiquitous neuronal WASP (N-WASP) and three Scar/WAVE family proteins. 
WASP proteins serve a scaffolding fiinction to bring together actin monomers and 
Arp2/3 to form a nucléation core (Gruenheid and Finlay, 2003). N-WASP exists in 
an auto-inhibited conformation, but is activated by the binding of a variety of 
proteins that relieve the auto-inhibition or serve an accessory function to increase the 
rate of actin polymerisation by Arp2/3. These include Cdc42, profilin, some tyrosine 
kinases, Nckl, Grb2, WASP-interacting protein (WIP) and calmodulin (Condeelis, 
2001).
Mammalian cells have the capacity to form several types of cell extensions 
that are dependent on de novo actin polymerisation. These extensions are mediated 
by local re-arrangements of the actin cytoskeleton in the cell cortex, the region just
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beneath the plasma membrane. Lamellipodia are sheet-like extensions and filopodia 
are long thin extensions of the cortex and plasma membrane (Condeelis et al., 2001). 
Formation of these extensions are regulated by a complex set of signalling pathways 
involving the small GTPases Cdc42 and Rac (Condeelis, 2001).
1.2.3 Motor proteins
Movements along microtubules and actin filaments are powered by motor 
proteins that must recognise their respective cargoes in order to function (Karcher et 
al., 2002). There are three motor protein superfamilies: kinesin motors transport 
cargo toward the microtubule plus end, cytoplasmic dynein transports cargo toward 
the microtubule minus end and myosin motors convey cargo along actin filaments. 
Structurally, motor proteins consist of two functional parts: a motor domain that 
reversibly binds to the cytoskeleton and converts chemical energy into motion, and 
the rest of the molecule, referred as the tail, that often interacts with cargoes (Vale, 
2003).
1.2.3.1 Cvtoplasmic dvnein
Movement along microtubules to the cell interior (retrograde transport) 
requires the motor cytoplasmic dynein (Vale, 2003). Cytoplasmic dynein was 
discovered in 1987 (Paschal et al., 1987). It is a massive multisubunits complex 
composed of four light intermediate chains, two intermediate chains, two road block 
light chains, two Tctexl light chains, the LC8 light chain and two heavy chains 
(Hirokawa, 1998). The N-terminal region of the heavy chain is thought to be the 
cargo-binding site. The intermediate chains function as a scaffold in the complex, as 
it binds simultaneously to the heavy-chain as well as to the 3 light chain classes and
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to the p i s u b u n i t  of dynactin. Dynein is associated with the protein complex 
dynactin that contains 10 subunits: plSO®'^ ®^ ,^ pl35^^^® ,^ p62, dynamitin (p50), actin- 
related protein 1 (Arpl), actin, actin capping protein a-subunit, actin capping protein 
p-subunit, p27 and p24. A schematic representation of cytoplasmic dynein and 
dynactin complex is given in figure 1.4. Overexpression of the dynamitin/p50 
subunit of dynactin disrupts the dynactin complex and impairs dynein-related 
functions (Echeverri et al., 1996). Dynactin may link dynein to different cargoes and 
could play a regulatory role in dynein-based transport (Vale, 2003).
Dynein has been reported to carry membranous cargoes such as Golgi- 
derived membranes, late endosomes and lysosomes toward the minus-end of 
microtubules. In addition to membrane compartments, cytoplasmic dynein also 
moves microtubule filaments and centrosomal proteins. Cytoplasmic dynein also 
positions the nucleus and changes the form of the mitotic spindle (Vale, 2003).
1.2.3.2 Conventional kinesin
The long-range movement of cellular materials along microtubules, from the 
centrosome towards the cell surface (anterograde transport), involves the kinesin 
family of motor proteins (Vale, 2003). Conventional kinesin (also called kinesin I or 
KIF5) was the first microtubule-based motor to be discovered (Brady, 1985; Vale et 
al., 1985). The kinesin superfamily counts now more than 45 members, containing 
three major classes according the position of the motor domain: N-type, middle-type 
and C-type (Hirokawa, 1998).
Conventional kinesin has been reported to convey membranous cargoes such 
as mitochondria, lysosomes, ER-derived membranes and non-membranous cargoes 
such as mRNA and intermediate filaments (Vale, 2003). Conventional kinesin
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consists of two 120kD heavy chains (KHCs) and two 64kD light chains (KLCs) 
(Vale et ah, 1985). The N-terminal domain of KHC contains the motor polypeptide 
that binds to microtubules. The C-terminal domain of KLC consists of 6 
tetratricopeptide (TPR) motifs (Gindhart and Goldstein, 1996). The TPR motif is a 
protein-protein interaction module found in multiple copies in a number of 
functionally different proteins (Lamb et al., 1995). A schematic representation of 
conventional kinesin is given in figure 1.5.
Both the C-terminal tail domain of KHC and the TPR domain of the KLC 
appeared to mediate cargo interactions (Vale, 2003). Interaction between 
conventional kinesin and cargoes are thought to occur via linker molecules. Kinectin, 
an ER integral membrane protein, was described as the kinesin universal receptor 
(Kumar et al., 1995), however, its restricted cellular and phylogenetic distributions 
have ruled out this hypothesis (Hollenbeck, 2001). MAP kinase scaffolding proteins 
(Bowman et al., 2000; Byrd et al., 2001; Verhey et al., 2001) and the amyloid 
precursor protein (Kamal et al., 2000) have also been proposed to mediate axonal 
kinesin-dependent transport. These proteins interact with the TPR domain of KLC 
(Bowman et ah, 2000; Kamal et al., 2000), whereas kinectin binds directly to the 
KHC (Ong et al., 2000).
The mechanisms involved in the regulation of kinesin-based transport are not 
well understood. It has been proposed that a transition from the folded into an 
extended conformation would activate the motor (Hackney et al., 1992). Chaperone 
binding would be involved in this process (Tsai et al., 2000). It is also possible that 
binding of kinesin to its cargo is the trigger for activation (Verhey et al., 1998). 
Phosphorylation of the light or/and the heavy chain could also be involved in 
activation (Hollenbeck, 1993; Lee and Hollenbeck, 1995). These levels of regulation
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are not exclusive to each other and, on the contrary, they could tune further the 
activity of kinesin (Verhey and Rapoport, 2001).
1.2.3.3 Unconventional mvosins
In addition to the well-characterised myosin II of muscle and non-muscle 
cells (conventional myosin), at least 18 structural classes of myosin have been 
identified (Karcher et al., 2002). The classes are based on sequence comparison of 
their conserved motor domain. The myosin heavy chain consists of an N-terminal 
ATP and actin-binding motor domain. This motor domain is linked to a C-terminal 
tail via a neck domain that serves as the binding site for myosin light chain. This 
light chain, which is the same LC8 light chain that is found in cytoplasmic dynein, 
may have a structural role (Vale, 2003). The tail domain is thought to direct the 
interaction with the cargo (Mermall et al., 1998).
Class V myosins are one of the most ancient and widely distributed groups of 
the myosin superfamily and have been shown to be involved in the transport of 
membranous cargo, such as secretory vesicles and pigment organelles 
(melanosomes) (Cheney and Rodriguez, 2001). Three myosin Vs (Va, Vb and Vc), 
which exhibit different tissue distributions, have been described.
Unconventional myosin VI associates with both the Golgi complex and the 
leading, ruffling edge of the cell (Buss et al., 1998). Myosin VI may therefore play a 
role in membrane vesicular traffic from the Golgi to the leading edge of the cell 
(Buss et al., 2002). Since antibody inhibition of myosin VI results in re-organisation 
of the cortical actin cytoskeleton, the motor could also be involved in cell motility. 
Myosin VI is the only minus-end directed actin motor known (Wells et al., 1999).
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530-kD cytoplasmic dynein heavy chain
74‘kO intermediate chain ^
55“kD tight intermediate chain
Dynamitin
Capping protein - Spectrin
Arp1, Actin
(H irokaw a, 1998)
Figure 1.4. Schematic representation of cytoplasmic dynein and 
dynactin complex. Dynein is a massive multisubunits eomplex 
composed of four light intermediate chains, two intermediate chains, 
two road block light chains, two Tctexl light chains, the LC8 light 
chain and two heavy chains (the light chains are not represented here). 
The N-terminal region of the heavy chain is thought to be the cargo- 
binding site. The intermediate chains function as a scaffold in the 
complex, as it binds simultaneously to the heavy-chain as well as to the 
3 light chain classes and to the pi subunit of dynactin. Dynein is
associated with the protein eomplex dynactin that contains 10 subunits 
including: plSO*^ ^^ ®^ , p i35^ ^^ ®^^, p62, dynamitin (p50), actin-related 
protein 1 (Arpl), actin, actin capping protein a-subunit and actin 
capping protein P-subunit. Cytoplasmic dynein is linked with cargo 
membranes indirectly through a putative interaction among membrane 
receptor, ankryin, spectrin, Arpl, dynamitin and the 74 kDa 
intermediate chain (Hirokawa, 1998).
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Catâiylic motor domain
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(Verhey and Rappoport, 2001)
Figure 1.5. Domain structure of conventional kinesin. Kinesin heavy 
chain (KHC, red) contains the catalytic motor domain, the neck linker and 
neck domains, the coil 1 and coil 2 regions of the stalk domain, and the 
coiled and globular regions of the tail domain. Kinesin light chain (KLC, 
blue) contains an a-hclical hcptad repeat region and six tetratricopeptide 
repeat (TPR) motifs (Verhey and Rappoport, 2001).
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Myosin X is a recently discovered myosin that is widely distributed in 
vertebrate tissues, but is present at relatively low levels (Berg ct ah, 2000). Myosin X 
is enriched at the tip of filopodia and other actin rich protrusions (Berg ct ah, 2000). 
GFP-taggcd myosin X undergoes forward and backward movements within filopodia 
and would then mediate intrafilopodial movements (Berg and Cheney, 2002). The 
cargoes of myosin X are still unknown.
1.3 Viral transport and motor proteins
Viral assembly and replication often take place in specialised structures, 
called viral inclusions or virus factories, located in the nucleus or in the perinuclear 
cytoplasm. Recent work has focussed on understanding how viruses travel to, and 
from, these specialised sites during infection. The size of virus particles, which can 
be as large as 200 nm, is such that they are unlikely to move in the viscous cytoplasm 
by diffusion alone. For instance, a herpesvirus capsid would require 231 years to 
diffuse 10 mm in the axonal cytoplasm (Sodeik, 2000). Furthermore, random 
diffusion could not provide specific directional movement. The simplest method for 
a virus to achieve directional movement is to use the normal cellular transport 
systems associated with the actin or mierotubule cytoskeleton (Ploubidou and Way, 
2001).
1.3.1 Use of microtubule-based transport for movement of viruses in the cell
One common viral strategy uses microtubules for directed long-range 
transport of virus components inside cells (Ploubidou and Way, 2001; Smith and
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Enquist, 2002; Sodeik, 2000). Support for this assertion comes from several 
experiments. First, mierotubule-destabilising drugs reduce retrograde and 
anterograde transport of many unrelated viruses, such as herpes simplex virus type 1 
(HSV-1), human adenovirus C type 2 and 5 (Ad2 and Ad5), murine polyomavirus 
and canine parvovirus (CPV) (Gilbert et al., 2003; Mabit et al., 2002; Suikkanen et 
al., 2003; Suomalainen et al., 1999). Second, electron microscopy studies have 
revealed association of viruses, such as parvovirus and ASFV, with microtubules in 
vitro (de Matos and Carvalho, 1993; Suikkanen et al., 2003). Finally, GFP-taggcd 
recombinant viruses, such as W  and human immunodeficiency virus type-1 (HIV-1) 
have been successfully used to image virus moving along microtubules in living cells 
(Carter et al., 2003; Hollinshead et al., 2001; McDonald et al., 2002; Rietdorf et al., 
2001).
Introduction of dominant-negative proteins or overexpression of proteins that 
impair motor function have revealed that microtubule-based transport of viruses 
require motor proteins.
1.3.1.1 Use of dvnein-based transport for movement of viral components along 
microtubules
Overexpression of the dynactin subunit p50/dynamitin blocks retrograde 
transport of several unrelated viruses such as W ,  HSV-1, Ad2, ASFV and HIV-1 
(Alonso et al., 2001; Heath et al., 2001; Mabit et al., 2002; McDonald et al., 2002; 
Ploubidou et al., 2000). These observations suggest that these viruses use 
cytoplasmic dynein to be delivered in a retrograde manner to their replication sites. 
Consistent with this, immunoelectron microscopy showed that incoming HSV-1 
particles co-localise with cytoplasmic dynein heavy chain and dynactin in vivo
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(Dohner et a l, 2002; Sodeik et a l, 1997). GFP-tagged HSV-1 eapsids move at 2.2 
jim/sec in the retrograde direction (Bearer et a l, 2000) and this rate is comparable to 
dynein-based motility of endogenous organelles.
A few viral proteins have been shown to interact with components of the 
dynein complex in vitro. Yeast two-hybrid assays have revealed interactions between 
the dynein light chain LC8 and ASFV envelope protein pJ13L and with the P 
phosphoprotein of two lyssaviruses (Alonso et a l, 2001; Jacob et a l, 2000; Raux et 
a l, 2000). Co-precipitation experiments have shown that the UL34 protein of HSV- 
1, which is associated with incoming capsids, interacts with the intermediate chain of 
dynein (Ye et a l, 2000). To study the interaction between the dynein light chain LC8 
and numerous viral proteins in vitro, a library of viral polypeptides was synthesised 
on a cellulose membrane (pepscan technique) and incubated with purified LC8 
(Martinez-Moreno et a l, 2003). The strong binding of the adenovirus protease, HSV- 
1 proteins UL9 and U19, W  polymerase, human papillomavirus E4 protein, yam 
mosaic virus polyprotein, human respiratory syncytial virus attachment glycoprotein, 
human coxsackievirus capsid protein A3 and the AMV179 protein of an insect 
poxvirus to LC8 have been demonstrated this way. However, it needs to be 
established that these in vitro interactions are relevant in vivo for retrograde transport 
of viruses or viral components.
Cytoplasmic viral assembly sites become dispersed in cells over-expressing 
p50/dynamitin, suggesting that the maintenance of virus factories is also dynein- 
dependent. Examples include assembly sites induced by W ,  ASFV, Mason-Pfizer 
monkey virus and mammalian reoviruses (Heath et a l, 2001; Parker et a l, 2002; 
Ploubidou et a l, 2000; Sfakianos et a l, 2003). Exploitation of the microtubular
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motor dynein is then used by numerous viruses to reach and/or maintain sites 
favoured for replication and assembly.
1.3.1.2 Use of kinesin-based transport for movement of viruses along microtubules 
A link between members of the kinesin family and the intraeellular 
movement of HSV-1, W  and retroviruses has been revealed recently.
Conventional kinesin heavy chain has been located to the surface of 
unenveloped HSV-1 by immunogold electron microscopy in chick neurones 
(Diefenbach et al., 2002). Consistent with these findings, HSV-1 tegument protein 
US 11 interaction with conventional kinesin heavy chain have been demonstrated in 
vitro (Diefenbach et al., 2002). US 11 also interacts with the light chain of the 
kinesin-related protein PATl (Benboudjema et al., 2003). It would be interesting to 
learn if both these interactions are relevant for HSV-1 anterograde transport.
After envelopment by Golgi-derived membranes (Schmelz et al., 1994), the 
intracellular enveloped virions (lEV) of W  associate with conventional kinesin 
(Rietdorf et al., 2001). By blocking kinesin activity using a dominant negative 
strategy, it has been demonstrated that conventional kinesin is required for the 
transport of lEV particles to the cell surface along microtubules (Rietdorf et al., 
2001). The lEV membrane protein A36R is responsible for the motor recruitment to 
viral particles by interacting directly with kinesin light chain (Ward and Moss, 2004).
Y east-two-hybrids screening has shown that the Gag protein of murine 
leukaemia virus, Mason-Pfizer virus, simian immunodeficiency virus and HIV-1 
associate with the C terminus of unconventional kinesin KIF4 (Tang et al., 1999). 
KIF4 could then mediate the transport of retroviral Gag proteins to viral assembly 
sites located at the plasma membrane.
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1.3.1.3 Regulation of directed transport of viruses along microtubules
GFP-tagged individual pseudorabies virus (PRV) and Ad2 particles often 
reverse direction during their transport, suggesting that plus-end and minus-end 
directed motors are associated with individual particles simultaneously (Smith et al., 
2001; Suomalainen et al., 1999). This bi-directionality must require some form of 
regulation. For Ad2, the relative contribution of anterograde and retrograde transport 
on microtubules is regulated via viral activation of host-signalling pathways 
(Suomalainen et a l, 2001). A eAMP-dependent protein kinase (PKA) is activated 
after Ad2 entry and enhances, by an unknown mechanism, retrograde movement of 
the capsid. Inactivation of PKA with any of several inhibitors results in net capsid 
transport in the anterograde direction (Suomalainen et a l, 2001). HSV-1 and PRV 
transport in sensory axons is optimised for fast retrograde transport during entry and 
faster anterograde transport during egress (Bearer et a l, 2000; Smith et a l, 2001). 
Unlike adenoviruses, HSV-1 encodes two serine/threonine protein kinases, UL13 and 
US3. Phosphorylation of viral proteins by UL13 and US3 causes them to detach from 
the capsid core and these dissociation could play a role in the regulation of 
herpesvirus transport (Smith and Enquist, 2002).
1.3.2 Use of actin-based transport for movement of viruses in the cell
Numerous viruses interact with actin at various stage of their life cycle, both 
disrupting and re-arranging the actin network to their own advantage (Cudmore et 
a l, 1997). Early in infection, actin polymerisation is used by some viruses, such as 
Ad2, HIV-1 and simian virus 40, to promote their internalisation by endocytosis
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(Iyengar et al., 1998; Li et al., 1998; Pelkmans et al., 2002). At late stage of 
infection, W  uses actin polymerisation at the plasma membrane for its cell-to-cell 
spread (Hollinshead et al., 2001; Rietdorf et al., 2001; Ward and Moss, 2001). 
Particles are found at the tip of so-called actin tails that protrude from the eell surface 
(Cudmore et al., 1995). W  recruits a complex of cellular adaptor proteins that 
promote aetin polymerisation underneath the viral particle (see section 1.3.3.3). 
Similarly, actin-containing projections are formed at the surface of cells infected 
with FV3, HSV-1, human respiratory syncytial virus and murine mammary tumour 
virus (Damsky et al., 1977; Krempien et al., 1984; Mortara and Koch, 1986; Murti et 
al., 1985; Ulloa et al., 1998). It would be interesting to see if these viruses also use 
actin polymerisation to spread efficiently from cell-to-cell and if mierotubule-based 
motility is used to first reach the plasma membrane. Taken together, these 
observations suggest that actin polymerisation could be used by viruses at the edge of 
infected cells, both during entry to facilitate endoeytosis-mediated transport and 
during egress to enhance cell-to-cell spread.
It is not excluded that some viruses use actin polymerisation to promote their 
intracytoplasmic transport. This seems to be the case for the baculovirus Autographa 
californica M nuclear polyhedrosis virus (AcMNPV), which might induce actin 
polymerisation to enhance its transport from the cell periphery to nuclear assembly 
sites. Following entry, thick actin cables, stretching from the plasma membrane to 
the nucleus, appear in the cytoplasm of AcMNPV infected eells. Single 
nucleocapsids are loealised at the tip of these aetin cables (Charlton and Volkman, 
1993).
Non-musele myosin II has been reported to play a role in both HSV-1 egress 
and HIV-1 release (Sasaki et al., 1995; van Leeuwen et al., 2002). HSV-1 infection
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re-organises the distribution of myosin II, inducing its accumulation into viral 
assembly sites (van Leeuwen et al., 2002). In vitro analyses have revealed an 
interaction between HSV-1 tegument protein Vp22 and myosin II. Release of HSV-1 
into the extracellular medium was inhibited by the drug butanedione monoxime, 
which inhibits myosin activity (van Leeuwen et al., 2002). Co-localisation of myosin 
II with HIV-1 particles at the plasma membrane has been shown by 
immunofluorescence analyses (Sasaki et al., 1995). Moreover, an inhibitor of myosin 
light chain kinase, for which myosin II is the only downstream effector known, 
blocks HIV budding (Sasaki et al., 1995). Taken together, these studies suggest that 
myosin II is involved in HSV-1 and HIV-1 egress. However, it needs to be 
demonstrated first, that HSV-1 and HIV-1 are transported along actin filaments and 
second, that myosin II plays a direct role in this transport.
1.3.3 Vaceinia virus transport: a well characterised example
The most extensively documented example of intraeellular transport of 
viruses comes from studies on W .  W  is the prototype of the Poxviridae, whieh 
comprises a large group of enveloped double-stranded DNA viruses that replicate 
and assemble in the cytoplasm. W  has a complex morphogenesis (Smith et al., 
2003). Viruses begin their assembly at perinuclear viral factories, where the viral 
genome is replicated. Infectious intracellular mature virions (IMV) emerge from the 
factories and most of them stay in the cell until eell lysis (Smith et al., 2003). 
However, a subset of IMV is transported to the trans-Golgi network (TGN) where 
they gain an extra double membrane by wrapping (Sehmelz et al., 1994). These 
wrapped forms are called intracellular enveloped virions (lEV). lEV move then to
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the eell periphery, where their outer envelope fuses with the plasma membrane to 
produce eell-associated enveloped virions (CEV). If a CEV partiele becomes 
detached from the cell it is called extracellular enveloped virions (EEV) (Smith et al., 
2003). The morphogenic pathway of W  is illustrating in figure 1.6.
1.3.3.1 Retrograde transport of vaccinia virus along microtubules 
Microtubules are required for the retrograde transport of incoming W  cores
to the perinuclear assembly sites (Carter et al., 2003; Mallardo et al., 2001; 
Ploubidou et al., 2000). Video microscopy analyses have revealed that GFP-tagged 
W  cores co-localise with microtubules and move in a stop-start manner with an 
average speed of 51.8 jim/minute, consistent with microtubular movement (Carter et 
al., 2003). Overexpression of the dynactin subunit p50/dynamitin blocks retrograde 
transport of W ,  suggesting that this movement involve cytoplasmic dynein 
(Ploubidou et al., 2000). However, colocalisation of viral cores with a eomponent of 
the dynein complex has not been detected. The eore viral proteins L4R and AlOL 
bind microtubules in vitro and could therefore mediate viral retrograde movement 
(Ploubidou et al., 2000).
1.3.3.2 Anterograde transport of vaceinia virus along microtubules
The IMV form of W  leaves the virus factory and travels to the TGN where it 
acquires an extra double membrane (Schmelz et al., 1994). The movement of IMV 
from the factory to the TGN requires microtubules (Sanderson et al., 2000) but the 
nature of the mierotubule motor involved in this traffic is unknown. The partieipation 
of conventional kinesin is excluded here since IMV do not reeruit the motor 
(Rietdorf et a l, 2001). The viral protein A27L is involved in this movement because
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if expression of the A27L gene is repressed, IMV are not transported away from 
factories (Sanderson et a l, 2000).
After wrapping into TGN-derived membranes, the lEV particles are 
transported along mierotubules to the cell surface (Geada et a l, 2001; Hollinshead et 
a l, 2001; Rietdorf et a l, 2001; Ward and Moss, 2001). Video mieroseopy has 
revealed that lEV movement is saltatory and unidirectional (Geada et a l, 2001; 
Rietdorf et a l, 2001). Rates of movement are consistent with the mobility of kinesin 
motors, ranging from 1 to 4 jim/sec (Geada et a l, 2001; Hollinshead et a l, 2001; 
Rietdorf et a l, 2001; Ward and Moss, 2001). Additional immunofluoreseence studies 
have shown that lEV were labelled with antibodies against the light chain of 
conventional kinesin. Requirement of kinesin for movement of lEV from the TGN to 
the plasma membrane has been demonstrated using a dominant-negative strategy. 
Over-expression of the TPR domain of kinesin light chain, that can bind cargo but 
not the heavy-chain, inhibits the accumulation of lEV in the cell periphery (Rietdorf 
et a l, 2001). Two lEV proteins are involved in this movement: F12L and A36R. In 
the absence of F12L, lEV are formed but not transported to the eell surfaee (van Eijl 
et a l, 2002; Zhang et a l, 2000). The membrane protein A36R recruits conventional 
kinesin by a direct interaction with the TPR domain of the light chain (Ward and 
Moss, 2004). A36R also interacts with the lEV envelope protein A33R (Ward et al, 
2003) and the kinesin-binding domain of A36R overlaps with the A33R interaction 
site. The binding of A36R is mutually exclusive to either A33R or kinesin light 
chain, suggesting that A33R plays a regulatory role in the kinesin-based transport of 
lEV (Ward and Moss, 2004).
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1.3.3.3 Actin-based motility of vaccinia vims
At the cell surface, the outer membrane of the lEV fuses with the plasma 
membrane, resulting in the formation of CEV. Actin polymerisation occurs on the 
cytosolic face of the plasma membrane, directly beneath the CEV particle, and 
propels it away from the cell surface forming actin tails (Rietdorf et al., 2001; Ward 
and Moss, 2001).
The viral protein A36R is also involved in the formation of actin tails 
(Rietdorf et al., 2001; Rottger et al., 1999; Sanderson et al., 1998a; Wolffe et a l,
1998). The protein is tyrosine-phosphorylated by a Src-kinase family member and 
this forms a binding site for Nckl (Frischknecht et a l, 1999b). Recruitment of Nckl 
to vaccinia particles leads to subsequent recruitment and activation of N-WASP, 
which brings together Arp2/3 complex and an actin monomer to initiate actin 
polymerisation, directing the virus away from the plasma membrane (Moreau et a l,
2000). The adaptor protein Grb2 is also a component of the W  tail forming complex 
and acts in a cooperative manner with Nckl to stabilise the complex (Scaplehom et 
a l, 2002).
W  has then maximises the use of the host cytoskeleton by using 
microtubules for long-range directed movement and actin polymerisation at the 
plasma membrane for the final push into neighbouring cells (Hollinshead et a l, 
2001; Rietdorf et a l, 2001). The transition from microtubule transport to actin-based 
motility is regulated by tyrosine phosphorylation of protein A36R by cellular Scr 
kinase (Frischknecht et a l, 1999b). Scr-mediated phosphorylation of A36R occurs 
only at the plasma membrane and induces the dissociation of A36R with 
conventional kinesin.
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Figure 1.6. The morphogenic pathway of Vaccinia virus.
Different stages of W  egress ean be defined using 
inhibitors of IMV wrapping (IMCBH), actin (cytochalasin 
D) and mierotubule (nocodazole) polymerization, and Sre- 
family kinase (PPl). The A27L protein and microtubules 
are needed for the movement of IMV from the factory to 
site of wrapping. IMV wrapping to form lEV requires the 
B5R and F13L proteins. Movement of lEV to the cell 
surface requires microtubules and the F12L protein. Actin 
tail formation requires the A33R, A34R and A36R proteins 
and the phosphorylation of the A36R protein that can be 
inhibited by PPl. Release of CEV to form EEV is affected 
by the A33R, A34R and B5R proteins (Smith et al, 2003).
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1.4 Aims of the project
The aim of this project was to investigate the mechanism used by ASFV to 
reach the cell surface from perinuclear assembly sites.
The large 200 nm diameter of ASFV particles (Rouiller et al., 1998), coupled 
with the high viscosity of the cytoplasm, makes it unlikely that the virus will move 
by free diffusion. In common with other large viruses (Sodeik, 2000), ASFV 
transport is likely to be mediated by microtubules. Consistent with this, early studies 
have shown that up to 50% of ASFV virions bind to microtubules in vitro (de Matos 
and Carvalho, 1993). Therefore, this project attempted to determine whether 
microtubules are required for movement of ASFV from virus factories to the cell 
surface.
Within a few months of the project being started, it was established that the 
late ASFV protein pE120R was involved in ASFV movement from assembly sites to 
the cell surface (Andres et a l, 2001b). Investigating the role played by pE120R 
during ASFV spread form assembly sites was therefore planned.
Lastly, it was decided to examine whether ASFV particles would use the 
actin cytoskeleton to be transported at the edge of the cell, in a manner similar to W  
(Rietdorf et a l, 2001; Ward and Moss, 2001).
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2 MATERIALS AND METHODS
2.1 Media, buffers and solutions
Unless specified below all products were purchased from Sigma (USA) or 
BDH Chemicals (UK). All media were autoclaved or filter-sterilised before use. All 
solutions were prepared in sterile or distilled water unless otherwise stated.
2.1.1 Cell culture media
HEPBS-DMEM: N-2-hydroxyethylpiperazine-N-2-ethanesulphonic acid (HEPES) 
buffered Dulbecco’s Modified Eagle’s Medium (DMEM) containing 2 or 10% (v/v) 
foetal calf serum (PCS), 100 U/ml streptomycin, 100 U/ml penicillin and 20 mM L- 
glutamine.
RPMI: Roswell memorial park institute medium (RPMI) containing 2 or 10% (v/v) 
PCS, 100 u/ml streptomycin, 100 U/ml penicillin and 2 OmM L-glutamine. 
EDTA-trvpsin: 136 mM NaCl, 5.3 mM KCl, 5.5 mM NaHCOs, 0.02% (w/v) trypsin, 
0.01% (w/v) ethylenediaminetetraacetic acid (EDTA), and 0.1% (w/v) phenol red.
2.1.2 Bacterial culture media
Lauria Broth (LBl medium: 1% (w/v) tryptone, 0.5% (w/v) yeast extract, 0.5% (w/v) 
NaCl in dHiO.
Agar plates: 1.5% (w/v) Bacto agar (Oxoid N® 1) in LB medium.
Ampicillin resistance: 50 pg/ml ampicillin.
Tetracvcline resistance: 50 pg/ml tetracycline.
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2.1.3 Protein analysis buffers
2.1.3.1 Cell Ivsis buffers
lOOOX small proteases inhibitors (SPI): 1 mgml'^ leupeptine, 1 mgmf^ pepstatin, 1 
mgml'^ antipain, 1 mgml'^ chymostatin.
IPX immunoprécipitation Ivsis buffer (IPBl: 0.5 mM Tris, pH 7.5, 120 mM NaCl, 
0.5 mM EDTA, l%(v/v) Brij-35, 10 mM iodoacetimide, 1 mM 
phenylmethylsulphonyl fluoride (PMSF), 1 pgml'^ SPI, pH 7.9.
RIPA buffer: 1% (v/v) Nonidet-P-40, 2% (w/v) sodium dodecyl sulphate (SDS), 50 
mM Tris, pH 7.5,250 mM NaCl, 1 mM PMSF, 1 pgml'^ SPI, pH 7.9.
2.1.3.2 Sodium-dodecvlsulnhate nolvacrvlamide electrophoresis (SDS-PAGE )
2.1.3.2.1 Common SDS-PAGE system
4X resolving gel buffer: 1.5 M Tris, 0.4% SDS, pH 8.8
2X stacking buffer: 0.5 M Tris, 0.2% SDS, pH 6.8
lOX running buffer: 250 mM Tris, 2 M Glycine, 0.1% SDS, pH 8.3
5X sample preparation buffer (SPB): 25% (v/v) glycerol, 7.5% (w/v) SDS, 13.5%
(v/v) p-mercaptoethanol, 0.1% (w/v) bromophenol blue, 62.5 mM Tris pH 6.8.
Destain solution: 10% (v/v) methanol, 10% (v/v) glacial acetic acid.
Salicylate solution: 1 M sodium salicylate.
2.1.3.2.2 Tris-tricine SDS-PAGE system
lOX tris-tricine running buffer: 1 M Tris, IM Tricine, 0.1% (w/v) SDS.
IX gel buffer: 3 M Tris, 0.3% (w/v) SDS pH 8.45.
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2.1.3.3 Western blot buffers
Phosphate buffered saline (PBS): 1 OmM Na2HP0 4 , 150 mM NaCl, pH 7.5.
Tris buffered saline ITBSl: 150 mM NaCl, 20 mM Tris, pH 7.5.
Blocking buffer: 5% (w/v) skimmed milk powder, 0.1% (v/v) Tween-20 in PBS. 
Washing buffer: 0.1% (v/v) Tween-20 in PBS.
Blocking buffer for nhosphotvrosine antibody: 3% bovine serum albumin (BSA), 
0.1% (v/v) Tween-20 in TBS.
Washing buffer for phosphotvrosine antibodv: 0.1% (v/v) Tween-20 in TBS. 
Antibody incubation buffer: 10% (y/y) normal goat serum (NGS) in blocking buffer. 
Transfer buffer: 33% (y/y) methanol, 1/20 lOX running buffer in water.
2.1.4 Immunofluorescence microscopy buffers
Paraformaldehyde fixative: 4% (w/v) paraformaldehyde (PFA) in PBS, pH 7.5-8.0. 
PHEM: 60 mM PIPES, 25 mM HEPES, 10 mM EGTA, 1 mM MgCb.pH 7.4 
Blocking buffer: 0.1% (w/v) BSA in PBS.
Mouse block buffer: 2% (w/v) normal mouse serum in blocking buffer.
2.1.5 DNA manipulation buffers
2.1.5.1 Agarose gel DNA electrophoresis buffers
5OX TAE buffer: 2 M Tris-base, 5.5% (y/y) glacial acetic acid, 5OmM EDTA. 
Ethidium bromide solution: 1.5% (w/v) ethidium bromide in dH20.
2.1.5.2 Plasmid DNA preparation buffers
Suspension medium: 50 mM glucose, 25 mM Tris/HCl (pH 8.0), 10 mM EDTA.
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Lvsis buffer: 0.2 MNaOH, 1% (w/v) SDS.
Potassium acetate buffer: 3 M potassium acetate, 11% (v/v) acetic acid.
TE Buffer: 10 mM Tris-HCl, pH 8.0 and 1 mM EDTA, pH 8.0.
2.2 Cell lines and viruses
2.2.1 Cell lines
Vero African green monkey kidney cells (ECACC 84113001) and BHK TK- 
Syrian hamster kidney fibroblasts (ECACC 85011423) were obtained from the 
European Collection of Animal Cell Cultures (Porton Down, UK). Max cells are 
swine kidney cells that were obtained from the Federal Research Centre for Virus 
Diseases of Animals (Tübingen, Germany). BHK, Max and Vero cells were grown at 
37°C in HEPES-DMEM supplemented with 10% FCS.
Porcine aortic endothelial cells (PAEC) were isolated from swine aorta by 
Penelope Powell (lAH, Pirbright, UK) as described before (Vallee et a l, 2001). 
They were maintained on gelatine-coated flasks and cultured at 37°C in RPMI 
supplemented with 10% FCS.
2.2.2 Viruses
The attenuated tissue-culture adapted Badajoz 1971 (Ba71v) and Uganda 
strains of ASFV have been described previously (Carrascosa et a l, 1985; Detray, 
1963). Virulent ASFV Malawi Lil/20 was isolated from a domestic pig in Lilongwe, 
Malawi, in 1983 (Haresnape et al, 1984). The Malawi stock used in this study was 
prepared by Penelope Powell (lAH, Pirbright, UK) as described before (Vallee et a l, 
2001).
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Recombinant Vaccinia virus Ankara-T7 polymerase (MVA-T7) is an 
attenuated, host-range restricted, W  strain encoding the bacteriophage T7 RNA 
polymerase gene (Sutter et al., 1995). MVA-T7 and western reserve W  strains 
VTF7.3 (Fuerst et al., 1986) were obtained from Bernard Moss (National Institutes of 
Health, Bethesda, USA).
2.2.3 Virus infection protocols
2.2.3.1 Preparation of ASFV stock
Prior to infection, Vero or Max cells were washed in serum free medium. 
Appropriate inoculums of virus were added to a 175cm^ flask of cells. Vero cells 
were infected with the Ba71v strain of ASFV, and Max cells with the Uganda strain 
of ASFV. Cells were then incubated at 37°C until 100% cytopathic effect were 
observed, viruses were extracted by freeze-thawing at -70®C. Finally, cell debris was 
removed by centrifugation at 1500 g for 10 minutes and the virus containing 
supernatant was stored at 4®C or -70°C.
2.2.5.2 Titration of ASFV stock
Ten-fold serial dilutions of ASFV stocks were incubated with 80% confluent 
Vero or MAX cells in a 96 well plate for 16 hours (hrs) at 37°C. The supernatant was 
removed and the plate washed gently by flooding three times with PBS. Cells were 
then fixed with methanol at room temperature (RT) for 20 minutes and washed a 
further three times with PBS. Cells were blocked with 10% FCS in PBS for 20 
minutes at RT, followed by a final wash in PBS. Next, cells were incubated with 
monoclonal antibody 4H3 (anti-p73 capsid protein of ASFV) diluted in PBS
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containing 10% FCS (RT, 20 minutes). The plate was washed three times in PBS. 
Cells were then incubated with goat anti-mouse antibody conjugated to horseradish 
peroxidase (HRP), diluted 1/500 in 10% FCS in PBS for 20 minutes. The plate was 
washed three times in PBS and then incubated with substrate containing 0.4mg/ml 3- 
amino-9-ethylcarbazole and 0.1% hydrogen peroxide in 0.1 M acetate buffer, pH 5.2, 
(RT, 30 minutes). Finally, the plate was flooded with water and read under a light 
microscope. A red/brown precipitate was formed in infected cells, allowing the 
number of plaque/infection units in the original stock to be calculated. A typical 
Ba71v stock contained 5X10^ pfu/ml and a typical Malawi stock contained 2X10^ 
pfu/ml.
2.2.3.3 Preparation of Vaccinia virus stock
MVA-T7 or VTF7.3 strains of W  were added to a 175 cm^ flask of BHK 
cells and made up to a total volume of 7ml with DMBM-HEPES (with 2% FCS). 
Cells and viruses were incubated for 2-3 hrs at 2>TC and then a fiirther 13ml of 
DMEM-HEPES (with 2% FCS) was added. Cells were incubated for several days 
until they were dead or dying. Viruses were then extracted by freeze-thawing at -  
20°C, cell debris was removed by centrifugation at 1500 g for 10 minutes and the 
virus containing supernatant was then stored at -20°C.
2.2.3.4 Virus infection.
Cells were infected for 1 hour (h) at 37°C, then washed and the medium was 
replaced with DMEM containing 2% FCS. Infection was allowed to progress for the 
indicated time.
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2.3 Antibodies
2.3.1 Antibodies to viral proteins
SB2 and SBl 1 were generated by Sharon Brookes (lAH, Pirbright, UK). SB2 
was raised in rabbits to the synthetic peptide AKPARQGHNPATGBPI 
corresponding to amino acids 65-80 of p5AR, which is the sequence corresponding 
to the DNA binding motif of the ASFV protein (Neilan et al., 1993b). SB ll was 
raised in rabbits to the synthetic peptide NSPIQYLKEDSRDRTSIGSLEYDB 
corresponding to amino acids 5-27 of pE120R. Synthetic peptides were supplied by 
Seven Biotech LTd, UK. Mouse monoclonal antibody 4H3 recognises p73, the major 
capsid protein of ASFV. 4H3 was generated by Trevor White (lAH, Pirbright, UK) 
and has been previously described (Cobbold et al., 1996). The anti-pJ13L rabbit anti­
serum was also generated at Pirbright (Sun et al., 1995). C l8, the mouse monoclonal 
antibody specific for the ASFV early protein p30, was a gift from Dan Rock (Plum 
Island Animal Disease Centre, New York, USA)(Afonso et al., 1992). Biotinylated 
Cl 8 was generated at Pirbright by Mari-Clare McCrossan.
2.3.2 Antibodies to cellular proteins
Antibody 63-90, directed against the conventional kinesin light chain, was 
provided by Scott Brady (University of Texas, Dallas, USA)(Stenoien and Brady, 
1997). Monoclonal antibodies against y-tubulin (clone GTU-88), a-tubulin (clone B- 
5-1-2) and acetylated-a-tubulin (clone 6 -llB -l) were purchased from Sigma. 
Pericentrin was visualised with the PRB-432C antibody, purchased from Covance
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Research Product (USA). The mouse monoclonal antibody 1D3 recognises two ER 
luminal proteins: calreticulin and protein disulphide isomerase (Vaux et al., 1990).
2.3.3 Antibodies to common epitopes
The anti-V5 antibody was purchased from Invitrogen (USA). The mouse anti- 
GFP antibodies were purchased from Chemicon International (USA) and from BD 
bioscience (USA). Anti-phosphotyrosine antibody 4G10 was obtained from Upstate 
(USA).
2.3.4 Coniugated antibodies and dyes
Goat anti-mouse and anti-rabbit Alexa"^ ^^  (green), Alexa^ "^^  (red) and Marina 
blue (blue) conjugates were purchased from Molecular Probes (The Netherlands). 
Goat anti-rabbit and anti-mouse horseradish-peroxidase (HRP) conjugates were 
purchased from Promega (UK). 4 -6-diamidino-2-phenylindole (DAPI) was 
purchased from Sigma. Streptavidin^^" ,^ Phalloidin"^^  ^ and phalloidin^^"  ^ were 
purchased from Molecular Probes.
2.3.5 Antibodv purification
Antisera against p5AR and pE120R were purified using caprilic acid as 
previously described (Harlow and Lane, 1988). Two volumes of 60 mM sodium 
acetate buffer pH 4.0 were added to one volume of serum. 0.75 ml of caprilic acid 
per 10ml were dropped into the solution and stirred for 30 minutes at RT. The
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mixture was centrifuged at 5000g for 10 minutes. The supernatant was transferred to 
dialysis tubing and dialysed versus PBS overnight at 4°C.
2.4 Cell culture techniques
2.4.1 Transfection
Cells were grown to 70% confluency (either on 24 well plates or on Petri 
dishes) and were transiently transfected with a plasmid using a liposomal “Transfast” 
transfection system (Promega, UK). 1.6 pi of Transfast and 150pl of serum-free 
DMEM were mixed with Ipg of plasmid per well. The mixture was vortexed and left 
for 10 minutes at RT. In the meantime, cells were washed three times with serum- 
free DMEM. Cells were incubated with the transfection mixture at 37°C for one 
hour. Cells were then topped up with DMEM supplemented with 10% FCS.
For EL and T7 driven expression, cells were transfected 2 hrs prior to 
infection with ASFV or MVA-T7.
2.4.2 Drug treatments
In order to depolymerise microtubules, nocodazole (Sigma) was added into 
the culture medium to a final concentration of 10 pg/ml. To stabilise microtubules, 
paclitaxel (Sigma) was used at a final concentration of 10 pM. Nocodazole and 
paclitaxel were dissolved in dimethyl sulphoxide (DMSO). Cytochalasine-D 
(Calbiochem, USA) was used at a final concentration of lOmM to prevent actin 
polymerisation. To inhibit DNA replication, cells were incubated with cytosine a-D- 
arabinofuranoside (Ara-C) (Sigma) at a final concentration of 50 pg/ml at 1.5 hour
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post-infection (hpi). Brefeldin A (BFA) (Sigma) was used at a dilution of 10 pg/ml 
to block the transport of proteins from the BR to the Golgi (Lippincott-Schwartz et 
ak, 1989).
2.4.3 Microtubule nucléation assay
At 12 hpi, nocodazole was added to the culture medium to a final 
concentration of 10 pg/ml to depolymerise microtubules. At 16 hpi, the cells were 
washed 3-4 times in warm medium to remove nocodazole. Washed cells were 
incubated in medium without nocodazole for the indicated time at 37°C to re-initiate 
microtubule polymerization and immediately fixed.
2.4.4 Indirect immunofluorescence
Cells were cultured on 13-millimetre glass coverslips in DMEM to 
approximately 80% of confluency. Cells were washed with cold PBS three times and 
fixed with 100% methanol for 10 minutes, 4% PFA for 20 minutes or 4% PFA- 
PHEM for 20 minutes with shaking at RT. Cells were rinsed with PBS three times, 
permeabilised in 0.1% (v/w) Triton-X-100 for 15 minutes, rinsed again three times 
and blocked in blocking buffer for 60 minutes. Cells were incubated with the primary 
antibody in the same solution for one hour with shaking. Cells were then washed in 
PBS and incubated with the Alexa^^ ,^ Alexa^ "^^  or Marina blue conjugated secondary 
antibody at 1:500 dilution of a mg/ml stock in blocking solution for 30 minutes in 
the dark. Cells were washed three times in PBS before being dyed for 5 minutes with 
a 1:20,000 dilution of a 5 mg/ml stock of DAPI in PBS. Cells were finally washed in
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distilled water and coverslips were mounted onto Superfrost slides (BDH, UK) using 
Fluoromount G (Southern Biotechnology, USA).
When used, biotinylated Cl 8 was added following an additional mouse- 
specific blocking step and detected using Streptavidin^^" .^ For staining actin, cells 
were incubated for 20 minutes in the dark with fluorescent phalloidin with a 1:40 
dilution in blocking buffer of a 6.6 pM stock.
2.4.5 Images analyses
In most studies, preparations were viewed at 63X with a Leica TCS NT 
confocal microscope. Preparations were also viewed at 60X/1.4 NA with a Nikon 
E800 microscope and images were captured with a Hamamatsu C-4746A CCD 
camera. Some of the images were deconvolved using the Improvision Openlab 3.1 
software (Improvision, UK). 0.2 pm thick optical sections were analysed.
The lengths of the phalloidin-stained projections were quantified by tracing 
the distance from the cell margin to the tip of the structure on images collected with 
the confocal microscope. The measures were calculated by the Profile program of the 
Leica Software (Leica Microsysytems, UK).
2.4.6 Live cell microscopv analvsis
Cells for live analysis were cultured onto 3 5-mm diameter glass-based dishes 
(Iwaki, UK). At the specified time of analyses, dishes were seated on a Leica 
DMIRBE inverted microscope equipped with the scanning head of the Leica TCS 
NT confocal microscope. A temperature chamber built around the microscope 
maintained the cells at 37°C. Preparations were analysed with a 63X differential
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interference contrast (DIC) lens. Frames were usually taken every 5 seconds. Movie 
files were created using QuickTime (Apple, USA).
2.4.7 Preparation of EM samples
EM samples were prepared by Paul Monaghan and Pippa Hawes (lAH, 
Pirbright, UK) as follows.
2.4.7.1 Conventional section analvses
Vero or Max cells were plated onto Thermanox coverslips and infected with 
ASFV for the indicated time. They were fixed in situ with 2% glutaraldehyde in 0.05 
M phosphate buffer (pH 7.2 -  7.4, osmotic pressure adjusted to 350 mosmols with 
sucrose) for a minimum of 2 hrs. Samples were post-fixed in 1% osmium tetroxide in 
phosphate buffer for a minimum of 4 hrs, dehydrated through a graded series of 
ethanol and embedded in Agar 100 resin (Agar Scientific, UK). After overnight 
polymerisation at 60°C, the coverslips were peeled from the resin block leaving the 
cells embedded in the resin. Sections were cut parallel to the coverslip surface on a 
Diatome diamond knife (Leica Microsysytems, UK) and contrasted with uranyl 
acetate and lead citrate with an EM Stain (Leica Microsysytems). They were imaged 
in an FEI Tecnai 12 electron microscope at 100 kV.
2.4.7.2 Immunoelectron microscopv
Ultra thin 60nm sections were obtained as described above. They were then 
picked up on a droplet of 2.3 M sucrose and placed on Formvar coated copper EM 
grids. For all labelling steps, 50 pi droplets were used. All steps were carried out at
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RT unless otherwise stated. The samples were blocked in PBS/BSA for 30 minutes 
and then incubated with anti-pE120R antibodies in blocking buffer overnight, in a 
moist chamber. Samples were washed 3 times for 5 minutes in PBS and incubated 
with goat anti-rabbit antibodies coupled to 10 nm gold particles (Amersham 
Biosciences, UK), in blocking buffer for 90 minutes. Samples were washed 3 times 
for 5 minutes in PBS and fixed in 2% glutaraldehyde solution for 10 minutes. 
Samples were washed 6 times for 1 minute in ultra pure water and then stained with 
2% uranyl acetate for 1 minute on ice. The sections were coated in very thin layers of 
2% methyl cellulose containing 0.2% uranyl acetate to provide support. Samples 
were allowed to dry before being viewed with a FEI Tecnai 12 at 100 kV.
2.5 Protein analysis techniques
2.5.1 Sodium-dodecvlsulphate nolvacrvlamide gel electrophoresis (SDS-PAGE)
Two methods of SDS-PAGE were used in this study: the common SDS- 
PAGE system and the tris-tricine SDS-PAGE system, which was used to resolve 
proteins with a molecular mass less than 30 kDa. General protocols for gel 
preparation for the two systems are outlined below.
Table 2.1: Composition of a general SDS-PAGE.
Separating gel X % * Stacking gel 2.5%
Separating buffer 4 ml Stacking buffer 5 ml
Acrylogel 2.6 solution (BDH): 
40% acrylamide, 2.6 % bis- 
acrylamide (final ratio: 37:1)
0.4x ml Acrylogel 2.6 solution 1 ml
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dHzO 11.9 - (0.4x) ml dHzO 3.9 ml
10% ammonium persulphate 150 pi 10% ammonium persulphate 100 pi
Temed 15 pi Temed 15 pi
* Where x is the percentage content of acrylamide in the resolving gel. For example a 10% 
resolving gel would require 4ml Acrylogel 2.6 solution and 7.9ml dHzO.
Table 2.2: Composition of a 12.5% tris-tricine SDS-PAGE.
Resolving gel Stacking gel
Glycerol 2g None
Gel buffer 5 ml 1.5 ml
Acrylamide 4.7 ml 620 pi
Total volume made up to with dHzO 15 ml 6 ml
10% ammonium persulphate 150 pi 100 pi
Temed 15 pi 15 pi
2.5.2 Metabolic labelling and immunoprécipitation
Cells were starved in methionine- and cysteine-ffee DMEM for 15 minutes 
and then labelled with 0.5 Mbq/ml of ^^ S -methionine -cysteine (Amersham Life 
Science, UK) in fresh medium for 30 minutes, unless otherwise stated. Cells were 
washed with PBS and lysed at 4®C in IPB for 20 minutes. The lysates were pre­
cleared with insoluble protein A at 4°C for 1 h. Unlysed materials and insoluble 
protein A were removed by centrifugation (10,000g, 4®C, 10 minutes). Antigens were 
immunoprecipitated from the lysates by overnight incubation with antibodies 
immobilised with protein A coupled to Sepharose B beads (Sigma). Prior to use, 
beads (Protein A- Sepharose and 0.5 pi of purified antibody or 2 pi of antiserum) 
were tumbled overnight at 4°C and washed in lysis buffer five times. Finally, the
66
beads were washed 5 times in lysis buffer and boiled for 3 minutes in SPB. In most 
studies, proteins were resolved at 120 V by SDS-PAGE using 7.5% or 12.5% 
polyacrylamide. Proteins with a molecular mass less than 30 kDa were resolved by 
tris-tricine SDS-PAGE using 12.5% polyacrylamide. Gels were incubated for 20 
minutes in destain solution, washed three times with tap water and incubated for 20 
minutes in a salicylate solution. They were dried onto Whatman filter paper under 
vacuum for 45 minutes at 85°C. Dried gels were exposed to a film for several days 
(Kodak, UK) at -70°C and were subjected to autoradiography.
2.5.3 In vitro protein svnthesis
Proteins were synthesised in vitro using a T7 Quick coupled transcription/ 
translation system (Promega, USA) according the manufacturer’s instructions. 
Briefly, reactions were performed by adding, in order, the following components: 40 
pi Quick coupled rabbit reticulocyte lysates, 1 pg of plasmid vector, 0.5 MBq/ml of 
^^ S -methionine -cysteine (Amersham Pharmacia, UK) and dH20 to 50 pi. Reactions 
were vortexed, centrifuged and incubated at 30°C for 1 hr. Three pi of the mixture 
was immunoprecipitated with the appropriate antibody as described above.
2.5.4 Western blot analvses
Proteins were resolved by SDS-PAGE and transferred onto Protan BA85 
nitrocellulose membranes (Scleicher and Schuell, Germany) using a wet protein 
transfer unit (Biorad, USA) for 1 hr. Membranes were blocked overnight at 4°C in 
blocking buffer. After two washes in washing buffer, the membrane was incubated 
with the primary antibody (diluted in antibody incubation buffer) for 1 hr with 
shaking. Membranes were washed for 1.5 hr and incubated with the secondary
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antibody conjugated with HRP for 1 hr at RT. The membranes were extensively 
washed and incubated according to the instructions for the Super Signal kit (Pierce 
Chemical Co, USA). After 5 minutes, membranes were wrapped with Saran wrap for 
fluorography and exposed to X-ray film (Kodak, UK).
2.5.5 Computational analvsis
The program Motifs is a component of the Winconsin Package Version 10.1 
(Genetics Computer Group (GCG), USA). “Motifs” looks for sequence motifs by 
searching through proteins for the pattern defined in the Prosite Dictionary of protein 
sites and patterns.
2.6 DNA manipulation techniques
Buffers, enzymes, reagents and kits for molecular biology were purchased 
from Promega, USA.
2.6.1 Polymerase chain reaction tPCR)
The PCR were set up as follows: 5 pi 1 Ox Taq buffer , 4 pi MgCb, 1 pi 10 
mM dNTP, 2 pi lOOpM forward primer, 2 pi lOOpM reverse primer, 100 ng DNA 
template, 5 U (Ipl) Taq polymerase, made up to a final reaction volume of 50 pi 
with filtered water. The reaction mixture was overlaid with 40 pi mineral oil and 
placed in a Biometra Trio thermoblock.
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The following PCR cycling parameters were used:
Denature 94°C for 30 sec 
Denature 94°C for 30 sec
Anneal for 30 sec ^  30 cycles
Elongation 72°C for 1 minute per kb ^
Elongation 72°C for 10 minutes
Adjustment of the annealing temperature was made according to the Tm of 
the primers. After completion of the program, PCR products were mixed with 6X gel 
loading dye and the resulting mixture was run on a 1% (w/v) agarose gel. The DNA 
fragments were visualised by ethidium bromide staining. Appropriate PCR products 
were excised from gels and isolated as described below.
2.6.2 Purification of DNA fragments
DNA bands were purified using the Geneclean Turbo kit (BIO 101, USA). 
Briefly, the gel slices were melted in an equal volume of an aqueous solution of a 
guanidine chaotropic binding salt and transferred to a DNA binding column. The 
column was washed twice with a salt solution containing ethanol and the DNA was 
eluted with RNAse/DNAse-free elution solution.
2.6.3 Restriction enzvmes digestion
Digestion reactions were set up as follows: 2 pi 1 OX digestion buffer, 2 pi 
RNAse, 0.5 pi of each enzymes, 100 ng DNA template, made up to a final reaction 
volume of 20 pi with filtered water. DNA digestion was performed at 37°C in a 
water bath for at least 1 hr.
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2.6.4 Déphosphorylation of linearised plasmids
5’ ends of linearised plasmids were dephosphorylated with calf alkaline 
phosphatase. Two pi of lOX dephosphorylation buffer and 0.5 pi of alkaline 
phosphatase were added to the digestion products and incubated for 30 minutes at 
37°C. The alkaline phosphatase was then inactivated by the addition of 0.5 M EDTA 
and boiled for 10 minutes at 72°C.
2.6.5 Ligation
Ligation reactions were performed overnight at 15°C. Each reaction consists 
of 50-100 ng of linearised dephosphorylated vector, 0.5-1 pg of DNA insert, 1 pi of 
lOX ligation buffer, 1-3 U of T4 DNA ligase and distilled water to a final volume of 
20 pi.
2.6.6 Transformation of E. coli JM109 competent cells
Fifty pi of frozen E. coli JM109 competent cells was removed from -70°C 
and thawed on ice. Cells were transferred to a microcentrifuge tube containing 1-10 
ng of plasmid DNA or 2 pi of ligation reaction. The mixture was flicked gently, 
placed on ice for 20 minutes and heat-shocked for 45 seconds at 42°C. 950 pi LB 
broth was added to the mixture and the tube was incubated for 1.5 h at 37“C with 
shaking. Cells were pelleted at 1000 g for 10 minutes and re-suspended in 200 pi of 
LB broth. Finally, 50-150 pi of the mixture was plated onto an agar plate containing 
the appropriate antibiotic and incubated overnight at 37“C.
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2.6.7 Small scale preparation of plasmid DNA (minipreps)
Single colonies were picked from the agar plates and added to 5 ml of LB 
containing the appropriate antibiotic in a 20 ml Universal tube. The tubes were 
incubated overnight in a 37°C orbital shaker at 2000 rpm. 1.5 ml of the culture was 
removed and the bacteria were pelleted for 2 minutes at 16,000 g. The pellets were 
re-suspended in lOOpl of suspension medium and placed on ice for 5 minutes. 200 pi 
of lysis buffer was added; the suspension was mixed by inverting the tube 4-5 times 
and placed on ice for 5 minutes. 150 pi of potassium acetate buffer was added; the 
solution was mixed by inverting and placed on ice for a further 5 minutes. The 
suspension was centrifuged for 5 minutes at 16,000g. The supernatant was carefiilly 
decanted into 500pl of phenol/chloroform solution and mixed by vortexing. The 
mixture was centrifuged for 10 minutes at 16,000g and the top layer was pipetted off. 
The DNA was precipitated with 1 ml of ice-cold absolute ethanol and incubated at 
room temperature for 2 minutes. The DNA was pelleted by centrifugation at 16,000g 
for 10 minutes, rinsed in 70% ethanol and air-dried for 10 minutes. The pellet was 
redissolved in 20pl of TE.
2.6.8 Large scale preparation of plasmid DNA tmaxiprensl
For a preparation of a large concentration of DNA plasmid, the small-scale 
culture was diluted in 1/500 into LB containing the appropriate antibiotic. The 
vessels were incubated overnight at 37°C in an orbital shaker. The cells were 
harvested and pelleted at 6000 g for 20 minutes at 4°C. Cell pellets were re­
suspended in 10ml of suspension medium and left at room temperature for 5 minutes.
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Twenty ml of lysis buffer was added; the suspension was mixed by inverting the pot 
4-5 times and placed on ice for 5 minutes. Fifteen ml of potassium acetate buffer was 
added; the solution was mixed by inverting and placed on ice for a further 15 
minutes. The suspension was centrifuged for 15 minutes at 15,000 rpm in Sorval 
GSA rotor and the supernatant was removed. Then, the DNA extraction was 
performed using either a Qiagen-tip 500 column (Qiagen, UK).
The supernatant was filtered with a Millipore glass fibre filter. The 
supernatant was then added to an equilibrated Qiagen-tip 500 column and allowed to 
pass through the resin by gravity flow. The column was washed twice with Qiagen 
wash buffer and the DNA was eluted with 15 ml of Qiagen elution buffer. The DNA 
was precipitated with isopropanol and immediately centrifuged for 20 minutes at 
15,000 g. The pellet was rinsed in 70% ethanol, air-dried at RT and redissolved in 
300 pi of TE. DNA concentrations were determined with an Ultrospec 2100 UV 
spectrophotometer (Pharmacia biotech, UK).
2.6.9 Site directed mutation analvses
The QuickChange XL site-directed mutagenesis kit (Stratagene, USA) was 
used according to the manufacturer’s instructions to generate point mutations in the 
wild type E120R ORE. The following mutagenic primers were designed to contain 
the desired mutation (the wild-type residues to be mutated are indicated in bold and 
the corresponding mutations are indicated underlined).
Wild tvne sequence:
5 ’ -C ATTTGTTTCC AAAATT AAGCTCGC AT AAATCG AAGT AA AAATTG-3 ’
5 ’- CAATTTTTACTTCGATTTATGCGAGCTTAATTTTGGAAA CAAATG-3’
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Forward mutagenic primers:
Ser^^^for. 5’-C ATTTGTTTCC AAAATT AGGCTCGC AT AAATCG AAG -3’
S e /  ^  ^ for. 5 ’ -C ATTTGTTTCC AAAATT AAGCGCGC AT AAATCG AAGT AAAAATTG-3 ’
S e / ^  ^ for. 5 ’-CATTTGTTTCCAAAATTAAGCTCGCATAAAGCGAAGTAAAAATTG-3 ’ 
S e /1 5 ’116’119 for 5 ’- a t t t g t t t c c a a a a t t a g g c g c g c a t a a a g c g a a g t a a a a a t t G - 3 ’ 
Reverse mutagenic primers:
Ser"\ev . 5 ’- c t t c g a t t t a t g c g a g c c t t a a t t t t g g a a a c a a a t g - 3 ’
Se/^^rev. 5 ’- CAATTTTTACTTCGATTTATGCGÇGCTTAATTTTGGAAACAAATG-3’ 
Ser^^^rev. 5 ’- CAATTTTTACTTCGÇTTTATGCGAGCTTAATTTTGGAAACAAATG-3’ 
ggj.11 5 ,1 1 6 ,1 1 9 5 ’-a ATTTTCACTTCGCTTTATGCGCGCCTAATTTTGGAAACAA ATG-3’
Oligonucleotides were purchased from MWG Biotech, Germany. Reactions 
were set up as follows: 5 pi of reaction buffer, 10 ng of wild-type pcDNA-E120R, 
125 ng of each mutagenic primers, 1 pi lOmM dNTP, 3 pi of Quick-solution and 
dH20 to a final reaction volume of 50 pi. Then 1 pi of i^T u rb o  DNA polymerase 
was added to each reaction. The reaction mixtures were overlaid with 40 pi of 
mineral oil and placed in a Biometra Trio thermoblock.
The following cycling parameters were used:
Denature 95°C for 1 minute 
Denature 95°C for 50 sec 
Anneal 60°C for 50 sec ^  18 cycles
Polymerise 68°C for 11 minutes 
Polymerise 68°C for 7 minutes
The resulting product is a nicked circular DNA that contains the desired 
mutation. The methylated, non-mutated parental DNA is then digested with 1 pi of
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Dpn\ for 1 h at 37°C. Two pi of Z)pnl-treated DNA from each reaction were then 
transformed into 45 pi XL-Gold ultra-competent cells, which repair the nicked 
mutated DNA. XL-Gold ultra-competent cells were transformed as described below 
for of E. coli JM109 competent cells. Transformation reactions were plated on 
ampicillin plates and incubated overnight at 37°C. Single colonies were analysed by 
digestion of small-scale mutated plasmid. The small scale preparations were 
sequenced to verify that the clones contained the desired mutations.
2.6.10 Sequencing
Sequencing templates were 500 ng of small scale preparation of plasmid 
DNA diluted in 10 pi of deionised water. The DNA was heat-treated for 1 minute at 
96°C. The samples were prepared using the Dye Terminator Cycle Sequencing 
Quick-Start kit (Beckman Coulter, USA). The following reagents were added to the 
DNA sample: 3.2 pmoles of T7 primers, 4 pi of reaction buffer, 4 pi of Quick-start 
solution and dHaO to a final reaction volume of 20 pi. The following cycling 
parameters were used:
Denature 96°C for 20 sec 
Anneal 50°C for 20 sec ^  30 cycles
Polymerise 60°C for 4 minutes ^
The PCR products were then precipitated with 2 volumes of 3 M NaOAC, pH 
5.2. The DNA pellet was cleaned with 3 washes of 70% ethanol. Fourty pi of sample 
loading solution was added and samples were analysed with an automatic capillary 
sequencer CEQ 8800 Genetic Analyses System (Beckman Coulter, USA).
74
2.7 DNA materials
The shuttle vector pGEM-T, which was used to clone PCR products, was 
purchased from Promega (USA).
The pEL-GFP, pCMV-GFP-TPR-KLC, pEL-GFP-TPR-KLC, pEL-GFP- 
Grb2-, pEL-GFP- Nckl, pEL-GFP-N-WASP constructs were kindly given by 
Michael Way (Cancer Research UK) and have been described before (Frischknecht 
et a l, 1999b; Moreau et a l, 2000; Rietdorf et a l, 2001; Scaplehom et a l, 2002). 
peDNA-J13L-V5 and pTrcHisB-E120R have been produced by Amanda 
Childerstone and Sharon Brookes, respectively (IAH, Pirbright, UK). pT7-p73 was 
produced by Christian Cobbold (Cobbold et a l, 1996).
pET-21a-5AR was provided by Manuel Borca (Plum Island Animal Disease 
Centre, USA)(Borca et a l, 1996) and was used at a template to amplify the 5AR 
ORF using the primers 5 ' -GGGGCGGCCGCTCG AC A AAA AAA AAG-3 ' and 5’- 
TTTGÆ4TTCTTAATTTAACATATC-31 The primers were designed to incorporate 
Not\ and EcoRl restriction sites (italic) and to remove the 5AR start codon. 
Oligonucleotides were purchased from MWG Biotech, Germany. The annealing 
temperature of the PCR was 51 °C.
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3 ASFV transport from assembly sites to the plasma 
membrane is dependent on microtubules
Early studies have shown that ASFV particles associate with microtubules in 
vitro (de Matos and Carvalho, 1993) and recent work suggests that retrograde 
dynein-dependent microtubule transport is required during the early stages of ASFV 
infection (Alonso et al., 2001; Heath et al., 2001). 1 have examined whether 
microtubules are also required later in infection, for movement of ASFV from virus 
factories to the plasma membrane.
3.1 ASFV particles associate with microtubules at late times of 
infection
The distributions of microtubules and viral particles were studied at late times 
post-infection. Vero cells were infected with the Ba71v strain of ASFV and fixed 
with PFA at 12 and 16 hours post-infection (hpi). Cells were analysed by indirect 
immunofluorescence using a mouse monoclonal antibody against a-tubulin and a 
rabbit antibody specific for the late viral protein pE120R. Anti-pE120R antibodies 
recognise newly assembled ASFV particles, but not incoming particles (see section 
5.2.1). Protein distributions were detected by using appropriate secondary antibodies 
conjugated to Alexa Fluor 488 or 594. Cellular and viral DNA were labelled with 
DAPl. Figure 3.1 A shows a cell positive for pE120R viewed at 12 hpi. In this cell, 
the punctate structures indicative of viral particles were concentrated in perinuclear 
areas that matched extranuclear DAPl staining (Fig. 3.1 A). This extranuclear DNA 
staining indicates ASFV assembly sites. At 12 hpi, few individual viral particles
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were seen in the cytosol, outside assembly sites (Fig. 3.1A). At 16 hpi, large numbers 
of particles were observed throughout the cytoplasm and at the cell periphery (Fig. 
3.1B).
The analysis also revealed that the organisation of microtubules was disrupted 
at 16 hpi. The tubulin stain was excluded from the core of the factory but some 
microtubule filaments were clearly in contact with the edge of the factory (Fig. 
3.IB). Microtubule re-organisation in ASFV infected cells will be described in detail 
in chapter 6.1.
Higher magnification analysis of merged pictures of microtubules and ASFV 
particles revealed that cytoplasmic viral particles (i.e. particles that were not in the 
assembly sites) were aligned with microtubules at 16 hpi (Fig. 3.2). In a typical 
experiment, approximately 82% of cytoplasmic viruses were associated with a 
microtubule (n=402). The remaining particles were in the peripheral regions of the 
cytoplasm near the cell surface (Fig. 3.2, arrows). Since the anti-pE120R antibody 
recognised newly formed virions (section 5.2.1), these observations suggest that 
ASFV particles might use mierotubules for their transport from assembly sites to the 
plasma membrane.
3.2 ASFV transport from assembly sites to the plasma membrane 
is reduced by nocodazole
To determine whether mierotubules were required for the movement of 
ASFV from assembly sites to the plasma membrane, infected cells were incubated 
with the microtubule-destabilising agent nocodazole or the microtubule-stabilising 
drug paclitaxel. Non-treated cells and DMSO treated cells were used as controls. The
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drugs were added at 12 hpi, a time when few virions are localised in the cytoplasm 
(Fig. 3.1). Cells were fixed 4 hrs later, at 16 hpi, and were analysed by 
immunofluoreseenee using an antibody to the structural protein pE120R (Fig. 3.3A). 
Viral dispersion was quantified by counting individual particles in the cytoplasm. 
Over 50 infected cells were examined for each drug treatment and the average 
number of viral particles was calculated (Fig. 3.3B). In DMSO-treated cells and non­
treated eells, an average of 180 particles per cell was observed in the cytoplasm 
(STD=40.4 and STD=28, respectively), whereas in nocodazole-treated cells, the 
average number of cytosolie particles was 21 (STD=8.8). Therefore,
depolymerisation of mierotubules from 12 hpi to 16 hpi resulted in approximately 
88% inhibition of ASFV spread (Fig. 3.3B). In contrast, when mierotubules were 
stabilised with paclitaxel, the average number of cytoplasmic viral particles was 185 
(STD=40.4), demonstrating that paclitaxel does not affeet ASFV dispersion from 
assembly sites (Fig. 3.3B). Altogether, these data suggest that movement of ASFV 
from the factories requires an intact, but not dynamic, microtubule network.
3.3 Replication and assembly of ASFV are not affected by 
nocodazole
It was important to establish that the depolymerisation of mierotubules by 
incubation with nocodazole from 12 hpi to 16 hpi was affecting virus dispersion from 
assembly sites rather than blocking the supply of viral proteins important for virus 
replication and/or assembly. The experiment above was repeated and the effects of 
nocodazole and paelitaxel on synthesis of two late viral proteins that are recruited 
into virus factories were tested.
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Figure 3.1. Distribution of mierotubules and viral particles at 12 and 
16 hours post-infection. Vero cells were infected with the Ba71v strain of 
ASFV and fixed with PFA 12 hours (A) or 16 hours (B) following 
infection. Samples were incubated with a rabbit antiserum raised against 
the late ASFV structural protein pE120R (red) and a mouse antibody 
against a-tubulin (green). Viral and cellular DNA were labelled with 
DAPl (blue). Images shown have been independently collected with a 
confocal laser scanning microscope and merged. Scale bars, 8pm.
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Figure 3.2. ASFV particles associate with mierotubules at 16 hours post­
infection. Vero cells were infected with the Ba71v strain of ASFV and fixed 
with PFA at 16 hours post infection. Samples were incubated with a rabbit 
antiserum raised against the late ASFV structural protein pE120R (red) and a 
mouse antibody against a-tubulin (green). Viral and cellular DNA were 
labelled with DAPl (blue). Images shown have been collected independently 
with a confocal laser scanning microscope and merged. The arrows indicate 
viral particles that do not align with mierotubules. Right panels show 
enlarged views of parts of the left panel. Scale bar, 4pm.
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The expression of the main ASFV capsid protein, p73, was assessed by 
immunoprécipitation. Cells were incubated with the drugs at 12 hpi and 
metabolically labelled for 4 hrs. The cells were lysed with IPB and 
immunoprecipitated with an antibody specific for p73 (Fig. 3.4, top panel). The level 
of expression of pJ13L, a late membrane protein recruited into virus assembly sites 
(Brookes et al., 1998), was examined by Western blot (Fig. 3.4, bottom panel). The 
cells were incubated with the drugs at 12 hpi and lysed with IPB 4 hours later. 
Western blots were performed with an antibody specific for pJ13L, as described in 
materials and methods. Figure 3.4 shows that incubation of nocodazole fi’om 12 hpi 
to 16 hpi did not affect the levels of expression of these two proteins.
Electron microscopy was used to examine the effects of nocodazole on ASFV 
assembly. Figure 3.5 compares virus factories in control cells with those incubated 
with nocodazole fi-om 12 hpi to 16 hpi. The morphology of ASFV particles, which 
appear as hexagons in cross section, was unaffected by nocodazole (Fig. 3.5, A and 
B). These data demonstrate that incubation of nocodazole from 12 hpi to 16 hpi did 
not affect ASFV morphogenesis. This analysis also revealed that factories formed in 
the presence of nocodazole contained higher numbers of fully assembled particles, 
seen as electron dense hexagons in images, when compared to control cells (Fig. 3.5, 
C and D, arrows).
Taken together, these results suggest that ASFV replicates and assembles 
normally when cells are incubated with nocodazole from 12 to 16 hpi. However, 
addition of the drug at 12 hpi prevents the spreading of mature particles from 
assembly sites.
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Figure 3.3. Effect of nocodazole and paclitaxel on ASFV dispersion from 
viral factories. Vero cells were infected with the Ba71v strain of ASFV. 
Nocodazole (10 pg/ml), paclitaxel (10 pM) or control (DMSO) were added 
at 12 hours post-infection and cells were incubated for a further 4 hours at 
37°C prior to fixation and processing for immunofluorescence. Virions were 
located with an antibody specific for the late ASFV structural protein 
pE120R. Panels A: Immunofluorescence images show viral dispersion in 
control cells and in cells incubated with drugs. Scale bars, 8 pm. Panel B: 
Cells were examined by microscopy as described above and viral dispersion 
was quantified by counting individual particles in the cytoplasm. Results are 
presented as the average number of virions present into the cytoplasm per 
cell (N= the number of cells evaluated). Error bars indicate the standard 
deviation of the means.
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Figure 3.4. Effect of nocodazole and paclitaxel on synthesis of viral 
late proteins. Vero cells were infected with the Ba71v strain of ASFV 
and nocodazole (10 pg/ml), paclitaxel (10 pM) or DMSO were added at 
12 hours post-infection. Half of the samples were metabolically labelled 
with ^^ S -methionine and -cysteine for 4 hours, lysed with IPB and 
immunoprecipitated using antibody specific for p73 (top). Samples were 
analysed by 12.5% SDS-PAGE. The other half of the samples were 
processed 4 hours later and lysed with IPB. Cell extracts were resolved 
by 12.5% SDS-PAGE and analysed by Western blot for expression of 
pJ13L (bottom).
Lane 1: no additions; Lane 2: DMSO control; Lane 3: noeodazole; Lane 
4: paclitaxel.
83
- nocodazole + nocodazole
s f'%.
gSaHMRa!
■ ■ -i.'''
w m m
Ï Æ a Ï AjL-
Figure 3.5. Effect of nocodazole on assembly of ASFV. Vero cells were infected 
with the Ba71v strain of ASFV. Nocodazole (lOpg/ml) or DMSO control were 
added at 12 hours post-infection and cells were incubated for a further 4 hours at 
37 C and then processed for electron microscopy. Micrographs A and B show thin 
section images of viruses formed in the presence or absence of nocodazole as 
indicated. Micrographs C and D show images of virus assembly sites at lower 
magnification. The arrows indicate electron-dense mature particles. Scale bars, 250 
nm (A and B), 2 pm (C), 5 pm (D).
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4 ASFV transport from assembly sites to the plasma 
membrane is dependent on conventional kinesin
The movement of cellular eargoes from the MTOC to the cell surface along 
mierotubules requires members of the kinesin family of molecular motors (Vale, 
2003). Recent reports have revealed a link between conventional kinesin and the 
movement of W  and HSV-1 in infected cells (Diefenbach et al., 2002; Rietdorf et 
al., 2001). In this chapter, we have investigated whether conventional kinesin was the 
motor responsible for ASFV microtubule-based anterograde transport.
4.1 ASFV assembly sites recruit conventional kinesin
To address the possibility that conventional kinesin was involved in ASFV 
transport from assembly sites to the cell periphery, the distributions of conventional 
kinesin and ASFV particles were analysed at late stages of infection. Vero eells were 
infected with Ba71v and fixed with PFA-PHEM at 16 hpi. Cells were processed for 
immunofluorescence using a mouse antibody specific for the N-terminal domain of 
the light chain of conventional kinesin (Stenoien and Brady, 1997) and a rabbit 
antibody that recognises the structural protein pE120R (see chapter 5.1). Cellular and 
viral DNA were labelled with DAPL In non-infected control cells, the kinesin light 
chain antibody produced dot-like staining throughout the cell (Fig. 4.1 A). A 
concentration of kinesin was noticeable at the cell periphery but not around the 
nucleus. In infected cells, the kinesin light chain was still distributed throughout the 
cytoplasm but was also concentrated in perinuclear areas that matched with viral 
factories (Fig. 4.IB). Approximately 70% of the cytoplasmic particles appeared
85
yellow in the merged pictures (n=352) (Fig. 4.IB, merged panels), suggesting a co- 
loealisation between a subpopulation of cytoplasmic particles and conventional 
kinesin light chain. This analysis suggests that conventional kinesin light chain is 
recruited into ASFV assembly sites and to most of cytoplasmic particles, suggesting 
that the motor complex could be involved in ASFV movement from assembly sites.
4.2 ASFV recruits the kinesin motor complex via the TPR domain 
of kinesin light chain
The N-terminal domain of conventional kinesin heavy chain contains the 
motor polypeptide that binds to mierotubules. The C-terminal domain of the light 
chain consists of 6 tetratricopeptide (TPR) motifs (Gindhart and Goldstein, 1996). 
The TPR motif is a protein-protein interaction module found in multiple copies in a 
number of functionally different proteins (Lamb et al., 1995). The TPR domain of 
conventional kinesin light chain (TPR-KLC) has been shown to mediate interaction 
with eargoes (Vale, 2003). GFP-tagged versions of the TPR domain can be used to 
identify cellular components that are recognised as cargo by kinesin light chain. This 
method has been used successfully to demonstrate that W  particles recruit 
conventional kinesin light chain (Rietdorf et al, 2001). To determine if ASFV 
recruits kinesin in a manner similar to W ,  we examined the localisation of GFP- 
TPR-KLC fusion polypeptides in infected eells.
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Figure 4.1. Conventional kinesin is recruited into ASFV assembly 
sites. Panels A. Distribution of kinesin light chain TKLC) in non-infected 
cells. Non-infected Vero cells were fixed with PFA-PHEM and 
processed for immunofluorescence using the mouse antibody 63-90 
specific for KEG (green). Cellular DNA was labelled with DAPl (blue). 
Panels B. Distribution of KLC in ASFV infected cells. Vero cells were 
infected with the Ba71v strain of ASFV, fixed at 16 hours post-infection 
with PFA-PHEM and processed for immunofluorescence. A rabbit 
antiserum specific for the structural protein pE 120R was used to locate 
virus particles (red) and conventional kinesin was identified using the 
mouse antibody 63-90 that recognises KLC (green). Viral and cellular 
DNA were labelled with DAPl (blue). Images have been collected with a 
confocal microscope. The bottom panels are enlarged views of parts of 
the merged images. Scale bars, 8 pm.
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4.2.1 CMV-GFP-TPR-KLC is not an appropriate tool to study the distribution of
conventional kinesin in ASFV infected cells
In the first series of experiments, the TPR-KLC was expressed in eells using a 
vector containing a cytomegalovirus (CMV) promoter. Cells were transfected with 
pCMV-GFP-TPR-KLC for 24 hrs to allow expression of the fusion protein, then 
infected with BaTlv for 16 hrs. Cells were fixed with PFA and analysed by indirect 
immunofluorescence. The subcellular localisation of TPR-KLC was monitored by 
the intrinsic fluorescence of GFP. Infected cells were identified using a mouse 
antibody specific for the early viral protein p30 (Afonso et al., 1992) and the 
distribution of p30 was visualised by a secondary antibody conjugated to Marina 
blue. Late infected cells were detected using a rabbit antibody against the late protein 
pE120R (see section 5.1) coupled to a secondary antibody conjugated to Alexa Fluor 
594. Figure 4.2 shows that the cells expressing GFP-TPR-KLC were usually negative 
for p30 (top panels). In some rare cases, we were able to find some cells that were 
positive for both GFP-TPR-KLC and p30 (Fig. 4.2, arrows). Unfortunately, these 
p30-positive cells expressing GFP-TPR-KLC were always negative for late viral 
antigens (Fig. 4.2). After several attempts it became apparent that it would not be 
possible to obtain late viral gene expression in cells expressing the TPR construct. It 
is possible that there is a competition between the CMV promoter and ASFV. An 
alternative means of expressing GFP-TPR in ASFV infected cells was therefore 
investigated.
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Figure 4.2. Expression of pCMV-GFP-TPR-KLC in ASFV infected cells.
Vero cells were transfected with pCMV-GFP-TPR-KLC and infected with BaVlv 
24 hours later. Cells were fixed 16 hours following infection with PFA and 
processed for immunofluorescence using a mouse antibody specific for the early 
viral protein p30 (blue) and a rabbit antibody specific for the late viral protein 
pE120R (red). The localisation of the TPR domain of kinesin light chain was 
monitored by the intrinsic fluorescence of GFP (green). Images have been 
collected with a Nikon E800 microscope. The arrows indicate a cell that expresses 
GFP-TPR-KLC and that is positive for p30. Scale bars, 8 pm.
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4.2.2 The EL promoter of Vaccinia vims is recognised bv ASFV transcriptional 
machinerv
ASFV and W  are closely related viruses and share some sequence similarity. 
One gene common to both viruses encodes a transcription factor (Iyer et al., 2001), 
suggesting that the transcriptional machinery of the two viruses are similar. 
Moreover, it has been demonstrated that some ASFV promoters are recognised by 
W  transcription factors (Hammond and Dixon, 1991). A series of experiments were 
performed to test if the synthetic early-late (EL) promoter of W  (Chakrabarti et al., 
1997) would be recognised by ASFV transcriptional machinery. The EL promoter 
has been adapted for use with the MVA-T7 strain of W  (Chakrabarti et al., 1997).
The first experiment tested the ability of the EL promoter to drive expression 
of GFP in cells infected with ASFV. Cells were transfected with pEL-GFP for 2 hrs 
to allow penetration of the vector into cells and then infected with Ba71v for 16 hrs. 
Cells were fixed with PFA and analysed by immunofluorescence. Infected cells/were 
detected with an antibody that recognises p73, the main ASFV capsid protein. Figure
4.3 shows that the GFP signal was not detected in p73 negative cells but only in p73 
positive cells (panel A, arrows), suggesting that the W -E L  promoter might be 
recognised by ASFV transcriptional machinery.
To confirm these data, Vero cells were transfected with pEL-GFP for 2 hrs, 
then infected with Ba71v for 16 hrs and processed for immunoprécipitation analyses 
using an antibody specific for GFP (Fig. 4.3B, lane 3). Cells that were mock- 
transfected and mock-infected were used as negative controls (Fig. 4.3B, lane 1). 
Cells transfected with pEL-GFP for 36 hrs were used to determine if the EL 
promoter would be expressed in non-infeeted cells (Fig. 4.3B, lane 2). Cells
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transfected with pEL-GFP for 2 hrs and infected with MVA-T7 for 16 hrs were used 
as positive controls (Fig. 4.3B, lane 4). No protein was detected in mock-transfected 
and moek-infeeted cells (Fig. 4.3B, lane 1). GFP was not expressed in transfected 
cells (Fig. 4.3B, lane 2), confirming that the EL promoter is not recognised by 
cellular transcription factors. GFP is a 27 kDa protein and a single 27 kDa protein 
was detected in transfected cells that had been infected with ASFV or MVA-T7 (Fig. 
4.3B, lanes 3 and 4). Altogether, the results demonstrate that the W  EL promoter is 
recognised by ASFV transcription factors. The EL promoter is therefore an 
appropriate tool to study protein distribution in ASFV infected cells.
To further study the localisation of conventional kinesin light chain in late 
ASFV infected cells, we took advantage of the pEL-GFP-TPR-KLC vector (Rietdorf 
et al., 2001).
4.2.3 ASFV particles recruit the TPR domain of kinesin light chain in assemblv 
sites
The first experiment tested the expression of the recombinant polypeptide 
GFP-TPR-KLC in cells infected with ASFV. Vero cells were transfected with pEL- 
GFP-TPR-KLC and infected with Ba71v two hrs later for 16 hrs (Fig. 4.4A, lane 2). 
Transfected cells that had not been infected were used as negative controls (Fig. 
4.4A, lane 1). Cells transfected with pEL-GFP-TPR-KLC and infected with MVA- 
T7 two hours later for 16 hrs were used as positive controls (Fig. 4.4A, lane 3).
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Figure 4.3. The synthetic EL promoter of Vaccinia virus is recognised by 
ASFV transcriptional machinery. Panels A. Vero cells were transfected with 
pEL-GFP and infected with Ba71v two hours later. Cells were fixed at 16 hours 
post-infection and processed for immunofluorescence using antibodies specific 
for the capsid protein p73 (red). Cellular and viral DNA were labelled with DAPl 
(blue). The distribution of the GFP signal was monitored by GFP intrinsic 
fluorescence (green). Images have been collected with a Nikon E800 
microscope. The arrows indicate a p73-positive cell that expresses GFP. Scale 
bar, lOpm. Panel B. Vero cells were transfected with pEL-GFP and infected 2 
hours later for 16 hours with either Ba71v (lane 3) or MVA-T7 (lane 4). Mock- 
transfected and mock-infected cells were used as controls (lane 1). Cells 
transfected with pEL-GFP for 36 hours were also analysed (lane 2). Cells were 
labelled with -methionine and -cysteine for 30 minutes and lysed with IPB. 
Samples were immunoprecipitated with anti-GFP antibodies and analysed by 
12.5% SDS-PAGE and autoradiography.
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Western blot analyses were performed using a GFP antibody. The samples 
were also probed with an antibody speeific for the protein p30 (Fig. 4.4B). p30 is a 
30 kDa ASFV protein that is expressed as early as 2 hpi (Afonso et al., 1992). A 30 
kDa protein was effeetively detected in lysates prepared from ASFV infected cells, 
but not in mock- or MVA-T7-infected cells (Fig. 4.4B). The size expected for the 
recombinant GFP-TRP-KLC polypeptide is 75 kDa since GFP is a 27 kDa protein 
and the TPR domain of KLC is a 48 kDa peptide. No protein was detected by GFP 
antibodies in lysates prepared from control cells (panel A, lane 1), confirming that 
EL driven expression required infection. In ASFV and MVA-T7 infected cells, the 
anti-GFP antibody detected two proteins at around 75 kDa (panel A, lanes 2 and 3, 
arrows). The slower migrating band was predominant. This extra-band might 
represent a post-translationally modified form of TRP-KLC. GFP does not undergo 
such modifications (Fig. 4.3B). These data demonstrate that the W  EL promoter can 
drive expression of GFP-TPR-KLC in ASFV-infeeted cells.
To study the distribution of GFP-TPR-KLC in cells infected with ASFV, 
Vero eells were transfected with pEL-GFP-TPR-KLC for 2 hrs and then infected 
with Ba71v. Cells were fixed with PFA at 12 hpi and analysed by 
immunofluorescence. The distribution of GFP-TRP-KLC was monitored by the 
intrinsic fluorescence of GFP. Virus particles were visualised by using a mouse 
antibody recognising p73. Figure 4.5 shows two infected eells viewed at 12 hpi. One 
cell was positive for the late viral antigen p73 (star), the other cell was negative for 
p73 (arrow). The cell negative for p73 (arrow) was however infected because it 
expressed the GFP-TPR-KLC, suggesting an early stage of infection. At this early 
stage of infection, the GFP-TPR-KLC signal was distributed throughout the
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cytoplasm (arrow). In the cell expressing p73 (star), the GFP probe was concentrated 
in a perinuclear site that matched ASFV factory. Previous immunofluorescence 
analyses have shown that in non-infected cells the CMV-GFP-TPR-KLC probe was 
also distributed throughout the cell (Fig. 4.2). This was also true for the distribution 
of GFP in infected eells (Fig. 4.3). All together, these results demonstrate that the 
GFP tagged version of TPR-KLC, but not GFP alone, is recruited into ASFV 
assembly sites as early as 12 hpi. They also agree with data obtained with the kinesin 
light chain antibody, where the antibody showed intense staining of virus assembly 
sites (Fig. 4.1).
ASFV factories contain viruses at various stages of assembly interweaved 
within a matrix of membranous material derived from the ER (Rouiller et al., 1998). 
To determine which of these structures were labelled by the TPR-KLC probe, the 
localisation of the GFP-TPR-KLC signal within the virus factory was studied in 
more detail. The experiment above was repeated and samples were stained with 
antibodies recognising the viral protein pJ13L that localises in the membranes within 
the factory (Brookes et al., 1998). In a second experiment, an antibody specific for 
the major capsid protein p73 was used to label virions. In a third experiment, ASFV 
particles were stained with antibodies speeific for the structural protein pEI20R. The 
bottom panels of figure 4.6 show that the GFP-TPR-KLC signal appeared yellow 
when merged with the p73 and pE120R signals, but not with the pJ13L signal. These 
experiments demonstrate that the GFP-TPR-KLC probe eoloealises with the 
structural proteins pE120R and p73 but not the membrane protein pJ13L. Therefore, 
the viral particles, and not the underlying membranous structures, are recognised by 
the TPR domain of conventional kinesin light chain as a cargo.
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Figure 4.4. Expression of pEL-GFP-TPR-KLC in ASFV infected cells.
Vero cells were transfected with pEL-GFP-TPR-KLC and infected 2 hours 
later with BaTlv (lane 2) or with MVA-T7 (lane 3). Mock-infected cells were 
used as controls (lane 1). Cells were lysed at 16 hours post-infection with IPB 
and analysed by 12.5% tris-tricine SDS-PAGE. Panel A: Lysates were probed 
with anti-GFP antibody. Panel B : Lysates were probed with antibody against 
the ASFV early protein p30.
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Figure 4.5. Distribution of GFP-TPR-KLC in cells infected with ASFV for 
12 hours. Vero cells were transfected with pEL-GFP-TPR-KLC and infected 2 
hours later with BaTlv. Cells were fixed at 12 hours post-infection with PFA 
and processed for immunofluorescence. An antibody against the capsid protein 
p73 was used to locate virus factories (red). Viral and cellular DNA were 
labelled with DAPl (blue). The localisation of the TPR domain of kinesin light 
chain was monitored by the intrinsic fluorescence of GFP (green). Images have 
been collected with a confocal microscope. The view shows the distribution of 
GFP-TPR-KLC in the presence (star) or absence (arrow) of p73. Scale bar, 20 
pm.
95
GFP-TPR-KLCGFP-TPR-KLCGFP-TPR-KLC
Merged images Merged images
Figure 4.6. Distribution of GFP-TPR-KLC in ASFV assembly sites at 12 
hours post-infection. Vero cells were transfected with pEL-GFP-TPR-KLC 
and infected 2 hours later with BaTlv. Cells were fixed 12 hours following 
infection with PFA and processed for immunofluorescence using antibodies 
against the viral membrane protein pJl 3L (left panels), the capsid protein p73 
(middle panels), or the structural protein pE120R (right panels) (red). Viral 
and cellular DNA were labelled with DAPl (blue). The localisation of the 
TPR domain of kinesin light chain was monitored by the intrinsic 
fluorescence of GFP (green). Images have been collected with a confocal 
microscope. Scale bars, 4 pm.
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4.2.4 When expressed at low levels. GFP-TPR-KLC labels cytoplasmic virions
The eonstruction of the GFP-TRP-KLC fusion protein replaces the N- 
terminal domain of kinesin light chain, which would normally interact with the 
kinesin heavy chain, with GFP. The resulting polypeptide binds eargo, but eannot 
reeruit the heavy ehain for transport on mierotubules. In eells expressing low level of 
GFP-TPR-KLC, eargoes with multiple interaction sites should be reeognised by both 
GFP-TPR-KLC probes and endogenous kinesin light chain. GFP-TPR-KLC would 
thus label the cargo but not affect its transport. In contrast, high levels of GFP-TPR- 
KLC expression should saturate the binding sites for the endogenous motor and 
block cargo transport.
The EL-GFP-TPR-KLC transfection experiment was repeated and eells were 
fixed 16 hrs after the addition of BaTlv. At this time point, fully-assembled particles 
were usually observed in the eytoplasm, outside the replication site (Fig. 3.1). Viral 
partieles were visualised by using a mouse antibody specific for p73. At 16 hpi, the 
GFP-TPR-KLC signal was intense in ASFV infected eells, indicative of a high level 
of expression (Fig. 4.7, thin arrow). In these bright green cells, GFP-TPR-KLC was 
concentrated into viral factories, eonfirming previous results (Fig. 4.5). No virions 
were visible in the cytoplasm of these cells (Fig. 4.7, thin arrow). If the same view 
was exposed 10 times longer, a seeond eell expressing GFP-TPR-KLC became 
visible (thiek arrow). Approximately 50 cytoplasmic virions, identified by the p73 
signal, were deteetable outside the assembly site in this cell expressing GFP-TPR- 
KLC at a low level. Interestingly, in this cell, the GFP-TRP-KLC signal was not only 
concentrated in perinuclear area but also distributed as dot-like struetures in the
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cytoplasm. These dot-like structures seemed to correspond to individual viral 
partieles (Fig. 4.5, white boxes). More eells expressing GFP-TRP-KLC at a low level 
were examined and 100% of cytoplasmic viral particles were found to be associated 
the GFP-TRP-KLC probe (Fig. 4.8, merged panel). Taken together, the result show 
that cytoplasmic virions are not detectable in cells expressing high levels of GFP- 
TRP-KLC and that, the GFP signal eoloealises with cytoplasmic particles, in eells 
expressing low level of GFP-TRP-KLC. This suggests that ASFV binds the TPR 
domain of conventional kinesin light chain and may use the motor complex for its 
transport from assembly sites to the cell surface. The dominant negative properties of 
GFP-TRP-KLC were studied in more detail in the next section.
4.3 ASFV anterograde transport is conventional kinesin dependent
Before performing quantitative analyses on the effect of over-expression of 
GFP-TPR-KLC on ASFV anterograde transport, we engineered a control EL vector 
that would express another GFP fusion protein that targets ASFV assembly sites. 
These controls are essential to determine whether over-expression of GFP and/or 
over-expression of a protein that localises in viral factories do not perturb the 
movement of ASFV.
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Figure 4.7. Distribution of GFP-TPR-KLC in cells infected with 
ASFV for 16 hours. Vero cells were transfected with pEL-GFP-TPR- 
KLC and infected 2 hours later with Ba71 v. Cells were fixed with PFA 
at 16 hours post-infection. Cells were processed for 
immunofluorescence using an antibody against the capsid protein p73 
(red). Viral and cellular DNA were labelled with DAPl (blue). The 
localisation of the TPR domain of kinesin light chain was monitored by 
the intrinsic fluorescence of GFP (green). Images have been collected 
with a confocal microscope. These panels show two cells that expressed 
GFP-TPR-KLC: one at high levels (thin arrow), the second one at low 
levels (thick arrow). Exposure times are given in seconds (brackets). 
The white boxes are enlarged views of parts of the corresponding 
panels. Scale bar, 20 pm.
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Figure 4.8. ASFV particles bind the TPR domain of kinesin light 
chain. Vero cells were transfected with pEL-GFP-TPR-KLC and 
infected with ASFV two hours later. Cells were fixed at 16 hours post­
infection and processed for immunofluorescence using antibodies 
speeific for the late viral protein p73 (red). The distribution of the TPR 
domain of kinesin light chain was monitored by the intrinsic 
fluorescence of GFP (green). Viral and cellular DNA were labelled 
with DAPI (blue). Images have been collected sequentially with a 
confocal microscope. Scale bars, 8 pm.
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4.3.1 Expression and localisation of pGFP-5AR in ASFV infected cells
4.3.1.1 Construction of the expression vector pEL-GFP-5AR
p5AR is a structural ASFV DNA-binding protein that is thought to be 
involved in viral DNA packaging (Borca et al., 1996; Neilan et al., 1993b). The 
cDNA encoding the protein was available in the laboratory and was used at a 
template to amplify the 5AR ORE and clone it into pEL-GFP. The primers were 
designed to incorporate Not\ and EcoRl restriction sites and to remove the 5AR start 
codon. PGR products were analysed by agarose electrophoresis, purified and ligated 
into the shuttle vector pGEM-T. The ligation products were transformed in E. coli 
JM109 as described in materials and methods. The presence of 5AR ORE was 
identified by restriction digestion of small-scale preparation of pGEM-T-5AR (data 
not shown). The pGEM-T-5AR construct was then digested with Notl-EcoR\ and the 
5AR fragment was purified and ligated into the Notl-EcoRI sites of the expression 
vector pEL-GFP to generate N-terminally GFP-tagged p5AR (pGFP-5AR). The 
predicted size of the 5AR fragment after digestion is 312 bp. Positive clones were 
identified by digesting small-scale preparations of pEL-GFP-5AR with Not\-EcoR\, 
as shown in figure 4.9.
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Figure 4.9. Sub-cloning 5AR into pEL-GFP. pEL-GFP-5AR clones 
were digested by Not\ and EcoRl. Digested DNA was run on a 1% 
agarose gel and visualised with ethidium bromide. Sizes of DNA markers 
are shown on the left o f the gel and the predicted size of the fragments 
are shown on the right, in base-pairs.
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Figure 4.10. Expression of pGFP-5AR in ASFV infected cells. Vero 
eells were transfected with pEL-GFP-5AR and infected 2 hours later with 
Ba71v (lane 3). Mock-infected cells were used as a control (lane 1) as well 
as infected but non-transfected cells (lane 2). Cells were lysed with RIPA 
buffer at 16 hours post-infection and analysed by 12.5% tris-tricine SDS- 
PAGE. Cell lysates were probed with an anti-p5AR antiserum (panel A) or 
with anti-GFP antibodies (panel B).
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4.3.1.2 Expression of pGFP-5AR in ASFV-infected cells produces an intact 40 kPa 
protein
To ensure that the recombinant protein pGFP-5AR was not degraded and was 
expressed at the expected size in ASFV-infected cells, Western blot analyses were 
performed. Vero cells were transfected with pEL-5AR-GFP and infected with Ba71v 
two hrs later (Fig. 4.10, lane 3). Non-infected cells were used as controls (Fig. 4.10, 
lane 1) as well as infected but non-transfected cells (Fig. 4.10, lane 2). The cells were 
lysed with RIPA buffer at 16 hpi. Samples were probed with antibodies specific to 
p5AR (panel A) or to GFP (panel B). Since GFP is a 27 kDa protein and p5AR is a 
13 kDa protein, the expected size of the recombinant pGFP-5 AR protein is 40 kDa. 
Figure 4.10 shows that a 40 kDa protein, which was recognised by both anti-GFP 
and anti-5 AR antibodies, was expressed in ASFV-infected cells (lane 3, panels A and 
B). In infected cells, the 5AR anti-serum also recognised the endogenous 5 AR at 13 
kDa (lanes 2 and 3, panel A). These data demonstrate that pEL-GFP-5AR expresses 
the expected recombinant protein in ASFV-infected cells.
4.3.1.3 Distribution of pGFP-5AR in ASFV-infected cells
The localisation of pGFP-5AR in infected cells was compared with the 
localisation of endogenous p5AR by indirect immunofluorescence analyses. The 
cellular localisation of endogenous p5AR was first examined in Vero cells infected 
with BA71v (Fig. 4.11 A). Cells were fixed at 12 hpi with PFA and stained with a 
rabbit anti-p5AR serum and a mouse antibody specific for the non-structural protein 
p30. The p5AR signal was not detected in uninfected cells while in the cells positive 
for p30, the p5AR signal matched viral factories, as expected for a structural protein
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(Fig. 4.11 A, arrows). p5AR was also distributed in the nuclei of infected cells (Fig. 
4.11 A). To determine the subcellular localisation of the recombinant pGFP-5AR, 
Vero cells were transfected with pEL-GFP-5AR and infected two hrs later with 
Ba71v. Cells were fixed at 12 hpi with PFA. pGFP-5AR localisation was monitored 
by the intrinsic fluorescence of GFP. Infected cells were identified with a positive 
staining for ASFV capsid protein p73. The GFP-5AR signal was located in viral 
factories as well as in cell nuclei (Fig 4.1 IB), indicating that pGFP-5AR and 
endogenous p5AR have a similar distribution in ASFV-infected cells.
Altogether, these data show that the cloning of 5AR into pEL-GFP was 
successfiil. The vector could therefore be used as a control to study the effects of 
GFP-TPR-KLC expression on ASFV dispersion from viral factories.
4.3.2 Movement of ASFV from assemblv sites is inhibited in cells expressing high
level of GFP-TPR-KLC
To study the effect of high level of GFP-TPR-KLC expression in ASFV- 
infected cells, Vero cells were transfected with pEL-GFP-TPR-KLC or with the 
control vector pEL-GFP-5AR and infected two hrs later with Ba71v. Cells were 
fixed at 16 hpi and analysed by indirect immunofluorescence using an antibody 
specific for p73 (Fig. 4.12A). pGFP-5AR and GFP-TPR-KLC localisation were 
visualised by the intrinsic fluorescence of GFP. Figure 4.12A shows that both pGFP- 
5AR and GFP-TPR-KLC target viral assembly sites, confirming previous 
observations (Fig. 4.5 to 4.8 and 4.11). Viral dispersion was quantified by counting 
small bright red dots, indicative of individual particles, in the cytoplasm of cells 
expressing GFP-TPR-KLC or pGFP-5 AR.
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Figure 4.11. Distribution of endogenous p5AR and pGFP-5AR in ASFV 
infected cells. Vero cells were infected with Ba71v for 12 hours, fixed with 
PFA and processed for immunofluorescence. Viral and cellular DNA were 
labelled with DAPI (blue). Panels A. Samples were labelled with a mouse 
antibody against the early viral protein p30 (red) and a rabbit antiserum raised 
against p5AR (green). Panels B. Vero cells were transfected with pEL-GFP- 
5AR 2 hours prior Ba71v infection. Samples were labelled with a mouse 
antibody against the capsid protein p73 (red). The localisation of pGFP-5AR 
was monitored by the intrinsic fluorescence of GFP (green). Images have been 
eollected with a Nikon E800 microscope. The arrows indicate viral factories. 
Scale bars, 20 pm.
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As a second control, particles were counted, on the same coverslip, in 
infected cells that did not express the GFP probes. Over 200 infected cells were 
examined (Fig. 4.12B). For the pGFP-5AR experiment, an average of 131 particles 
was observed in the cytoplasm of cells that did not express the GFP construct (STD= 
48.5). In cells expressing the GFP construct, an average of 135 particles was 
observed in the cytoplasm (STD= 34.3). This result shows that high level of pGFP- 
5AR expression has no effect on viral spread from assembly sites (Fig. 4.12B). For 
the GFP-TPR-KLC experiment, an average of 147 particles was observed in the 
cytoplasm of control cells (STD= 27.6), whereas in cells expressing high level of 
GFP-TPR-KLC, the average number of cytoplasmic particles was 5 (STD= 1.1) (Fig. 
4.12B). These data demonstrate that approximately 97% of ASFV transport 
throughout the cytoplasm is blocked by the dominant negative GFP-TPR-KLC 
polypeptide, suggesting that ASFV transport is dependent on conventional kinesin.
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Figure 4.12. Conventional kinesin is required for ASFV transport from assembly 
sites to the cell surface. Panels A. Localisation of ASFV particles in cells expressing 
GFP-TPR-KLC or dGFP-5AR. Vero cells were transfected with pEL-GFP-TPR-KLC 
or pEL-GFP-5AR as indicated. Cells were infected with Ba71v two hours later, fixed 
at 16 hpi and processed for immunofluorescence. Virus particles were identified with 
an antibody against p73 (red). The distribution of GFP-TPR-KLC and GFP-5AR were 
indicated by the intrinsic fluorescence of GFP. Cells expressing high levels of GFP 
were selected. Images have been collected with a Nikon E800 microscope. Scale bars, 
20 pm. Panel B. Quantification of ASFV spread to the cell peripherv in cells 
expressing GFP-TPR-KLC or pGFP-5AR. Infected cells expressing pEL-GFP-TPR- 
KLC or pEL-GFP-5AR were prepared as described above. The numbers of virus 
particles present in the cytoplasm were compared with cells on the same coverslip that 
were infected but did not express either GFP-TPR-KLC or GFP-5AR. Results are 
presented as the average number of virions present into the cytoplasm per cell. (N= 
number of cells evaluated). Error bars indicate the standard deviation of the means.
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Figure 4.12, continued.
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5 Does pE120R recruit conventional kinesin?
When the expression of the structural protein pE120R is reduced 100 fold, 
virions assemble normally but remain confined to assembly sites (Andres et ah, 
2001b), showing that pE120R is required for the transport of ASFV to the cell 
periphery. The results of the chapter 4 suggest that anterograde transport of ASFV is 
dependent on conventional kinesin and that virions recruit the motor complex via the 
TPR domain of the light chain. The interaction between pE120R and TRP-KLC was 
therefore investigated. An antibody was raised in our laboratory against a peptide 
corresponding to amino acids 5-27 of pE120R and the specificity of the antibody 
(SBl 1) was first tested.
5.1 Characterisation of the antibody raised against pE120R
In order to express pE120R in cells, the E120R ORF was subcloned into the 
mammalian expression vector pcDNA3.1.Zeo+ (pcDNA) from a vector expressing 
pE120R in bacteria (pTrcHisB-E120R).
5.1.1 Sub-cloning E120R ORF downstream a CMV promoter
E120R ORF was excised from pTrcHisB using the restriction enzymes 
BamHl and Hindlll and ligated into the BamHl and HindUl sites of pcDNA vector. 
The correct insertion and orientation of E120R ORF in pcDNA were checked by 
digestion of small-scale preparations of pcDNA-E120R with Xhol and HindUl. The 
size of the E120R ORF is 360 bp (Martinez-Pomares et al., 1997) and it contains a 
Xhol restriction site 50 bp downstream of its codon start. The five clones tested all
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contained a 310 bp insert (Fig. 5.1), confirming the correet insertion and orientation 
of E120R into pcDNA. If the gene would have been cloned in the opposite direction, 
a 50 bp insert would have been visualised.
5.1.2 Biochemical analvsis of El20R-transfected cells
To test the specificity of SBl 1, biochemical analyses of mock-transfected and 
Vero cells transfected for 48 hrs were performed. The predicted molecular mass of 
pE120R is 13.6 kDa (Yanez et a l, 1995). E120R-ORF was expressed transiently into 
Vero cells as described in materials and methods. The products were lysed with IPB 
at 48 hours post-transfection, immunoprecitated with SB ll and analysed by 12.5% 
tris-tricine SDS-PAGE. Figure 5.2A shows that SB ll immunoprecipitated a single 
13.5 kDa protein from cells expressing the E120R ORF (lane 2) but not from mock- 
transfected cells (lane 1). These data suggest that SB ll recognises pE120R and does 
not cross-react with host proteins.
SB ll was further characterised by probing Western blots as described in 
materials and methods. Lysates were prepared from mock-transfected cells and from 
cells transfected for 48 hours with pcDNA-E120R. Figure 5.2B shows that no protein 
was detected in mock-transfected cell extracts (lane 1), confirming that S B ll does 
not cross-react with cellular proteins. A single 13.5 kDa was detected in transfected 
cell extracts (lane 2). These results are consistent with the immunoprécipitation 
analysis (Fig. 5.2 A) and confirm the specificity of SB ll for pE120R.
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Figure 5.1. Cloning E120R reading frame into pcDNA. pcDNA- 
E120R clones were digested by Xhol and HindlM. Digestion produets 
DNA were run on a 1% agarose gel and visualised with ethidium 
bromide. Sizes of DNA markers are shown on the left of the gel and the 
predicted size of the fragments are shown on the right, in base pairs.
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Figure 5.2. Characterisation of the antiserum raised against pE120R.
Vero eells were moek-transfeeted (lane 1) or transfeeted with peDNA-E120R 
(lane 2) and lysed with IPB at 48 hours post-transfeetion Panel A. Cells were 
labelled with ^^ S -methionine and -eysteine for 30 minutes and lysed with 
IPB. Samples were immunopreeipitated with anti-pE120R antibody and 
analysed by 12.5% tris-tricine SDS-PAGE and autoradiography. Panel B. 
Cell lysates were resolved by 12.5% tris-trieine SDS-PAGE, transferred to a 
nitroeellulose membrane and probed with anti-pE120R antibody.
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5.1.3 Analvsis by immunofluorescence of E120R-transfected cells
Finally, the ability of SB ll to react with pE120R by immunofluorescence 
was tested. E120R ORF was expressed transiently into Vero cells and fixed with 
PFA at 48 hors post-transfection. Cells were analysed by indirect 
immunofluorescence using SB ll and, as a cytoplasmic marker, a mouse antibody 
that recognises two ER proteins. DNA was labelled with DAPI. Figure 5.3 shows 
that in expressing cells pE120R was distributed throughout the cell. The signal 
indicative of pE120R was detected in a relatively low number of cells, approximately 
5%. Altogether, the data demonstrate that SB ll can detect pE120R by both 
biochemical and immunofluorescence analyses.
5.2 pE120R localises at the surface of mature virions
5.2.1 pE120R is incomorated into newlv assembled ASFV particles
To examine the cellular localisation of pE120R in ASFV-infected cells, Vero 
cells were infected with Ba71v and fixed with PFA at 4, 8, 12 and 16 hpi (Fig. 5.4). 
Cells were analysed by indirect immunofluorescence using SB ll and C l8, an 
antibody speeific for the early non-structural protein p30 (Afonso et al., 1992). At 4 
and 8 hpi, no signal indicative of pE120R was detectable in p30 positive cells (Fig. 
5.4A and B). At 12 and 16 hours, the p30-positive cells were also pE120R-positive. 
At 12 hpi, the pE120R signal was concentrated in perinuclear areas corresponding to 
viral factories (Fig. 5.4C).
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Figure 5.3. Distribution of pE120R in transfected cells. Vero eells were 
transfected with peDNA-E120R and fixed 48 hours post-transfeetion with 
PFA. Cells were proeessed for immunofluoreseenee using a mouse antibody 
that reeognised the ER proteins calreticulin and protein disulphide isomerase 
(green) and a rabbit anti-pE120R antiserum (red). Cellular DNA was labelled 
with DAPI (blue). Images were collected with a Nikon E800 microscope. 
Seale bar, 20 pm.
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At 16 hpi, the pE120R signal remained concentrated in faetories but also 
showed a punctuate distribution throughout the cytoplasm (Fig. 5.4D). pE120R is 
described as a structural protein (Andres et a l, 2001b) and the dots labelled with 
anti-pE120R antibodies might thus correspond to individual virus particles.
To confirm that pE120R was only detectable after late viral DNA replication, 
infected cells were incubated with 50 pg/ml of cytosine a-D-arabinofuranoside (Ara- 
C) (Fig. 5.4E). Ara-C is a selective inhibitor of DNA replication and can be used to 
prevent expression of late viral DNA-dependent proteins. The drug was added at 2 
hpi, a time calculated to allow virus attachment and entry but before the onset of 
viral DNA replication. Cells were incubated for a further 14 hrs, and then proeessed 
for immunofluorescence using SB ll and C l8. Viral factories were not detectable in 
p30-positive cells, demonstrating that the drug had effectively inhibited DNA- 
dependent viral replication (Fig. 5.4E). No pE120R signal was detectable with the 
anti-pE120R anti-serum in infected cells (Fig. 5.4E), confirming that pE120R 
expression is dependent on viral DNA replication.
To confirm that the bright small dots labelled with anti-pE120R antibodies 
were viral particles (Fig. 5.4D), the immunofluoreseenee analyses was repeated using 
SBl 1 and an antibody specific for the main ASFV capsid, p73. Vero cells were fixed 
with PFA at 16 hpi. Figure 5.5 shows that anti-p73 and anti-pE120R antibodies 
strongly labelled the viral factories. The individual viral particles seattered 
throughout the cytoplasm that were recognised by anti-p73 were also labelled with 
anti-pE120R (merged images), confirming that anti-pE120R antibodies label viral 
particles.
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Figure 5.4. Distribution of pE120R in ASFV infected cells. Vero cells 
were infected with Ba71v strain of ASFV and fixed at 4 (A), 8 (B), 12 (C) or 
16 hours post-infection (D). Samples were incubated with a rabbit antiserum 
raised against pE120R (red) and a mouse antibody against the early viral 
protein p30 (green). Viral and cellular DNA were labelled with DAPI (blue). 
The experiment was repeated and the drug Ara-C (50pg/inl) was added at 2 
hours post-infection (E). Cells were incubated for a further 14 hours at 37°C 
prior to fixation. Images were collected with a Nikon E800 microscope. 
Scale bars, 8 pm.
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Figure 5.5. pE120R is incorporated into ASFV particles. Vero eells 
were infeeted with Ba71v strain of ASFV and fixed with PFA at 16 
hours post-infeetion. Samples were proeessed for immunofluoreseenee 
and ineubated with a rabbit anti serum raised against pE120R (green) 
and a mouse antibody against the eapsid protein p73 (red). Viral and 
eellular DNA were labelled with DAPI (blue). Images were eollected 
with a eonfoeal mieroseope. The white boxes show enlarged views of 
the corresponding images. The right bottom panel is an enlarged view 
of a digital overlay of the 3 images. Seale bar, 8 pm.
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5.2.2 pE120R associates with the external laver of virions
We investigated the Realisation of pE120R in ASFV particles by 
immunoelectron microscopy. Vero cells were fixed at 16 hpi and processed for 
immunogold labelling as described in materials and method. Previous EM analyses 
have revealed that ASFV factories contain membrane-like structures and an ordered 
series of assembly intermediates possessing one to six sides of the hexagon present in 
complete virus. They also contain fiilly assembled particles that appear as electron 
dense hexagons (Fig. 1.2) (Andres et al., 1998; Rouiller et al., 1998).
Figure 5.6 shows that within the assembly sites, gold particles indicative of 
pE120R were found mainly associated with mature icosahedral particles (panels A 
and B, white arrows). Assembly intermediates were occasionally labelled with gold 
particles (yellow arrows). In contrast, non-polyhedral membranous structures were 
not labelled (red arrows). Within the virus particles, the labelling was associated with 
the external layer of the virions (Fig. 5.6C). Mature virions that localised at the 
plasma membrane were also labelled with gold particles (Fig. 5.6D). This study 
indicates that pE120R binds the outer surface of mature particles. These results 
confirm previous lEM studies showing that pE120R is located at the surface of 
intracellular virions (Andres et al., 2001b). In this position, pE120R would have 
access to the kinesin light chain.
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Figure 5.6. pE120R localises to the surface of virions. Ultrathin 
sections of Vero cells infected for 16 hours with Ba71v were processed 
by freeze-substitution and were incubated with anti-pE120R antibodies 
followed by protein-gold labelling. Panels A and B. Within the virus 
factory, gold particles were found associated both with icosahedral 
particles lacking an electron dense nucleoid (yellow arrows) and with 
mature virions (white arrows). The red arrows indicate non-polyhedral 
membranous structures. Scale bars, 250 nm. Panels C and D. Within 
the viral particles, the labelling was associated with the external layer 
of the virions. Scale bars, 200 nm.
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Figure 5.6., continued.
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5.3 Biosynthesis of pE120R in infected cells
5.3.1 pE120R undergoes posttranslational modifications at late stages of infection
The expression of pE120R during infection was analysed by Western blot 
using SB ll. Vero cells were lysed at 8, 12 and 16 hpi with IPB and processed for 
analysis using 12.5% tris-tricine SDS-PAGE. The apparent molecular mass of 
pE120R in transfected cells is 13.5 kDa (Fig. 5.2B). pE120R was not detected at 8 
hpi (Fig. 5.7A, lane 1), in agreement with the immunofluorescence data (Fig. 5.4). 
pE120R was detected at 12 hpi at 13.5 kDa (Fig. 5.7A, lane 2). At 16 hpi, 4 bands, 
with mobilities ranging from approximately 13.5 to 15.5 kDa were visible (Fig. 5.7A, 
lane 3). The 2 fastest migrating isoforms were predominant. These data demonstrate 
that pE120R is expressed at around 12 hpi and suggest that the protein could undergo 
post-translational modifications between 12 and 16 hpi.
SB ll detected a single band at approximately 13.5 kDa, both in cells 
transfected cells with pcDNA-E120R for 48 hours and in cells infected with ASFV 
for 12 hours (Fig. 5.2B and 5.7A, lane 2). To compare more accurately the mobility 
of these two bands, the extracts of transfected cells and infected cells were resolved 
on the same gel (Fig. 5.7B, lanes 2 and 3). Mock-infected cells and cells infected for 
16 hours were also included in the analysis (lanes 1 and 4, respectively). pE120R had 
the same mobility when transiently expressed in cells as in cells taken 12 hours after 
infection (lanes 2 and 3). These 13.5 kDa proteins co-migrated with the fastest of the 
4 forms of pE120R seen at 16 hpi (lane 4). Since a single form of pE120R is detected 
in transfected cells and at 12 hpi, a late virus component might be required for 
modification of pE120R.
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To examine the contribution of virus infection to pE120R modification, the 
Westem-blot analysis was repeated using extracts of transfected cells that had been 
infected 2 hours later with MVA-T7 strain of W  (Fig. 5.7C, lane 3). Mock-infected 
cells (lane 1) and cells infected with ASFV for 16 hours (lane 2) were added as 
controls. No protein was detected in mock-infected cells (lane 1). Four bands, 
ranging from 13.5 to 15.5 kDa were recognised by SB ll in extracts taken 16 hours 
after ASFV infection (lane 2), in agreement with the previous analyses. These 4 
forms were also detected in MVA-T7 infected cells expressing E120R (lane 3). 
These results show that modifications of pE120R can be reconstituted using MVA- 
T7. This indicates that either both viruses activate the cellular component responsible 
for pE120R modifications, or that they encode proteins that modify pE120R directly.
5.3.2 pE120R is not serine phosphorvlated at its C terminus during MVA-T7
infection
Sequence comparison using the GCG protein motif database revealed that 
pE120R contains three putative serine phosphorylation sites, all located at its C 
terminus; serine 115, 116 and 119. Phosphorylation at these positions was studied by 
site-directed mutagenesis, converting the codons to glycine (115) or alanine (116 and 
119). A vector containing all 3 mutations was also produced. Vero cells were 
transfected with the mutants pE120R-S^^^, pE120R-S^^^, pE120R-S^^^ or pE120R- 
gii5,116,119 infected 2 hrs later with MVA-T7 strain of W  (Fig. 5.8, lanes 2 to 5).
Cells transfected with the wild-type E120R vector and infected 2 hrs post- 
transfeetion with MVA-T7 for 16 hours were also analysed (lane 1).
121
A B C
kDa 1 2  3 1 2  3 4 1 2  3
f
15 ----- m
10 -
Figure 5.7. pE120R undergoes post-translational modifications at 
late times of infection. Vero cells were lysed with IPB at different 
times following infection and/or E120R transfection. Cell lysates were 
resolved by 12.5% tris-tricine SDS-PAGE, transferred to a 
nitrocellulose membrane and probed with anti-pE 120R antibody. Panel 
A. Cells were infected with Ba71v and lysed at 8 (lane 1), 12 (lane 2) 
or 16 hours post-infection (lane 3). Panel B. Cells were transfected 
with pcDNA-E120R for 48 hours (lane 2) or infected with Ba71 for 12 
or 16 hours (lanes 3 and 4, respectively). Mock-transfected mock- 
infected cells were used as controls (lane 1). Panel C. Vero cells were 
transfected with pcDNA-E120R and infected with MVA-T7 2 hours 
later for 16 hours (lane 3). Mock-infected cells were used as negative 
controls (lane 1) and cells infected with Ba71v for 16 hours were used 
as positive controls (lane 2).
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Figure 5.8. pE120R is not serine phosphorylated at its C terminus 
during MVA-T7 infection. Vero cells were transfected with wild-type 
or mutants pcDNA-E120R and infected 2 hours later with MVA-T7. 
Cells were lysed with IPB at 16 hours post-infection. Lysates were 
resolved by 12.5% tris-tricine SDS-PAGE, transferred to a 
nitrocellulose membrane and probed with anti-pE120R antibody.
Lane 1: cells transfected with wild-type pcDNA-E120R; Lane 2: cells 
transfected with pcDNA-E120R-S'Lane 3: cells transfected with 
pcDNA-E 120R-S' ^ L a n e  4: cells transfected with pcDNA-E120R- 
S*^ ;^ Lane 5: cells transfected with pcDNA-E12()R-S” ”’’'' ’^’' ' ‘^.
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Cells were lysed with IPB and samples were resolved with 12.5% tris-tricine 
SDS-PAGE. Western blot analyses were performed using SB ll. As shown in figure 
5.8, none of the single mutations abolished modifications of pE120R (lanes 2 to 4). 
The triple pE120R mutant also produced four forms of pE120R (lane 5). These 
analysis show that pE120R is not serine phosphorylated at its C terminus during 
MVA-T7 infection.
5.3.3 pE120R interacts with the main capsid protein p73
To investigate further the biosynthesis of pE120R during ASFV infection, 
immunoprécipitation analyses were performed. Vero cells were mock-infected or 
infected with Ba71v for 16 hrs and lysed with IPB. Figure 5.9 shows that SB ll 
immunoprecipitated three proteins that were not detected in uninfected cells: two low 
molecular mass proteins of approximately 14 kDa and 16 kDa and an additional 70 
kDa protein (Fig. 5.9, arrows). The two low molecular weight proteins could be two 
pE120R isoforms. The additional 70 kDa band might represent a protein that 
interacts with pE120R. Previous work has shown that pE120R interacts with the 
main ASFV capsid protein p73 (Andres et al., 2001b) and we therefore investigated 
whether the 70 kDa protein detected here was p73. Mock-infected and Ba71v- 
infected Vero cells were lysed at 16 hpi with IPB and extracts were 
immunoprecipitated with 4H3, an anti-p73 antibody. The material 
immunoprecipitated with 4H3 was Western-blotted with SB ll (Fig. 5.10).
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Figure 5.9. The anti-pE120R antibody immunoprecipitates 3 proteins in 
infected cells. Vero cells were infected with Ba71v for 16 hours (lane 2) or 
mock infected (lane 1), labelled with -methionine and -cysteine for 30 
minutes and lysed with IPB. Lysates were immunoprecipitated with the anti- 
pE120R antibody SBll and analysed by 12.5% tris-tricine SDS-PAGE and 
autoradiography.
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Figure 5.10. pE120R interacts with the major capsid protein p73 at 16 
hours post-infection. Vero cells were infected with Ba71v for 16 hours (lane 2) 
or mock-infected (lane 1) and lysed with IPB. Cell extracts were 
immunoprecipitated with an antibody specific for p73, resolved by 12.5% tris- 
tricine SDS-PAGE, transferred to a nitrocellulose membrane and probed with 
SBll.
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Since SB ll specificity for pE120R has been ascertained (Fig. 5.2), this 
experiment suggests that two molecular forms of pE120R interact with the major 
capsid protein p73. These results are in agreement with previous work showing that 
material immunoprecipitated with anti-pE120R antibody contains p73 (Andres et al., 
2001b).
5.4 Investigation of the interaction between pE120R and TPR- 
KLC
In order to investigate the putative interaction between pE120R and the TPR 
domain of conventional kinesin light chain, co-immunoprecipitation analyses were 
performed in vitro and in vivo.
5.4.1 pE120R does not interact with GFP-TPR-KLC in vitro
pE120R and GFP-TPR-KLC were transcribed and translated in vitro in a cell- 
free system, either separately (Fig. 5.11, lanes 1 and 2) or together (Fig. 5.11, lanes 3 
and 4). The products were immunoprecipitated with SB ll (lanes 1 and 3) or with 
anti-GFP antibody (lanes 2 and 4). SB ll immunoprecipitated a single 13.5 kDa 
protein when pE120R was expressed alone (lane 1), confirming previous results (Fig. 
5.2). The antibody specific for GFP immunoprecipitated a single product at 
approximately 75 kDa (lane 2), which is the size of the recombinant polypeptide 
GFP-TRP-KLC (Fig. 4.4). When the two proteins were expressed together (lanes 3 
and 4), SB ll did not co-immunoprecipitate GFP-TPR and anti-GFP antibodies did 
not co-immunoprecipitate pE120R. This experiment demonstrates that pE120R does
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not interact with the TPR domain of conventional kinesin light chain when 
synthesised in vitro. pE120R undergoes post-translational modifications during 
ASFV infection (Fig. 5.7) and it is possible that these modifications, that do not 
occur in vitro (Fig. 5.2 and 5.11), play a role in the binding with TPR-KLC. Since 
previous experiments had shown that MVA-T7 infection modifies pE120R (Fig. 5.7), 
co-immunoprecipitation experiments were performed using lysates of transfected 
cells infected with MVA-T7.
5.4.2 pE120R does not interact with GFP-TPR-KLC in vivo
Vero cells were transfected with pcDNA-E120R (Fig. 5.12, lane 1), pEL- 
GFP-TPR-KLC (Fig. 5.12, lane 2) or with the 2 vectors together (Fig. 5.12, lanes 3 
and 4). Two hrs later, cells were infected with the MVA-T7 strain of W . The cells 
were metabolically labelled for 45 minutes at 16 hpi and lysed with IPB. Cell 
extracts were immunoprecipitated with SB ll (lanes 1 and 3) or with anti-GFP 
antibodies (lanes 2 and 4) and analysed by 12.5% tris-tricine SDS-PAGE. Three 
forms of pE120R were immunoprecipitated by SB ll in the corresponding 
transfected cells (lane 1). GFP antibodies recognised two proteins at around 75 kDa 
(lane 2), in agreement with previous Western blots analyses (Fig. 4.4). A few extra 
proteins were immunoprecipitated by GFP antibodies, including a predominant 65 
kDa protein. The nature of this protein is unknown. When pE120R and GFP-TRP- 
KLC were expressed together (lanes 3 and 4), SB ll did not co-immunoprecipitate 
GFP-TPR-KLC and GFP antibodies did not co-immunoprecipitated pE120R. Taken 
together, these data suggest that pE120R does not bind directly to the TPR domain of 
conventional kinesin light chain.
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Figure 5.11. Investigation of the interaction between pE120R and GFP-TPR- 
KLC by in vitro co-immunoprecipitation analyses. pE120R (lane 1) and GFP- 
TPR-KLC (lane 2) were expressed in a cell free system containing -methionine 
and -cysteine and the products were immunoprecipitated with anti-pE120R and anti- 
GFP antibodies, respectively. The two proteins were expressed together and 
immunoprecipitated with anti-pE120R antibodies (lane 3) or anti-GFP antibodies 
(lane 4). Samples were analysed by 12.5% tris-tricine SDS-PAGE and 
auto rad in granh v.
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Figure 5.12. Investigation of the interaction between pE120R and GFP-TPR- 
KLC by in vivo co-immunoprecipitation analyses. Vero cells were transfected 
with pcDNA-E120R (lane 1), pEL-GFP-TPR-KLC (lane 2) or the 2 vectors together 
(lanes 3 and 4). Two hours post-transfection, cells were infected with MVA-T7 for 
16 hours. Cells were labelled with '^S -methionine and -cysteine for 45 minutes and 
lysed with IPB. Lysates were immunoprecipitated with anti-pE120R antibodies 
(lanes 1 and 3) or anti-GFP antibodies (lanes 2 and 4) and resolved by 12.5% tris- 
tricine SDS-PAGE.
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The role of pE120R in ASFV transport is thus likely to be indirect. One could 
imagine that pE120R interacts with the protein that recruits conventional kinesin 
light chain to the virus. If this protein is a viral protein, a good candidate is the main 
capsid component p73, which binds to pE120R (Fig. 5.9 and 5.10) (Andres et al., 
2001b). We have therefore investigated the interaction between p73 and the TPR 
domain of conventional kinesin light chain.
5.5 Investigation of the interaction between p73 and TPR-KLC
5.5.1 p73 interacts with GFP-TPR-KLC in vitro
A construct containing the p73 coding region was available in our laboratory 
(Cobbold et al., 1996) and was used to study the putative interaction between p73 
and GFP-TPR-KLC. p73 and GFP-TPR-KLC were transcribed and translated in vitro 
in a cell-free system, either separately (Fig. 5.13, lanes 1 and 2) or together (Fig. 
5.13, lanes 3 and 4), as described in materials and methods. The products were 
immunoprecipitated with anti-GFP antibodies (lanes 2 and 3) or with 4H3, an 
specific antibody that recognises the conformationally mature form of p73 (lanes 1 
and 4) (Cobbold et al., 1996; Cobbold et al., 2001). As expected from previous work 
(Cobbold et al., 2001), 4H3 immunoprecipitated a single 70 kDa protein (lane 1). 
The antibody specific for GFP immunoprecipitated a single 75 kDa product (lane 2), 
which is the size of the recombinant polypeptide GFP-TRP-KLC (Fig. 4.4). When 
the two proteins were expressed together, GFP antibodies also immunoprecipitated 
p73 (lane 3). No signal was detected in lane 4, suggesting that 4H3 antibodies do not 
bind to p73 when the protein is co-expressed with GFP-TPR-KLC. This experiment
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suggests that p73 interacts with GFP-TPR-KLC in vitro and that the interaction 
between p73 and GFP-TPR-KLC hides p73 epitopes that are recognised by 4H3.
5.5.2 The interaction between p73 and GFP-TPR-KLC cannot be detected in vivo
To confirm the interaction between the main ASFV capsid protein p73 and 
TPR-KLC during ASFV infection, Vero cells were transfected with pEL-GFP-TPR- 
KLC and infected 2 hrs later with Ba71v. Cells were metabolically labelled for 45 
minutes, lysed at 16 hpi, and immunoprecipitated with anti-GFP antibodies (Fig. 
5.14). Mock-transfected cells and cells transfected with pEL-GFP were also analysed 
(lanes 1 and 2, respectively). No signal was detected in mock transfected cell extracts 
(lane 1). A 27 kDa band was recognised in cells expressing GFP (lane 2), as expected 
from previous results (Fig. 4.3). An extra unidentified 25 kDa protein was also 
immunoprecipitated by anti-GFP antibodies. In cells transfected with pEL-GFP- 
TPR-KLC, anti-GFP antibodies immunoprecipitated two proteins at around 75 kDa 
(lane 3). This 75 kDa double band was also detected by immunoprécipitation 
analyses of MVA-T7 infected cells expressing GFP-TPR-KLC (Fig. 5.12). Similarly, 
Western blot analyses have shown that two 75 kDa proteins were detected by anti- 
GFP antibodies in cells expressing GFP-TPR-KLC and infected with Ba71v or 
MVA-T7 (Fig. 4.4). Taken together these results suggest that the two 75 kDa 
proteins detected by Western blot and immunoprécipitation analyses are likely to 
represent two forms of the polypeptide GFP-TPR-KLC. No additional proteins were 
immunoprecipitated by anti-GFP antibodies in ASFV-infected cells (Fig. 5.14, lane 
3), suggesting that this experiment is not appropriate to detect the binding partner(s) 
of TPR-KLC.
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Figure 5.13. Investigation of the interaction between p73 and GFP- 
TPR-KLC by in vitro co-immunoprecipitation analyses. p73 (lane 1) 
and GFP-TPR-KLC (lane 2) were expressed in a cell free system 
containing -methionine and -cysteine and the products were 
immunoprecipitated with anti-p73 and anti-GFP antibodies, 
respectively. The two proteins were expressed together and 
immunoprecipitated with anti-GFP antibodies (lane 3) and anti-p73 
antibodies (lane 4). Samples were analysed by 12.5% tris-tricine SDS- 
PAGE and autoradiography.
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Figure 5.14. No viral protein co-precipitates with GFP-TPR-KLC 
in ASFV infected cells. Vero cells were mock-transfected (lane I), 
transfected with pEL-GFP (lane 2), or with pEL-GFP-TPR-KLC (lane 
3) and infected 2 hours later with Ba71 v. Cells were labelled with ^^ S - 
methionine and -cysteine for 45 minutes, lysed with IPB at 16 hours 
post-infection and immunoprecipitated with anti-GFP antibodies. 
Samples were analysed by 12.5% tris-tricine SDS-PAGE and 
autoradiography.
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6 Centrosome damage could explain microtubule re­
organisation in ASFV infected cells
Previous chapters have demonstrated that ASFV particles require 
microtubules and the motor conventional kinesin for their transport from assembly 
sites to the plasma membrane. Immunofluorescence analyses also revealed that the 
organisation of the microtubule network was disrupted at late stages of infection 
(Fig. 3.1). In this chapter, this microtubule re-organisation is described in more 
details. The effect of ASFV infection on centrosome integrity was also investigated. 
Finally, I have examined whether the viral protein pJ13L, which shares some 
sequence similarities with cellular microtubule associated proteins (MAPs) (Alonso 
et al., 2001), could be involved in microtubule re-arrangements and/or centrosome 
instability.
6.1 Effect of ASFV infection on the micro tubule network
6.1.1 ASFV infection disrupts microtubule organisation
The distribution of microtubules in Vero cells infected with Ba71v for 8, 12 
and 16 hrs was analysed by immunofluorescence using a mouse monoclonal 
antibody against a-tubulin (Fig. 6.1). At 8 hrs, infected cells were identified using a 
biotinylated antibody against the non-structural protein p30, which is expressed as 
early as 2 hpi (Afonso et al., 1992). At 12 and 16 hpi, infected cells were visualised 
using a rabbit antiserum specific for the structural protein pE120R. Cellular and viral 
DNA were labelled with DAPI. Figure 6.1 A shows that at 8 hpi no obvious changes
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in the astral organisation of the microtubule cytoskeleton were noticeable in infected 
cells. Microtubules radiated out from a perinuclear aster to the cell periphery both in 
cells positive and negative for p30 (arrows). At 12 hpi, microtubule converging 
centres were no longer detectable. Microtubules were partially excluded from the 
viral factories and more condensed at the cell periphery (Fig. 6.IB).
At 16 hpi, microtubules were completely excluded from viral factories and 
were often forming quasi-spherical rings around the cytoplasm (Fig. 6.1C). Cells 
with long projections containing microtubule bundles were also observed at 16 hpi 
(Fig. 6. ID, arrows). Interestingly, virions were often seen associated with these long 
microtubules (Fig. 6.ID, white boxes). These observations are in agreement with 
previous work showing microtubules re-arrangement in Vero cells infected with the 
Lisbon-60 ASFV strain (Carvalho et al., 1988).
6.1.2 ASFV infection induces the stabilisation and hvoer-acetvlation of
microtubules
In chapter 1, we investigated the role of the microtubule network in ASFV 
transport from assembly sites to the cell surface. When conventional kinesin function 
was abolished by using a dominant negative TPR construct, ASFV spread was 
inhibited at 97% (Fig. 4.12), suggesting that kinesin-based transport is the unique 
mechanism exploited by ASFV to reach the cell periphery. However, when infected 
cells were incubated with the microtubule-destabilising drug nocodazole from 12 to 
16 hpi, “only” 88% of ASFV spread to the cell periphery was inhibited (Fig. 3.3). 
One explanation for this discrepancy where 12% of ASFV particles move in the 
absence of intact microtubules could be that ASFV infection protects a subset of 
microtubules against nocodazole depolymerisation.
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Figure 6.1. ASFV infection disrupts microtubule 
organisation. Vero cells were infected with the Ba71v strain 
of ASFV and fixed with PFA at 8 (A), 12 (B) or 16 hours 
post-infection (C and D). Samples were incubated with an 
antibody against a-tubulin (green). Infected cells were 
visualised with a biotinylated antibody specific for the early 
viral protein p30 (A) or a rabbit antibody specific for the late 
ASFV structural protein pE120R (B to D) (red). Viral and 
cellular DNA were labelled with DAPI (blue). Preparations 
were viewed with a Leica TCS NT confocal microscope. 
The arrows indicate microtubule organising centres in panel 
A and microtubule bundles in panel D. Scale bars, 8 pm.
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Figure 6.1, continued.
134
To test this hypothesis, Vero cells were infected with Ba71v and incubated 
with 10 pg/ml of nocodazole at 12 hpi for 4 hrs. Cells were fixed at 16 hrs with PFA 
and processed for immunofluorescence by using a mouse antibody against a-tubulin 
and a rabbit antiserum specific for the structural protein pE120R. Cellular and viral 
DNA were labelled with DAPI. Figure 6.2A shows that microtubules were totally 
depolymerised in cells negative for pE120R signal (star). In infected cells, a 
subpopulation of microtubules that were not depolymerised and therefore resistant to 
the drug treatment was observed (arrow). These microtubules appeared as bright 
fluorescent tracks within a strong diffuse fluorescence signal provided by 
depolymerised tubulin. The numbers of non-depolymerised microtubules varied from 
cell to cell. Panels A and B of figure 6.2 compare the distribution of ASFV particles 
in cells with low or high numbers of intact microtubules. There was a positive 
correlation between the number of stabilised microtubules and the number of viral 
particles in the cytoplasm of nocodazole-treated cells (compare top and bottom 
panels). These data suggest that ASFV infection partly stabilises the microtubule 
network.
The immunofluorescence analysis was repeated using an antibody against 
acetylated-tubulin. Although its role is not clear, acetylated tubulin is known to 
accumulate in stable but not dynamic microtubules (Pipemo et al., 1987; 
Rosenbaum, 2000). Vero cells were infected with the Ba71v strain of ASFV and 
fixed with PFA at 16 hpi. Cells were analysed by indirect immunofluorescence using 
a mouse monoclonal antibody against acetylated a-tubulin and the rabbit anti- 
pE120R antibody. Figure 6.3A shows that the acetylated a-tubulin signal was 
brighter in infected cells (arrow) when compare to cells negative for viral antigens
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(stars). Acetylated a-tubulin appeared to be concentrated around the virus assembly 
site. Immunofluorescence preparations viewed at higher magnification showed that 
all cytoplasmic viral particles were aligned on acetylated microtubules (Fig. 6.3B, 
right panels). The acétylation of a-tubulin was also analysed by Western blot of total 
cell lysates collected at different times post-infection. Vero cells were infected for 
the indicated time with BaVlv and samples were processed as described in materials 
and methods. Immunodetection of p30 was used as a marker of infection. The overall 
level of a-tubulin was also studied. Figure 6.4 shows that p30 was first detected at 8 
hpi and that the levels of expression of the protein increased while the infection 
progressed. The level of acetylated tubulin increased at around 12 hpi, a time that 
correlated with the start of ASFV movement into the cytoplasm from the virus 
factory (Fig. 3.1). At 16 hpi, the level of acetylated tubulin is lower than at 12 hpi. 
The overall level of a-tubulin stayed constant during infection showing that ASFV 
increased acétylation of tubulin rather than increasing the synthesis of tubulin in the 
cells (Fig. 6. 4).
Altogether, these experiments suggest that ASFV infection induces the 
stabilisation and hyper-acetylation of microtubules and that these cytoskeleton 
manipulations may be linked to virus movement throughout the cytoplasm.
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Figure 6.2. A subpopulation of microtubules is resistant to nocodazole 
treatment in cells infected with ASFV. Vero cells were infected with Ba71v strain 
of ASFV and nocodazole (lOpg/ml) was added at 12 hours post-infection. Cells 
were incubated for a further 4 hours at 37 C prior to fixation with PFA and 
immunofluorescence microscopy analyses. Infected cells were identified using a 
rabbit antiserum raised against the viral structural protein pE120R (red). A mouse 
antibody against a-tubulin was used to label tubulin (green). Viral and cellular DNA 
were labelled with DAPI (blue). Images were collected with a Nikon E800 
microscope. The star indicates a cell that is pE 120R-negative while the arrow 
indicates stabilised microtubules in a pE120R-positive cell. Scale bars, 8 pm. The 
figure compares cells with low (panel A) and high (panel B) numbers of stabilized 
microtubules.
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Figure 6.3. Distribution of acetylated microtubules in ASFV 
infected. Vero cells were infected with BaVlv strain of ASFV and fixed 
at 16 hours post-infection. Samples were incubated with a rabbit 
antiserum raised against the viral structural protein pE 120R (red) and a 
mouse antibody against acetylated a-tubulin (green). Viral and cellular 
DNA were labelled with DAPI (blue). Samples were viewed with a 
confocal microscope. Scale bars, 8 pm. Panels A. The stars indicate two 
cells that are pE120R negative while the arrow indicates stabilised 
microtubules in a pE120R-positive cell. Panels B. Preparations were 
viewed at a higher magnification. Images shown were collected 
independently and digitally overlayed. Right panels are enlarged views 
of parts of the left image.
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4Figure 6.3, continued.
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Figure 6.4. Level of expression of a-tubulin, acetylated a- 
tubulin, y-tubulin and pericentrin in ASFV infected cells. Vero 
cells were infected with BaVlv strain of ASFV and lysed with IPB 
at the indicated times. Proteins were resolved by 12.5% tris-tricine 
SDS-PAGE. Samples were analysed by Western blot with 
antibodies specific for p30, a-tubulin, acetylated a-tubulin and y- 
tubulin as indicated. The level of pericentrin was assayed by 
immunoprécipitation. Cells were labelled with '^S -methionine and 
-cysteine for 60 minutes, prior to be lysed and immunoprecitated 
with anti-pericentrin antibodies.
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6.2 ASFV infection disrupts centrosome assembly and function
6.2.1 ASFV infection reduces the centrosomal recruitment of 7-tubulin and
pericentrin
Pericentrin and y-tubulin are centrosome proteins that play a role in 
microtubule nucléation and organisation (Dictenberg et al., 1998; Young et al.,
2000). For nucléation to take place, pericentrin and y-tubulin must first be recruited 
to and assemble onto the centrosome. Given the loss of microtubule radiation from 
the centrosome observed in infected cells (Fig. 3.2 and 6.1), the effect of ASFV 
infection on the recruitment of nucleating proteins to the centrosome was studied.
The location of y-tubulin was analysed in Vero cells infected with BaVlv for 
8, 12 and 16 hrs. Cells were fixed with methanol and processed for 
immunofluorescence analyses. A mouse antibody specific for y-tubulin was used to 
localise the centrosomal protein. At 8 hpi, infected cells were identified with a 
biotinylated antibody specific for the early viral protein p30. At 12 and 16 hpi, 
infected cells were visualised with a rabbit antibody specific for the late structural 
protein pE120R. Figure 6.5 shows that 8 hrs following infection, the y-tubulin signal 
had a similar intensity in p30-positive and -negative cells. At 12 hrs, the y-tubulin 
signal was often diminished in cells positive for the protein pE120R when compared 
to cells negative for viral antigen (Fig. 6.5, thin arrow).
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Figure 6.5. Distribution of y-tubuiin in ASFV infected cells. Vero cells were 
fixed with methanol 8 (A), 12 (B) or 16 (C) hours after infection with BaVlv strain 
of ASFV. Samples were processed for immunofluorescence and incubated with a 
mouse antibody against y-tubulin (green). Infected cells were visualised with a 
biotinylated antibody specific for the early viral protein p30 (A) or with a rabbit 
antibody specific for the late structural protein pE120R (B and C) (red). Viral and 
cellular DNA were labelled with DAPI (blue). Preparations were viewed with a 
Nikon E800 microscope. The left panels are overlays of ten 0.2pm-thick optical 
sections of the same view. The thin arrow indicates a cell with a reduced level of 
y-tubulin. The thick arrows show cells that have lost the y-tubulin signal. Scale 
bars, 8 pm.
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More than 120 cells were closely examined and the analyses revealed that 
approximately 50% of cells positive for the protein pE120R exhibited a reduced y- 
tubulin signal at 12 hpi (n=121). At 16 hrs, the y-tubulin signal was reduced in 
approximately 30% of infected cells and not longer detectable in 60% of infected 
cells (n=124) (Fig. 6.5, thick arrow). To ensure that the loss of y-tubulin signal did 
not arise because the centrosome was out of the plane of focus, ten 0.2 pm-thick 
optical sections of the same view were taken and overlaid.
The same experiment was repeated using a rabbit antibody for pericentrin 
and, to identify infected cells, a mouse antibody recognising the early protein p30 or 
a mouse antibody specific for the ASFV capsid protein p73 (Cobbold et al., 1996). 
Identical results were found (Fig. 6.6). At 8 hrs, the pericentrin signal had a similar 
intensity in p30-positive and -negative cells. At 12 hrs, the pericentrin signal was 
clearly diminished in approximately half of the cells positive for the protein p73 
when compared to cells negative for viral antigen (n=108) (Fig. 6.6, thin arrow). At 
16 hpi, pericentrin staining was either reduced (47%) (thin arrow) or lost (45%) 
(thick arrow) whereas clearly visible in all cells negative for viral antigens (n=l 17).
These experiments demonstrate that reduction of y-tubulin and pericentrin 
signal at the centrosome occurs late during infection and suggest involvement of late 
viral gene expression. To confirm these findings, Vero cells were incubated with 50 
pg/ml cytosine a-D-arabinofuranoside (ARA-C) 2 hrs after BaVlv infection. ARA-C 
is a selective inhibitor of DNA replication and can be used to prevent expression of 
late viral DNA-dependent proteins. Cells were incubated for a further 14 hrs, and 
then processed for immunofluorescence analysis. Infected cells were identified with
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positive staining for the non-structural protein p30, which is expressed as early as 2 
hpi (Afonso et al., 1992). Figure 6.7 shows that cells positive for p30 were lacking 
extranuclear DAPI staining, indicating that the drug had effectively inhibited ASFV 
late DNA replication. No reduction of centrosome markers was observed in p30- 
positive cells, compared to p30-negative cells, demonstrating that centrosome 
damage is dependent on late viral gene expression.
The reduction of y-tubulin and pericentrin at the centrosome observed at late 
times post-infection could result from protein degradation or redistribution. To 
distinguish between the two possibilities, the level of expression of y-tubulin and 
pericentrin were analysed at different times post-infection. The expression of y- 
tubulin was examined by Western blot analyses and the level of pericentrin was 
assessed by immunoprécipitation analyses. Vero cells were infected with ASFV for 
the indicated times and processed as described in material and methods. For 
pericentrin immunoprécipitation, infected cells were metabolically labelled for 60 
minutes. Figure 6.4 shows that the level of y-tubulin slightly increased at around 12 
hpi and remained at the same level to 16 hours, while the level of pericentrin stayed 
constant while infection progresses. The experiment suggests that the reduction of y- 
tubulin and pericentrin signal at the centrosome in ASFV infected cells is due to a 
reduction of centrosomal recruitment of the nucleating proteins, rather than 
degradation of the proteins.
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Dapi / pericentrin
Dapi / pericentrin
Figure 6.6. Distribution of pericentrin in ASFV infected cells. Vero cells 
were fixed with methanol 8 (A), 12 (B) or 16 hours (C) after infection with 
Ba71v strain of ASFV. Samples were processed for immunofluorescence 
and incubated with a rabbit antibody against pericentrin (green). Infected 
cells were visualised with a mouse antibody specific for the early viral 
protein p30 (A) or with a mouse antibody specific for the late capsid protein 
p73 (B and C) (red). Viral and cellular DNA were labelled with DAPI 
(blue). Preparations were viewed with a Nikon E800 microscope. The left 
panels are overlays of ten 0.2 pm-thick optical sections of the same view. 
The thin arrow indicates a cell with a reduce level of pericentrin. The thick 
arrows show cells that have lost the pericentrin signal. Scale bars, 8 pm.
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Dapi / pericentrin
Dapi / Y-tubuim
Figure 6.7. Reduction of proteins signal at the centrosome is dependent of late 
viral protein synthesis. The drug Ara-C (50 pg/ml) was added at 2 hours post­
infection and cells were incubated for a further 14 hours prior to fixation. DNA 
was labelled with DAPI (blue) Panel A. The samples were incubated with a rabbit 
antibody against pericentrin (green) and mouse antibody against the early viral 
protein p30 (red). Panel B. The samples were incubated with a mouse antibody 
against y-tubulin (green) and biotinylated antibody against p30 (red). Preparations 
were viewed with a Nikon E800 microscope. The left panels are overlays of ten 
0.2 pm-thick optical sections of the same view. Scale bars, 8 pm.
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6.2.2 ASFV infection affects centrosome function
It is known that centrosomes with reduced levels of pericentrin and y-tubulin 
have a diminished capacity to nucleate microtubules (Young et al., 2000). The 
capacity of microtubules to re-nucleate following their depolymerisation by the drug 
nocodazole in infected Vero cells was therefore tested. Nocodazole was added at 12 
hpi at a concentration of 10 pg/ml and cells were incubated for a further 4 hrs. The 
cells were washed three times and microtubules were allowed to repolymerise for 
one, three or 15 minutes, prior to PFA fixation. Cells were processed for 
immunofluorescence using a mouse antibody specific for a-tubulin. Viral factories 
were located by extranuclear DAPI staining of viral DNA and by the presence of 
viral particles revealed by the rabbit anti-pE120R antibody (Fig. 6.8). In uninfected 
cells, one minute following nocodazole washout, new microtubules were observed 
growing out from the centrosome as small star-like structures (arrows) while in 
infected cells, such structures were not observed (Fig. 6.8A). After three minutes 
following removal of nocodazole, microtubules started to elongate from the 
centrosome toward the cell periphery in cells negative for viral antigens (Fig. 6.8B, 
arrows). In infected cells, microtubules were still not repolymerised (Fig. 6.8B). 
After 15 minutes following removal of nocodazole, microtubules eventually 
repolymerised in infected cells but did not converge into a perinuclear centre (Fig. 
6.8C). The data demonstrate that, in cells infected with ASFV, the ability of the 
centrosome to nucleate microtubules is highly compromised. Disruption of 
centrosome function in ASFV infected cells could explain microtubules re­
organisation observed at late times post-infection (Fig. 6.1).
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Dapi a-tubulin pE120R
Figure 6.8. The ability of the centrosome to nucleate microtubules is highly 
compromised in ASFV infected cells. Nocodazole (lOpg/ml) was added at 12 
hours post-infection and cells were incubated for a further 4 hours. Prior to 
fixation, the drug was washed-out to allow microtubules to repolymerise for the 
indicated times. Samples were incubated with a specific antibody for the late 
ASFV structural protein pE120R (left panels) and with an antibody against a- 
tubulin (middle panels). Viral and cellular DNA were labelled with DAPI (left 
panels). Preparations were viewed with a Nikon E800 microscope. The arrows 
indicate the position of the centrosome. Scale bars, 8 pm.
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6.3 pJ13L is not directly responsible for microtubule re­
arrangement in ASFV infected cells
W  and HSV-1 encode proteins that, when expressed alone, bind to and 
reorganise the microtubule network, in a manner reminiscent of cellular microtubule- 
associated proteins (MAPs) (Elliott and O'Hare, 1998; Ploubidou et a l, 2000). It has 
been suggested that microtubule re-organisation during W  and HSV-1 infection 
could be partly explained by high level of expression of these virally encoded MAPs 
(Ploubidou et a l, 2000). The sequence of the ASFV protein pJ13L resembles 
proteins of the 190 kDa family of mammalian MAPs in containing six repeats of a 
proline-, alanine- and threonine-rich domain (Alonso et a l, 2001). Given the effects 
of W  and HSV-1 MAPs on microtubule organisation in expressing cells, we 
examined if pJ13L would perturb the microtubule network in a similar manner. To 
test this hypothesis, immunofluorescence experiments were performed in cells 
expressing pJ13L.
6.3.1 pJ13L exhibits a ER-like distribution in expressing cells
Vero cells were transiently transfected with the expressing vector pcDNA- 
TOPO-V5-J13L that was available in our laboratory. Cells were fixed with PFA at 
48 hrs post-transfection and processed for immunofluorescence analyses using a 
rabbit anti-serum specific for pJ13L (Sun et a l, 1995) and a mouse antibody against 
a-tubulin. Figure 6.9 shows that, in expressing cells, pJ13L exhibited an ER-like 
pattern that did not match the distribution of microtubule filaments. These data are in
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agreement with recent work showing that pJ13L targets the ER when expressed 
alone (Rodriguez et al., 2004). Interestingly, the normal astral microtubule 
organisation seemed disrupted in cells expressing pJ13L, suggesting that pJ13L 
expression could lead to micro tubule re-arrangement. Nonetheless, these changes are 
not mediated by a direct interaction between pJ13L and microtubules.
6.3.2 The level of pericentrin and y-tubulin are not affected bv nJ13L
To investigate whether pJ13L would be involved in the loss of nucleating 
proteins at the centrosome in ASFV-infected cells (Fig. 6.5 and 6.6), the above 
experiment was repeated. Cells were transfected with the expressing vector pcDNA- 
TOPO-V5-J13L and fixed with PFA 48 hours later. Cells were processed for 
immunofluorescence analyses and incubated with a rabbit antibody against 
pericentrin or a mouse antibody against y-tubulin. The localisation of pJ13L was 
visualised by using a rabbit anti-serum specific for pJ13L (Sun et al., 1995) or a 
mouse antibody against the V5 epitope. Figure 6.10 shows that no reduction of 
centrosome markers was observed in pJ13L expressing cells, compared to control 
cells, suggesting that pJ13L expression does not affect the recruitment of pericentrin 
or y-tubulin to the centrosome.
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a-tubulin
Figure 6.9. Distribution of a-tubulin in cells expressing pJ13L. Vero cells 
were transfected with pcDNA-TOPO-V5-J13L and fixed with PFA 48 hours 
later. Cells were processed for immunofluorescence analyses by using a rabbit 
anti-pJ 13 L antibody (red) and a mouse antibody against a-tubulin (green). 
Cellular DNA was labelled with DAP I (blue). Images were collected with a 
Nikon E800 microscope. Scale bars, 8 pm.
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Dapi + Y tubulin
Dap! + pericentrin
Figure 6.10. Distribution of 7-tubuIin and pericentrin in cells expressing pJ13L.
Vero cells were transfected with pcDNA-TOPO-V5-J13L. Cells were fixed with 
PFA 48 hours later and were processed for immunofluorescence. Cellular DNA was 
labelled with DAPI (blue). Panels A. Cells were labelled with a rabbit anti-pJ13 L 
antibody (red) and a mouse antibody against y-tubulin (green). Panels B. Cells were 
labelled with a mouse anti-V5 antibody (red) and a rabbit antibody against 
pericentrin (green). Images were collected with a Nikon E800 microscope. Scale 
bars, 8 pm.
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7 ASFV uses an actin-based transport at the plasma 
membrane
Approximately 80% of mature ASFV particles are found aligned on 
microtubule filaments at 16 hpi (Fig. 3.2). The virions that are not associated with 
microtubules are found in the peripheral regions of the cytoplasm (Fig. 3.2, arrows). 
Actin filaments are most highly concentrated in the cell cortex beneath the plasma 
membrane. The association of ASFV particles with actin filaments in this location 
was therefore investiagted.
7.1 ASFV associates with actin filaments at the edge of the cell
7.1.1 Immunofluorescence analvses
The distribution of microfilaments and virions was studied at late stages of 
infection. Vero cells were infected with the cell-culture adapted BaTlv strain of 
ASFV and fixed at 14 and 16 hpi with PFA. Cells were analysed by indirect 
immunofluorescence using a rabbit antiserum specific for the structural protein 
pE120R. Actin filaments were stained with phalloidin. Cellular and viral DNA were 
labelled with DAPI. At 14 hpi, the punctate structures indicative of mature viral 
particles were concentrated in the viral factory but also observed throughout the 
cytoplasm (Fig. 7.1 A). However, at this time, none of the virions had reached the cell 
surface and there was no noticeable association between cytoplasmic particles and 
actin filaments in the cytoplasm. At 16 hrs, some particles were observed at the edge 
of the cell (Fig. 7.1B).
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An enlarged view of this area revealed that a dozen virions were aligned on a 
microfilament projecting from an infected cell towards a uninfeeted one (Fig. 7.IB, 
white box). Particles were also found associated with phalloidin-stained projections 
deriving from the plasma membrane of infected cells (Fig. 7.1C). These long 
projections filled with actin were not observed in non-infected cells, or at 14 hpi 
(Fig. 7.1 A). Some particles were associated with the tip of the projections (Fig. 7.1C, 
arrows) while others were visualised along the structures (arrowheads). Some of 
these projections were free of virions. These observations demonstrate an association 
between ASFV and mierofilaments at the cell periphery.
To ensure that these interactions between ASFV and actin were not 
associated with adaptation to cell-culture, the above experiment was repeated using 
porcine aortic endothelial cells (PAEC) infected with the virulent Malawi strain of 
ASFV for 14 and 16 hrs. Figure 7.2A shows two cells: one positive for late viral 
antigens and the other one negative for late viral antigens. At this time point, all viral 
particles were concentrated in viral factories. The analysis also revealed that the 
organisation of the actin network was affected by the Malawi strain of ASFV. While 
uninfected cells showed characteristic thick actin stress fibres, these were completely 
lost in cells positive for the late protein pE120R (Fig. 7.2A). No phalloidin-stained 
projections were observed in non-infected cells, or in cells infected for 14 hours (Fig. 
7.2A). At 16 hpi, viral particles were distributed throughout the cytoplasm, and as 
seen for Vero cells, actin-containing projections were observed at the surface of 
infected cells. All the projections were tipped with a single ASFV particle (Fig. 7.2B, 
arrows), suggesting that the virus particles induced the formation of the actin 
structures. The experiment indicates that infection with both tissue-culture adapted 
and field isolates of ASFV induced actin projections at the cell surface.
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Figure 7.1. Distribution of actin and ASFV particles in Vero cells at 14 and 16 
hours post-infection. Vero cells were infected with the Ba71v strain of ASFV and 
fixed with PFA at 14 hpi (A) and 16 hours post-infection (B and C). Samples were 
incubated with a rabbit antiserum specific for the late ASFV structural protein pE120R 
(red). Actin was stained with phalloidin (green). Viral and cellular DNA were labelled 
with DAPI (blue). Images shown have been collected independently with a confocal 
laser-scanning microscope and merged. Panel B: the white box is an enlarged view of 
part of panel B. Panel C: The right panels are enlarged views of parts of the left panel. 
The arrows indicate viral particles located at the tip of phalloidin-stained projections. 
The arrowhead shows a viral particle align with a phalloidin-stained projections. Scale 
bars, 8 pm.
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Figure 1.1. Distribution of actin and ASFV particles in PAEC 
cells at 14 and 16 hours post-infection. PAEC cells were infected 
with the Malawi strain of ASFV and fixed with PFA at 14 hours 
post-infection (A) and 16 hours post-infection (B). Samples were 
incubated with a rabbit antiserum specific for the late ASFV 
structural protein pE120R (red). Actin was stained with phalloidin 
(green). Viral and cellular DNA were labelled with DAPI (blue). 
Images shown have been collected independently with a Nikon E800 
microscope and merged. The arrows indicate viral particles located 
at the tip of phalloidin-stained projections. The white box is an 
enlarged view of panel B. Scale bars, 8 pm.
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The experiment was repeated using a third strain of ASFV. Max cells were 
infected with the cell-culture-adapted Uganda strain for 16 hrs, fixed and analysed by 
indirect immunofluorescence as described above. At 16 hpi, viral particles were 
observed in perinuclear assembly sites and throughout the cytoplasm. Particles were 
also concentrated at the cell periphery, in actin-rich areas (Fig. 7.3, arrows). As seen 
for Vero and PAEC cells, actin-containing projections were observed at the plasma 
membrane (Fig. 7.3). Interestingly, many projections contained more than one virus. 
At this magnification, the tip of some projections appeared free of virus (Fig. 7.3). 
High magnification analyses revealed that the actin projections could also have more 
than one virion at the tip (Fig. 7.4A, arrows). Linear arrays of ASFV particles were 
also seen underneath the plasma membrane, where they were aligned on cortical 
fibres stained with phalloidin (Fig. 7.4A, arrowheads). In the next experiment, 
differential interference contrast (DIC) microscopy was used to study ASFV 
association with the cellular projections. Right and left panels of figure 7.4B 
compare DIC images with immunofluorescence analysis of ASFV distribution. Virus 
particles, identified by positive staining with the antibody against pE120R, 
corresponded to punctate structures aligned along cellular projections of the DIC 
images (Fig. 7.4B, enlarged views). The use of DIC optic therefore provides a means 
of following cellular projections and virus without the need for immunofluorescence 
processing.
More than 160 actin projections were measured using the program Profile of 
the Leica Software. They had an average length of 10.5 jLim (n=162, STD=4.42) and 
some extended more than 35pm. They were always unbranched.
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Altogether, these observations show that infection with the Ba71v, Malawi 
and Uganda strains of ASFV induce the formation of long unbranched actin 
projections that originate from the plasma membrane. All actin projections were 
tipped with a single virion in Malawi-infected cells. In Ba71v and Uganda infected 
eells, although projections were always associated with one or more viral particles, 
they were not always tipped by a viral particle. Therefore, at this time of the 
analyses, it was not clear whether the particles themselves induced the formation of 
the projections. Uganda particles, but not Ba71v or Malawi, were also found aligned 
on cortical microfilaments. The distribution of ASFV along cortical actin fibres, 
along the projections and at the tip of the projections suggest that ASFV might move 
along these actin tracks.
During the course of the above experiments, it was determinant that Max 
cells handled ASFV infection well: they produced higher numbers of viral particles 
than PAEC and Vero cells (compare figures 7.IB, 7.2B and 7.3). They also allowed 
studies as late as 24 hpi whereas PAEC and Vero cells started to round up and detach 
from the coverslip at around 18 hpi (data not shown). We therefore used the 
Max/Uganda combination to further investigate the association between ASFV and 
actin.
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Figure 7.3. Distribution of actin and ASFV particles in Max cells at 16 
hours post-infection. Max cells were infected with the Uganda strain of ASFV 
and fixed with PFA at 16 hpi. Samples were incubated with a rabbit antiserum 
specific for the late ASFV structural protein pE120R (red). Actin was stained 
with phalloidin (green). Viral and cellular DNA were labelled with DAPI 
(blue). Images shown have been collected independently with a confocal 
microscope and merged. The arrows indicate an accumulation of virions 
beneath the plasma membrane. The white box is an enlarged view of the main 
image. Scale bar, 8 pm.
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Figure 7.4. High magnification analyses of the distribution of actin and 
ASFV particles in Max cells at 16 hours post-infection. Max cells were 
infected with the Uganda strain of ASFV and fixed with PFA at 16 hours 
post-infection. Samples were incubated with a rabbit antiserum specific for 
the late ASFV structural protein pE120R (green). Actin was stained with 
phalloidin (red). Images shown have been collected independently with a 
confocal microscope and merged. Panel A. The arrowheads indicate virions 
aligned on cortical actin filaments. The arrows show accumulation of 
virions at the tip of phalloidin-stained projections. Panel B compares DIC 
analyses with immunofluorescence image. Scale bars, 8pm.
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7.1.2 Actin proiections-associated virions are intracellular particles
The first experiments were designed to see if ASFV particles were associated 
with the outside of actin projections, as has been shown for W  (Ward and Moss,
2001). Max cells were infected with the Uganda strain of ASFV and fixed at 18 hpi 
with PFA. Cells were processed for indirect immunofluorescence by using a mouse 
antibody against the main capsid protein p73 and a rabbit antiserum specific for the 
structural protein pE120R. Control eells were permeabilised as usual, prior to 
labelling with antibodies (Fig. 7.5A). In a second experiment, non-permeabilised 
cells were incubated with anti-pE120R antibodies, then permeabilised with 0.5% 
Triton X-100 for 15 minutes and stained with anti-p73 antibodies (Fig. 7.5B). All 
images were collected with identical camera settings to allow comparison of 
fluorescence intensity. The pE120R staining was intense in permeabilised control 
cells (Fig. 7.5A), but non-detectable in non-permeabilised cells (Fig. 7.5B), 
providing evidence that intracellular virions could not be labelled with the anti- 
pE120R antibody in these conditions. In non-permeabilised cells, virions associated 
with cell projections were not labelled with the anti-pE120R antibody (Fig. 7.5B). In 
some rare cases, the particles located at the tip of the projections were weakly 
labelled with anti-pE120R antibodies (Fig. 7.5B, arrows). Altogether, the data 
suggest that virions associated with actin projections are intracellular particles. The 
weakly stained struetures may represent virions that have budded from the tip of the 
projections.
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pE120RpE120R
Figure 7.5. Actin projection-associated virions are 
intracellular particles. Max cells were infected with the Uganda 
strain of ASFV and fixed with PFA at 18 hours post-infection. 
Cells were processed for indirect immunofluorescence analyses 
and incubated with a rabbit antisemm specific for the structural 
protein pE120R (green) and a mouse antibody against the main 
capsid protein p73 (red). Panels A. Cells were permeabilised prior 
to labelling with antibodies. Panels B. Non-permeabilised cells 
were incubated with anti-pE120R antibodies, then permeabilised 
with 0.5% Triton X-100 for 15 minutes and stained with anti-p73 
antibodies. All images have been collected with a confocal 
microscope with identical camera settings to allow comparison of 
fluorescence intensity. Scale bars, 8 pm.
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7.1.3 Electron microscopic analvses
To further investigate the interaction between ASFV particles and actin, EM 
examinations of Max cells were performed at 18 hpi. The analysis showed that 
mature intracellular ASFV particles, which appeared as electron-dense hexagons in 
cross-section, were aligned on actin fibres in the cortical region of the cell (Fig. 
7.6A). These alignments of ASFV particles on mierofilaments were generally 
composed of 3 to 10 virions (Fig. 7.6A). The white appearance of some particles in 
this preparation was likely due to an embedding problem. This analysis confirms 
immunofluorescence observations (fig. 7.4A, arrowheads) and suggests that ASFV 
could use actin fibres as tracks to traverse the cell cortex toward the plasma 
membrane. High magnification analyses revealed that the actin tracks were 
composed of parallel actin filaments that did not appear to originate from the viral 
particles (Fig. 7.6B). Thus, the motile force that drives virions through the cortex is 
unlikely to be generated by actin polymerisation underneath the particles.
The actin projections induced by ASFV infection were then examined. 
Cutting sections parallel to full-length projections was difficult and, unfortunately, 
the projections were often damaged by sectioning (Fig. 7.7, A and B, arrows). 
Nonetheless, these analyses showed that virions were inside the projections (Fig. 7.7, 
C and D), confirming previous immunofluorescence experiments performed on non- 
permeabilised cells (Fig. 7.5). Actin filaments contained in the extensions were not 
cross-linked but long, unbranched and parallel (Fig. 7.7F), reminiscent of those 
present in filopodia (Small et al., 2002).
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Figure 7.6. Thin sections of Max cells infected with ASFV for 18 hours.
Max cells were infected with the Uganda strain of ASFV for 18 hours and 
processed for electron microscopy analyses as described in materials and 
methods. Images show alignment of virions on cortical mierofilaments. 
Scale bars, 5pm (A), 500 nm (B).
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Figure 7.7. Thin sections of Max cells infected with ASFV for 18 hours
Max cells were infected with the Uganda strain of ASFV for 18 hours and 
processed for electron microscopy analyses as described in materials and 
methods. Images show aetin-rich projections at the edge of infected cells. The 
arrows indicate projections damaged by sectioning. Panel E shows an enlarged 
view of the arrangement of actin filaments inside a projection. Scale bars, 3 
pm (A), 2 pm (B), 100 nm (C), 200 nm (D), 500 nm (E).
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7.1.4 Live cell imaging analvses
Immunofluorescence analyses revealed that virions were often associated 
with the tip of the fllopodia-like extensions, and were also aligned along the 
structures, as though in transit to or from the tip (Fig. 7.4). Since projection- 
associated virions are detectable by DIC (Fig. 7.4 and 7.5), the movement of ASFV 
along the actin-containing extensions was analysed by live cell DIC microscopy. 
Max cells were infected for 18 hrs with the Uganda strain of ASFV and viewed with 
an inverted microscope for live cell analyses (the panels of figure 7.8 are images 
taken from the 3 movies provided on the CD). The video analyses revealed that all 
extensions originated from the plasma membrane and all occurred from a single 
particle that remained at the tip of the structure (Fig. 7.8A, black arrows). All 
projections had a viral particle at their tip, including those that underwent retraction 
toward the plasma membrane (Fig. 7.8B, red arrows) and those that were moving 
freely in and out of the plane of focus (Fig. 7.8E, red arrows). Some projections 
could undergo growing and shrinking cycles (Fig. 7.8C, red arrows), whereas others 
remained stationary for more than 15 minutes (Fig. 7.8D, black arrows).
The live cell experiment also revealed that ASFV particles underwent 
forward and rearward movements along pre-existing extensions (Fig. 7.8E, black 
arrows). Intra-projection movement of particles was independent of the growing or 
shrinking state of the projection, i.e. a particle could move forward and/or rearward 
on a growing or shrinking projection (Fig. 7.8C, blue arrows). Particles that moved 
forward were able to reach the tip of the projection where they joined the particle that 
had induced the formation of the projection. As many as 5 viruses could accumulate
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at the tip of the same projection (Fig. 7.8D, black arrows). Particles moving forward 
were also able to “drive” actin polymerisation once they had reached the tip of a pre­
existing projection (Fig. 7.8F, black arrows). In the particular case shown in figure 
7.8F, the virion that was at the tip of the projection was moving rearward once the 
second virion had taken the “driving control” (red arrows). These live cells 
observations demonstrate that single ASFV particles induce the formation of the 
actin-projections. They suggest that ASFV actin-based motility could involve two 
mechanisms: actin polymerisation from the plasma membrane and intra-projection 
transport.
We were able to follow the movement of more than 150 individual particles 
on actin by video microscopy and their motility rates were calculated by using 
Profile Leica software. ASFV-induced actin projections grew at a rate of 3.1 pim/min 
(n=83, STD=1.81). The projections retracted at an average rate of 3.33 jim/min 
(n=24, STD=2.5). ASFV particles moved towards the projection tips (forward 
movement) at 2.13 jxm/min (n=14, STD-0.97) and the rate of rearward movement 
was 3.69 pm/min (n-37, STD=1.72). Note: these two last rates represent movement 
of virions on stationary projections and are therefore independent of actin flow at the 
tip of the projections.
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Figure 7.8. Time-lapse series of ASFV movement at the tip and within cellular 
protrusions. Max cells were infected with the Uganda strain of ASFV for 18 hours 
and processed for live cell imaging. The arrows follow individual viral particles. 
Time frames are given in second. Scale bars, 3 pm (A, B), 4 pm (C, D, E, F). These 
panels are still images taken from the videos provided on the CD.
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Figure 7.8, continued.
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7.2 Effects of cytochalasin-D and brefeldin-A on the formation of 
actin projections during ASFV infection
7.2.1 Effect of cvtochalasin-D on the formation of actin projections
The previous experiments suggested that ASFV particles might use actin 
polymerisation to move away from infected cells. The effect of the drug 
cytochalasin-D on the formation of the actin projections was therefore investigated. 
Cytochalasin-D binds to the end of actin filaments and prevents further 
polymerisation. Max cells were infected with the Uganda strain of ASFV and the 
drug was added at a final concentration of 10 mM at 12 hpi, a time when most of the 
virions are still concentrated in virus factories (Fig. 3.1). Cells were fixed at 18 hpi 
and were analysed by indirect immunofluorescence. Figure 7.9 shows that, in cells 
negative for viral antigens, the drug had drastic effects on the actin network: actin 
appeared as dot-like structures throughout the cytoplasm and actin fibres were no 
longer visible (panel A, thick arrow). In contrast, in infected cells, the effects of the 
drug were less evident and actin filaments still shaped the plasma membrane (Fig. 
7.9A). High magnification analyses of cytochalasin-D-treated cells revealed that 
ASFV particles were associated with actin projections derived from the plasma 
membrane (Fig. 7.9B, arrows), even though these projections were thinner than the 
ones usually observed in non-treated cells (compare to actin projections shown in 
figures 7.3 and 7.4). These experiments suggest that actin filaments are less sensitive 
to the drug treatment in ASFV infected cells than in control uninfected cells. They 
also show that the actin projections occur in the presence of cytochalasin-D.
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Figure 7.9. Effect of cytochalasin-D on actin distribution in ASFV infected 
cells. Max cells were infected with the Uganda strain of ASFV. Cytochalasin- 
D (lOmM) was added at 12 hours post-infection and cells were incubated for a 
further 6 hours at 37°C prior to fixation and processing for 
immunofluorescence. Virions were located with an antibody specific for the 
structural protein pE120R (green). Actin was stained with phalloidin (red). 
Viral and cellular DNA were labelled with DAPI (blue). Images shown have 
been collected independently with a confocal microscope and merged. The 
thick arrow indicates the distribution of actin in a cell negative for viral antigen. 
The thin arrows show the association of virions with actin-stained phalloidin 
projections. Scale bars, 20 pm (A), 8 pm (B).
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7.2.2 Effect of brefeldin-A on the formation of actin projections
We next investigated whether the delivery of ASFV particles at the plasma 
membrane was sufficient to induce the formation of actin projections. Brefeldin-A 
(BFA) blocks the transport of proteins from the ER to the Golgi and therefore their 
delivery at the plasma membrane (Lippincott-Schwartz et al., 1989). The effect of 
BFA on the induction of actin projections in ASFV infected cells was therefore 
investigated. Max cells were infected with the Uganda strain of ASFV and the cells 
were treated with 10 pg/ml of BFA 12 hpi, a time when most of the virions are still 
present in virus factories (Fig. 3.1). Cells were fixed at 18 hpi and were analysed by 
indirect immunofluorescence. DMSO treated cells were used as a control. Figure 
7. lOA shows that in control cells, actin projections induced by ASFV were clearly 
visible. By contrast, actin projections were not detectable in BFA-treated cells (Fig.
7.1 OB). A great accumulation of virions was observed at the cell cortex. These 
experiments demonstrate that the delivery of ASFV particles to the cell periphery is 
not sufficient for the nucléation of the actin structures. Cellular and/or non-structural 
viral factors must therefore be involved in the nucléation of the actin projections. The 
accumulation of virions underneath the plasma membrane suggests that de novo actin 
polymerisation is required for ASFV release.
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Figure 7.10. Effect of brefeldin A (BFA) on ASFV distribution. Max
cells were infected with the Uganda strain of ASFV. BFA (10 pg/ml) (B) or 
DMSO control (A) were added at 12 hours post-infection and cells were 
incubated for a further 6 hours at 37°C prior to fixation and processing for 
immunofluorescence. Virions were located with an antibody specific for the 
structural protein pE120R (red). Actin was stained with phalloidin (green). 
Viral and cellular DNA were labelled with DAPI (blue). Images shown have 
been collected independently with a confocal microscope and merged. Scale 
bars, 8 pm.
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7.3 GFP-N-WASP, GFP-Nckl and GFP-Grb2 are not recruited by 
ASFV at the cell periphery
The proteins N-WASP, Nckl and Grb2 are implicated in W  actin-tail 
formation. Endogenous and GFP-tagged N-WASP, Nckl and Grb2 are recruited to 
the tip of actin tails in W -infected cells. Using dominant negative polypeptides, the 
requirement of these proteins for the nucléation of the actin tail has been 
demonstrated (Frischknecht et al., 1999b; Moreau et al., 2000; Scaplehom et al., 
2002). The localisation of GFP-tagged versions of these proteins was therefore 
examined in ASFV-infected cells. The same pEL-GFP-N-WASP, pEL-GFP-Nckl or 
pEL-GFP-Grb2 constructs that were used in the W  studies have been used here. 
Previous studies have shown that these GFP-tagged proteins are fully functional 
(Frischknecht et al., 1999b; Moreau et al., 2000; Scaplehom et al., 2002). Max cells 
were transfected with pEL-GFP-N-WASP, pEL-GFP-Nckl or pEL-GFP-Grb2 for 2 
hrs and then infected with the Uganda strain of ASFV for 18 hrs. Cells were fixed 
with PFA and analysed by immunofluorescence. ASFV particles were detected with 
a rabbit antibody to the stmctural protein pE120R. Figure 7.11 shows that, in cells 
infected by ASFV, the GFP-tagged proteins were distributed throughout the cells. No 
recmitment of GFP-N-WASP, GFP-Nckl or GFP-Grb2 on ASFV particles was 
detected. These experiments suggest that ASFV does not recmit N-WASP, Nckl or 
Grb2 and therefore uses different mechanisms to activate actin polymerisation than 
W .
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Figure 7.11. ASFV does not 
recruit GFP-N-Wasp, GFP- 
Nckl or GFP-Grb2. Max cells 
were transfected with pEL-GFP- 
N-Wasp, pEL-GFP-Nckl or pEL- 
GFP-Grb2 and infected 2 hours 
later with Uganda for 18 hours. 
Cells were processed for 
immunofluorescence and an 
antibody against the structural 
protein pE120R was used to locate 
virions (red). Viral and cellular 
DNA were labelled with DAPI 
(blue). The localisation of the 
GFP-tagged proteins was 
monitored by the intrinsic 
fluorescence of GFP (green). 
Images shown have been collected 
independently with a confocal 
microscope and merged. Scale 
bars, 8 pm.
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7.4 Analysis of tyrosine phosphorylation in cells infected with 
ASFV
Tyrosine phosphorylation plays a key role in signal transduction pathways 
involved in the control of actin polymerisation at the plasma membrane. Consistent 
with this, tyrosine phosphorylation is required for W  actin-based mobility 
(Frischknecht et al., 1999a). Tyrosine phosphorylation in ASFV-infected cells was 
therefore analysed. Western blot analyses were performed using 4G10, a mouse 
antibody that recognises all tyrosine-phosphorylated proteins. Non-infected cells and 
cells infected for 18 hrs were lysed with IPB containing 1 mM NaVo3, a phosphatase 
inhibitor. Proteins were resolved with 12.5% tris-tricine SDS PAGE. The blots were 
probed with 4G10 antibodies and with antibodies specific for the ASFV early protein 
p30. p30 was effectively detected in ASFV infected cells (Fig. 7.12B, arrow). Figure 
7.12A shows that no extra phosphotyrosine signal was detected in ASFV infected 
cells (lane 2) when compared to control cells (lane 1). The profiles of the two lanes 
were almost identical, with the exception of a 32 kDa protein that produced a strong 
signal in control cells but not in infected cells (Fig. 7.12, arrow). This observation 
suggests that a cellular 32 kDa phosphoprotein is dephosphorylated at a tyrosine 
residue, or degradated, during ASFV infection. The nature of this protein is 
unknown. The experiment also suggests that no proteins become tyrosine 
phosphorylated during ASFV infection. The distribution of phosphotyrosine proteins 
in ASFV-infected cells was examined by indirect immunofluorescence. Max cells 
were infected with the Uganda strain of ASFV and fixed with PFA at 18 hpi. For 
comparison, the distribution of phosphotyrosine proteins was examined in BHK cells
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that were mock-infected or infected with VTF7.3 W  for 16 hrs. Phosphotyrosine 
epitopes were detected with the mouse antibody 4G10. ASFV particles were detected 
with a rabbit antiserum against the structural protein pE120R. VTF7.3-infected cells 
were identified by the presence of actin tails, which were stained with phalloidin. 
Fig. 7.13B shows that, in cells infected with W ,  the phosphotyrosine signal was 
observed at the tip of all actin tails. These results are in agreement with previous 
work (Frischknecht et al., 1999a). In mock-infected BHK cells, the phosphotyrosine 
signal localised at the tip of actin stress fibres (Fig. 7.13A). This may represent 
proteins involved in stress fibres elongation. In Max cells that were negative for 
ASFV late antigens, the dots indicative of phosphotyrosine proteins were distributed 
throughout the cytoplasm (Fig. 7.14). In Max cells that were positive for ASFV late 
antigens, the phosphotyrosine signal was recruited at the plasma membrane (Fig. 
7.14), suggesting that phosphotyrosine signalling occurs at the surface of ASFV 
infected cells.
High magnification analyses revealed that the phosphotyrosine signal was 
also recruited to the cellular protrusions along which ASFV particles were aligned. 
These projections were identified by DIG (Fig. 7.15). The number of projection- 
associated virions that appeared yellow in the merged pictures was highly variable 
(Fig. 7.15). In some cells, the proportion of yellow virions was very low (panel A), 
suggesting that only a few particles are associated with phosphotyrosine proteins. In 
other cases, a higher proportion of these virions were labelled with the 
phosphotyrosine antibody (Fig. 7.14B). The virions were located either at the tip of 
the projections (white arrows) or along the structures (red arrows). This analysis 
suggests that only a sub-population of virions associate with phosphotyrosine 
proteins.
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Figure 7.12. Detection of tyrosine-phosphorylated proteins in 
ASFV infected cells. Max cells were mock-infected (lane 1) or 
infected with Uganda (lane 2). Cells were lysed at 18 hours post- 
infeetion and analysed by 12.5% tris-tricine SDS-PAGE. Cell 
lysates were probed with 4G10, an antibody specific for tyrosine- 
phosphorylated proteins (panel A) or with an antibody that 
recognises the early ASFV protein p30 (panel BE
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Figure 7.13. Distribution of tyrosine-phosphorylated proteins in cells infected 
with WT Vaccinia virus. BHK cells were mock-infected (A) or infected with the 
VTF7.3 strain of Vaccinia virus (B). Cells were fixed at 18 hours post-infection and 
processed for immunofluorescence. Phosphotyrosine epitopes were detected with the 
mouse antibody 4G10 (green). Actin was stained with phalloidin (red). Viral and 
cellular DNA were labelled with DAPI (blue). Images shown have been collected 
independently with a confocal microscope and merged. Scale bars, 8 pm.
Figure 7.14. Distribution of tyrosine-phosphorylated proteins in cells infected 
with ASFV. Max cells were infected with Uganda strain of ASFV. Cells were fixed at 
18 hours post-infection and processed for immunofluorescence. Phosphotyrosine 
epitopes were detected with the mouse antibody 4G10 (red) and with an antibody that 
recognises the structural protein pE120R (green). Viral and cellular DNA were 
labelled with DAPI (blue). The left picture is an overlay of 2 views collected 
independently with a confocal microscope. Scale bar, 20 pm.
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Figure 7.15. High magnification analyses of the distribution of tyrosine- 
phosphorylated proteins in cells infected with ASFV. Max cells were infected 
with Uganda strain of ASFV. Cells were fixed at 18 hpi and processed for 
immunofluorescence. Phosphotyrosine epitopes were visualised with the mouse 
antibody 4G10 (red) and with an antibody that recognised the structural protein 
pE120R (green). Viral and cellular DNA were labelled with DAPI (blue). 
Images have been collected independently with a confocal microscope and 
merged. Scale bars, 8 gm.
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8 Discussion
8.1 ASFV anterograde transport is dependent on microtubules
The distributions of ASFV particles and microtubules in infected cells were 
investigated by immunofluorescence using anti-a-tubulin antibodies and an antibody 
raised against the late ASFV structural protein pE120R. The specificity of the anti- 
pE120R antibody was established by biochemical analysis of cells transfected with a 
vector expressing the E120R reading frame (Fig. 5.2). Immunofluorescence analyses 
demonstrated that pE120R antibodies recognise newly assembled virions, and not 
particles entering cells (Fig. 5.4). At 16 hpi, approximately 80% of these newly 
assembled virions were closely aligned with microtubules (Fig. 3.2). The alignment 
of ASFV with microtubules in cells is consistent with previous work showing the 
binding of ASFV to mierotubules in vitro (de Matos and Carvalho, 1993). Spread of 
ASFV from viral assembly sites was markedly inhibited when mierotubules were 
depolymerised by nocodazole from 12 hpi to 16 hpi (Fig. 3.3). These results show 
that intact mierotubules are required for movement of ASFV into the cytosol. 
Previous studies have also suggested a role for mierotubules during virus exit by 
showing that depolymerisation of mierotubules early during infection reduced yields 
of ASFV (de Matos and Carvalho, 1993). Early depolymerisation of mierotubules, 
however, slows the formation of virus assembly sites, and also inhibits virus 
replication (Carvalho et al., 1988; Heath et al., 2001). It is possible that the reduced 
virus yield observed in these earlier studies results from reduced production of 
viruses in cells, rather than a requirement for intact mierotubules during virus egress. 
In the current study, nocodazole was added 12 hrs after infection, a time which
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should allow late gene expression and virus assembly to occur before 
depolymerisation of mierotubules. In fact, incubation with nocodazole for a further 4 
hrs did not affect the synthesis of the late structural protein p73, or pJ13L, or the 
morphology of viruses in virus assembly sites (Fig 3.4 and 3.5). The major effect of 
nocodazole was to markedly increase the number of virions in the assembly sites 
(Fig. 3.5) and to reduce the number of virions in the cytosol (Fig. 3.3). The results 
suggest that once viruses are assembled, they need intact mierotubules to leave the 
virus factory. This conclusion is in agreement with previous EM studies showing that 
ASFV particles were retained at the periphery of the virus factory in cells incubated 
with colchicine, a microtubule-depolymerising agent (Carvalho et al., 1988).
Nocodazole did not block all anterograde movement of ASFV, suggesting 
that the dependence on mierotubules was not absolute (Fig. 3.3). The same 
observation holds for the retrograde transport of adenoviruses, HSV-1, adeno- 
associated virus (AAV), human foamy virus and murine polyomavirus (Gilbert et a l, 
2003; Glotzer et a l, 2001; Saib et a l, 1997; Sanlioglu et a l, 2000; Sodeik et a l, 
1997). This is also true for ASFV retrograde transport (Alonso et a l, 2001). The 
actin cytoskeleton might be considered as an alternative pathway for viral transport 
and its appears to be used as such by the baculovirus AcMNPV (Charlton and 
Volkman, 1993). For adenoviruses, the movement seen in nocodazole-treated cells is 
not the result of actin based transport because simultaneous treatment of cells with 
nocodazole and actin-disruptive agents does not block viral transport (Glotzer et a l, 
2001). For ASFV, the observation that mature particles do not associate with actin 
filaments in the cytoplasm suggests that movement along actin filaments, from 
assembly sites to the cell periphery, is unlikely to involve microfilaments (Fig.
7.1 A). Our data demonstrate that ASFV infection induces the stabilisation of a subset
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of mierotubules against depolymerisation by nocodazole (Fig. 6.2). 
Immunofluorescence analyses also revealed that ASFV infection induced the hyper- 
acetylation of mierotubules (Fig. 6.3A and 6.4) and that viral partieles were 
assoeiated with these acetylated mierotubules (Fig. 6.3B). Aeetylated a-tubulin is 
known to accumulate in stable but not dynamic mierotubules (Pipemo et al., 1987). 
These observations eould explain how 12% of viral particles reach the eell periphery 
in the presence of nocodazole. Taken together, our data suggest that ASFV moves 
along stabilised mierotubules and that the virus exploits no alternative route to travel 
from assembly sites to the plasma membrane.
W  infection also stabilises the microtubule network, and viral particles 
associate with a subpopulation of hyper-acetylated mierotubules (Ploubidou et al., 
2000). Dynamie mierotubules have a half-life of few minutes whereas stable 
mierotubules, whieh contain one or more types of post-translationally modified 
tubulin, have a half-life of hrs (Mandelkow and Mandelkow, 1995). AAV has been 
reported to traverse the cytoplasm in 15 minutes (Seisenberger et al., 2001) and this 
rate is eonsistent with the transport speeds of W ,  HSV-1 and Ad2 (Smith and 
Enquist, 2002). The rapid turnover of dynamic mierotubules means that they do not 
remain intact for the time required by viruses to traverse the cytoplasm. By 
stabilising the microtubule network viruses would seeure their microtubule-based 
transport throughout the eytoplasm.
How do viruses induee the stabilisation of the microtubule network? The viral 
proteins involved in microtubule stabilisation in VV, HSV-1 and reovirus-infeeted 
cells have been identified. When expressed alone, these proteins bind and stabilise 
mierotubules, in a manner similar to cellular microtubule-associated-proteins 
(MAPs). The HSV-1 tegument protein Vp22 was the first MAP to be described for
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an animal virus (Elliott and O'Hare, 1998). More recently, the W  proteins AlOL and 
L4R and the reovirus core protein p2 have also been classified as MAPs (Parker et 
al., 2002; Ploubidou et al., 2000). MAPs are also found in plant viruses, for example 
the movement protein of tobamoviruses (Heinlein et al., 1995). The sequenee of the 
ASFV protein pJ13L resembles proteins of the 190 kDa family of mammalian MAPs 
and pJ13L could therefore be responsible for microtubule stabilisation in ASFV 
infeeted eells (Alonso et a l, 2001). However, when expressed on its own, pJ13L 
exhibits an ER-like distribution and does not co-localise with mierotubules (Fig. 6.9). 
These observations are eonsistent with recent work showing that pJ13L targets the 
ER when it is transiently expressed in transfected cells (Rodriguez et a l, 2004). 
These findings suggest that pJ13L is unlikely to act as a MAP during ASFV 
infection. Another ASFV protein, yet to be discovered, may bind and stabilise 
mierotubules during infection, in a manner reminiscent of other viral MAPs.
8.2 ASFV anterograde transport is dependent on conventional 
kinesin
8.2.1 Conventional kinesin is required for ASFV anterograde transport
Immunofluorescenee analyses showed that conventional kinesin light chain 
was recruited into ASFV assembly sites and to most individual cytoplasmic particles 
(Fig 4.1). The incomplete coloealisation between the light chain and cytoplasmic 
virions could be explained by a limited access of the antibody to the epitope on 
kinesin in a putative ASFV-kinesin complex. In fact, the 63-90 antibody recognises 
the domain of kinesin light chain that binds the heavy chain (Gauger and Goldstein,
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1993; Verhey et a l, 1998). Another explanation is that only a subpopulation of 
ASFV particles associate with conventional kinesin at any given time point.
The TPR domain of conventional kinesin light chain (TPR-KLC) has been 
shown to mediate interactions with cellular cargoes (Vale, 2003). To investigate 
whether ASFV particles are recognised as cargo by conventional kinesin, we 
examined the localisation of a GFP-tagged version of TPR-KLC in ASFV infected 
cells. In the first series of experiments, the TPR-KLC was expressed in cells using a 
vector containing a CMV promoter. However, these experiments were unsuccessful 
because it was not possible to obtain late viral gene expression in cells expressing the 
TPR construct (Fig. 4.2). One interpretation is that over-expression of GFP-TPR- 
KLC at an early stage of infection inhibits ASFV replication and/or late viral gene 
expression. It is also possible that there is a competition between the CMV promoter 
and ASFV.
An alternative means of expressing GFP-TPR in ASFV infected cells was 
therefore required. Immunoprécipitation and immunofluorescence analyses showed 
that the synthetic EL promoter of W  was able to drive protein expression in ASFV 
infected eells (Fig. 4.3), indicating that this W  promoter was recognised by ASFV 
transcription factors. This is not surprising since the two viruses are closely related 
and share some sequenee similarities (Iyer et a l, 2001). One gene common to both 
viruses encodes a transcription factor (Iyer et a l, 2001), suggesting that the 
transcriptional machinery of the two viruses are similar. Moreover, it has been 
demonstrated that some ASFV promoters are recognised by VV transcription factors 
(Hammond and Dixon, 1991). Taken together, these results suggest that some 
promoters are conserved between Asfarviridae and Poxviridae.
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The EL-GFP-TPR-KLC vector (Rietdorf et ah, 2001) was used to further 
study the distribution of conventional kinesin light chain in late ASFV-infected eells. 
Immunofluorescenee analyses performed on infected eells expressing GFP-TPR- 
KLC showed that ASFV particles, in assembly sites and in the cytoplasm, co­
localised with GFP-TPR-KLC (Fig. 4.5 to 4.8), suggesting that ASFV was 
recognised as cargo by the TPR domain of kinesin light chain. Close inspection of 
these cells revealed that 100% of viruses at both sites bound to the GFP-TPR-KLC 
protein (Fig 4.8), indicating that the lack of complete coloealisation between ASFV 
particles and kinesin observed using the 63-90 antibodies is likely to be due to a 
limited access to epitopes (Fig. 4.1). Evidence for use of kinesin by ASFV to leave 
factories came from the observation that high level expression of the GFP-TPR-KLC 
protein, which binds cargo, but cannot associate with mierotubules, prevented 
movement of ASFV into the cytosol (Fig. 4.12). Taken together, the results 
demonstrate that ASFV recruits conventional kinesin into assembly sites, and 
subsequently uses the motor for transport from the factory to the plasma membrane. 
Since over-expression of GFP-TPR-KLC blocked 97% of ASFV dispersion from 
viral factories (Fig. 4A 2), conventional kinesin is likely to be the unique plus-end 
directed motor used by ASFV to reach the eell surface. A schematic diagram 
showing ASFV transport is represented in figure 8.1.
Conventional kinesin powers anterograde transport of a variety of 
membranous and non-membranous cellular cargoes such as mitochondria, 
lysosomes, ER, mRNA and intermediate filaments (Vale, 2003). The disruption of 
conventional kinesin activity by micro-injection of antibodies specific for the light 
chain results in the clustering of the intermediate filament protein vimentin, and 
mitochondria, near the centrosome (Gyoeva and Gelfand, 1991; Stenoien and Brady,
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1997; Tanaka et al., 1998). Inhibition of kinesin also alters the integrity of the Golgi 
apparatus (Allan et al., 2002). Signifieantly, ASFV infection produces a strikingly 
similar phenotype characterised by clustering of mitochondria and vimentin at the 
centrosome, and Golgi network redistribution (Heath et al., 2001; MeCrossan et al., 
2001; Rojo et al., 1998). These changes in cellular architecture caused by ASFV 
infection may be bystander effects resulting from recruitment of conventional kinesin 
into virus assembly sites where it is no longer available for the transport of these 
cellular cargoes.
How do these results for ASFV relate to the use of kinesin by other viruses? 
The bi-direetional movement of pseudorabies virus (PRV), observed in chick 
neurones makes it highly likely that both dynein and kinesin motors are used by viral 
partieles (Smith et al., 2001). Indeed, immunoelectron microscopy studies have 
shown kinesin heavy chain on the surface of unenveloped HSV-1 in human foetal 
axons (Diefenbach et al., 2002). In addition, the viral US 11 tegument protein 
associates with both conventional kinesin heavy chain and kinesin light-chain-related 
protein PATl in vitro (Benboudjema et al., 2003; Diefenbach et al., 2002). Kinesin 
may also be important for the transport of retroviral components since the C terminus 
of KIF-4, a member of the kinesin family has been found to interact with retroviral 
gag proteins in yeast-2-hybrid screens (Kim et al., 1998; Tang et al., 1999). 
However, it needs to be established that these in vitro interactions are relevant in vivo 
for HSV-1 and retrovirus transport. Conventional kinesin is also involved in the 
movement of W ,  but unlike ASFV, VV factories do not recruit endogenous kinesin 
light chain, or recruit GFP-TPR-KLC proteins (Rietdorf et al., 2001). Movement of 
IMV from the factory to the TGN is nonetheless dependent on mierotubules 
(Sanderson et al., 2000) and may therefore involve other members of the kinesin
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Figure 8.1. Schematic description of the intracellular transport of 
ASFV. Once delivered into the cytosol, viral nucleoprotein complexes are 
thought to travel towards replication sites on mierotubules by recruiting the 
minus-end microtubule motor dynein. After assembly in perinuclear viral 
factories, mature virions are transported along mierotubules by recruiting the 
plus-end directed motor conventional kinesin.
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family. After envelopment by the TGN, lEV envelope protein A36R recruits 
conventional kinesin by direet binding with the TPR domain of the light chain (Ward 
and Moss, 2004), which allows transport of lEV particles to the eell surface 
(Hollinshead et al., 2001; Rietdorf et al., 2001). A eomparison between ASFV and 
W  kinesin-based transport is represented in figure 8.2.
8.2.2 Reeruitment of conventional kinesin to ASFV particles
Early during ASFV infeetion, the GFP-TPR-KLC signal was distributed 
throughout the eytoplasm, but was recruited into the factory at a time when the 
eapsid protein p73 was expressed (Fig. 4.5). These observations suggest that a late 
signal may be required for reeruitment of kinesin to viral assembly sites. Relatively 
little is known about the mechanisms by which kinesin is reeruited to cellular eargoes 
(Kareher et al., 2002). Our results show that ASFV is recognised as eargo by the 
TPR domains of kinesin light chain, and in this way resembles other documented 
eargoes sueh as vaceinia lEV (Rietdorf et al., 2001), the amyloid precursor protein 
(Kamal et al., 2000), the Jun-N-terminal kinase-interacting proteins (JIPs) (Verhey et 
al., 2001) and their Drosophila homologue, Sunday Driver (Bowman et a l, 2000).
Reeruitment of kinesin light chain by ASFV could be mediated by a cellular 
protein that is recognised by TPR-KLC. Both JIPs (Bowman et a l, 2000; Byrd et a l, 
2001; Verhey et a l, 2001) and amyloid precursor protein (Kamal et a l, 2000) have 
been proposed to mediate kinesin-dependent transport via the TPR domain of the 
light chain in axons. Even though their role in non-neuronal eells needs to be 
established, it would be interesting to see if these proteins are reeruited into ASFV 
assembly sites. The integral ER membrane protein kinectin is also a eellular reeeptor
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Figure 8.2. Schematic description of the transport of ASFV and Vaccinia 
virus, from assembly sites to the plasma membrane. Anterograde transport of 
ASFV. Mature virions are transported along mierotubules from viral factories to 
the cell surface, by recruiting the plus-end directed motor conventional kinesin. 
Anterograde transport of Vaccinia virus. IMV are leaving the assembly sites along 
mierotubules towards the TGN by recruiting an un-identified motor. At the TGN, 
IMV are processed to form lEV, which are then able to recruit conventional 
kinesin to be transported to the plasma membrane.
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for kinesin (Kumar et ak, 1995). Kinectin would be a good candidate to mediate the 
interaetion between ASFV and kinesin since ASFV particles are wrapped by ER 
membranes (Andres et al., 1998; Cobbold et al., 1996; Cobbold and Wileman, 1998; 
Rouiller et al., 1998). However, kinectin recruits kinesin via the heavy chain (Ong et 
al., 2000) whereas our experiments have shown that ASFV recruits the motor via the 
TPR domain of the light chain (Fig. 4.5 to 4.12), making it unlikely that interaction 
of ASFV with kinesin is mediated by kinectin.
Alternatively, an ASFV structural protein could be responsible for kinesin 
reeruitment through direct recognition by TPR-KLC. This is the case for W :  the 
lEV envelope protein A36R recruits conventional kinesin via a direct interaction 
with TPR-KLC (Ward and Moss, 2004). One candidate for ASFV is the late 
structural protein pE120R, whieh is essential for virus transport from assembly sites 
to the plasma membrane (Andres et al., 2001b). The role of pE120R in ASFV 
transport was demonstrated by using an ASFV recombinant in which E120R gene 
expression was under the control of an E. coli lac repressor-operator system. When 
expression of pE120R was reduced 100 fold, ASFV particles assembled normally but 
virions remained confined to assembly sites and were not transported to the cell 
periphery (Andres et al., 2001b). EM analyses have shown that pE120R binds to the 
outer surface of virions (Fig. 5.6), a position where it would have access to kinesin 
light chain. These findings are in agreement with previous work (Andres et al., 
2001b). However, co-immunoprecipitation analyses performed in vitro failed to 
reveal a direct association between pE120R and the TPR domain of kinesin light 
chain (Fig. 5.11). The most straightforward interpretation of these findings is that 
post-translational modifications of pE120R (Fig 5.7), kinesin light chain 
(Hollenbeck, 1993; Lee and Hollenbeck, 1995), or both proteins, whieh do not occur
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in vitro, are required for a direct interaction. Co-immunoprecipitation analyses were 
therefore attempted in transfected cells but, again, it was not possible to detect an 
interaction between pE120R and TPR-KLC (Fig 5.12). Our data suggest that the 
interaction between pE120R and TPR-KLC may not be direct and an additional 
component may be required.
Immunoprécipitation analyses have shown that pE120R co- 
immunoprecipitated with a 70 kDa viral protein in cytoplasmic extracts (Fig. 5.9). 
Western blot analyses have shown that this protein was p73, the major eapsid protein 
(Fig. 5.10). These findings are in agreement with previous work (Andres et al., 
2001b) and are also consistent with the external localisation of pE120R in the virus 
particle (Fig. 5.6). pE120R could therefore play a role in ASFV motility via its 
interaction with p73. Co-immunoprecipitation analyses performed in vitro suggest 
that p73 directly interacts with TPR-KLC (Fig. 5.13). However, this interaction was 
not confirmed in vivo (Fig 5.14). Further experiments will be needed to determine 
whether p73 interacts with TRP-KLC during infection. The antibody used to 
immunoprecipitate p73 in vitro was a conformational-dependent antibody (Cobbold 
et al., 2001), suggesting that only eonformationally mature forms of p73 bind to 
TRP-KLC. This experiment also suggest that phosphorylation of TPR-KLC 
(Hollenbeck, 1993), which does not occur in vitro (Fig. 5.11 and 5.13) is not required 
for interaction with p73. It is tempting to hypothesise from these preliminary data 
that eonformationally mature p73 binds to conventional kinesin (Fig. 5.13) and that 
pE120R, which interacts with p73 (Fig. 5.10) (Andres et al., 2001b), plays a 
regulatory role in ASFV kinesin-based transport (see next section). Similarly, it has 
been proposed that two lEV envelope proteins play a role in lEV anterograde 
transport: A36R by directly binding to TPR-KLC and A33R by binding to A36R.
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The binding of A36R to either A33R or kinesin light chain is mutually exclusive and 
A33R could therefore act as a regulatory component in lEV kinesin-based transport 
(Ward and Moss, 2004). A diagram showing the recruitment of conventional kinesin 
to ASFV and W  represented in figure 8.3.
8.2.3 Regulation of ASFV anterograde transport
pE120R is involved in ASFV movement from assembly sites to the cell 
surface because if expression of the gene E120R is repressed, viral particles are not 
transported away from factories (Andres et al., 2001b). pE120R is post- 
translationally modified between 12 and 16 hpi (Fig. 5.7), a time of infection that 
corresponds to ASFV anterograde transport (Fig. 3.1). Exit of mature ASFV particles 
from the assembly sites could therefore be activated by post-translational 
modifications of pE120R. Such a regulatory signal would be essential to prevent the 
exit of assembly intermediates from the factories, and in this way ensure that these 
immature forms do not move away from the supply of structural components before 
assembly is completed. At 16 hpi, four pE120R forms, with mobilities ranging from 
approximately 13.5 to 16 kDa were detected by Western blot analyses (Fig. 5.7A). 
The number and sizes of pE120R isoforms detected in this study differ from those 
described in previous work (Andres et al., 2001b; Martinez-Pomares et al., 1997). 
Martinez-Pomarez and co-workers have detected two forms of pE120R with 
molecular masses at around 14.5 kDa whereas Andres and colleagues have described 
four pE120R forms ranging in size from 12 to 22 kDa. These discrepancies could 
arise from differenees in experimental conditions. In the published studies. Western 
blot analyses were performed with the classical method of SDS-PAGE whereas in
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this study, the tris-tricine SDS-PAGE system was used and thus provides better 
resolution for proteins with a molecular mass less than 30 kDa. The modifications 
producing the different forms of pE120R have not yet been explained. A single form 
of pE120R was detected both in transfected cell extracts and in extracts taken from 
cells infected with ASFV for 12 hrs (Fig 5.7B). In contrast, four pE120R forms were 
detected in cells infected for 16 hrs with ASFV or in transfected cells extracts 
infected for 16 hrs with the W  strain MVA-T7 (Fig. 5.7C). These experiments 
suggest that both viruses activate the eellular component responsible for modifying 
pE120R. Alternatively, both viruses might encode a protein that directly modifies 
pE120R. Among the genes common to ASFV and W ,  only one could be responsible 
for protein post-translational modification. This gene encodes a serine-threonine 
kinase and has no obvious eukaryotic cell counterparts (Iyer et al., 2001). This ORE 
is designated R298L in the ASFV genome and FIOL in the W  genome. The genome 
of the MVA-T7 strain of W  used in this study also contains the FIOL gene (Antoine 
et al., 1998). pR298L is packaged into ASFV particles and in vitro studies have 
demonstrated that it is an enzymatically active serine kinase (Baylis et al., 1993). 
However, its function during infection is unknown. It would be interesting to see if 
pR298L is able to phosphorylate pE120R.
Comparison of pE120R sequence with the GCG protein motif database 
revealed that the protein contains 3 serine phosphorylation sites: serine 115, 116 and 
119. To study serine phosphorylation at these positions, substitutions of the serine 
residues by alanine or glycine were produced by site-directed mutagenesis using the 
E120R expressing vector as a template. None of the serine mutations abolished 
modifications of E120R in the MVA-T7 system (Fig 5.8). These results show that
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A36R A36R
Figure 8.3: Putative recruitment of conventional kinesin to ASFV and 
Vaccinia virus particles. For ASFV, the main eapsid protein p73 could 
recruit conventional kinesin by binding to the TPR domain of the light chain. 
pE120R, which binds p73, could play a regulatory role in the transport. It is 
possible that the post-translational modifications of pE120R (pm) would be 
the signal for the exit of mature virions from assembly sites. For VV, the 
lEV envelope protein A36R binds the TPR domain of the light chain. The 
lEV envelope protein A33R also interacts with A36R. The binding of A36R 
to either conventional kinesin or A33R is mutually exclusive and could 
therefore act as a regulatory component of VV anterograde transport.
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pE120R is not serine phosphorylated at these C-terminal sites during MVA-T7 
infection and might therefore not be phosphorylated at these serines during ASFV 
infection. Engineering ASFV mutants in which the eight serine residues of E120R 
ORF would be singly substituted would be an ideal way to study pE120R putative 
serine phosphorylation during ASFV infection. Alternatively, the putative serine 
phosphorylation sites detected by bioinformatics analyses may not be relevant in 
vivo. Other post-translational modifications could explain the four pE120R forms. It 
is however excluded that pE120R is tyrosine-phosphorylated during ASFV infection 
because Western blot analyses performed with a specific phosphotyrosine antibody 
on ASFV-infected cell extracts did not revealed bands that could represent pE120R 
(Fig. 7.12). pE120R is unlikely to be ubiquinated during infection since Western 
blotting of ASFV-infected cell extracts with anti-ubiquitin antibody identified 3 
proteins with sizes that differ from the size of pE120R (Hingamp et al., 1995). 
Further investigations of pE120R post-translational modifications during infection 
might enlighten the mechanisms that regulate ASFV anterograde transport.
Another possible means of regulating ASFV anterograde transport may 
involve post-translational modification of the TPR domain of the kinesin light chain. 
TPR-KLC has been shown to be serine phosphorylated in vivo (Hollenbeck, 1993; 
Lee and Hollenbeck, 1995). The detection of two forms of TPR-KLC by Western 
blot analyses suggests that TPR-KLC is likely to be modified during ASFV infection 
too (Fig. 4.4A). Kinesin light chain is phosphorylated by glycogen synthase kinase 3 
(Szebenyi et al., 2002) and it would be interesting to see if this kinase is recruited 
into ASFV assembly sites.
a-tubulin post-translational modifications influence kinesin binding to 
mierotubules and would therefore be another way to regulate kinesin-based transport
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(Larcher et a l, 1996). Early studies have shown that in lobster axons only a subset of 
mierotubules were competent for vesiele transport (Miller et al., 1987). In vitro 
studies have demonstrated that conventional kinesin binds with higher affinity to 
polyglutamylated (Larcher et al., 1996) and detyrosinated tubulin (Kreitzer et al., 
1999; Liao and Gundersen, 1998). If this was also true for acetylated tubulin, 
acétylation induced by ASFV would not only stabilise the mierotubules (Fig. 6.3 and 
6.4) but also enhance binding of kinesin; both would facilitate transport of the virus 
from factories to the cell surface.
In summary, post-translational modifications of the TPR domain of the 
kinesin light chain, a-tubulin and/or the ASFV structural protein pE120R could play 
a role in activation and/or regulation of ASFV-kinesin based transport.
8.3 Microtubule re-organisation in ASFV infected cells
Numerous unrelated viruses, including HSV-1, HIV-1, VV, ASFV and Ad2, 
require an intact microtubule network for their retrograde and anterograde transport 
(Alonso et al., 2001; Dohner et al., 2002; Hollinshead et al., 2001; McDonald et al., 
2002; Ploubidou et a l, 2000; Suomalainen et a l, 1999) (Fig. 3.1 to 3.5). It is 
therefore surprising that viral infeetion often leads to microtubule network re­
organisation (Ploubidou and Way, 2001). This is the case in Vero cells infected with 
the Ba71v strain of ASFV where the microtubule network is highly re-organised at 
late times post-infection (Fig. 6.1). These observations are in agreement with 
previous work showing microtubule re-arrangements in Vero eells infected with the 
Lisbon-60 ASFV strain (Carvalho et a l, 1988). Similar cytoskeleton re­
arrangements, such as microtubule “rings” and bundles, have been described in VV
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and HSV-1 infected eells (Avitabile et a l, 1995; Kotsakis et a l, 2001; Ploubidou et 
a l, 2000). Even though this is a common feature of viral infection, the molecular 
mechanisms underpinning the re-arrangement of the microtubule network are not 
understood. It is possible that microtubule re-organisation is not under virus control 
but the result of side effects, such as accumulation of viral MAPs in the cytoplasm of 
infected cells (Ploubidou and Way, 2001). When expressed alone, viral MAPs do not 
only stabilise mierotubules (see discussion above) but also trigger their re­
arrangement. For instance, cells expressing HSV-1 Vp22 or the movement protein of 
tobacco mosaic virus display abnormal microtubule arrays (Boyko et a l, 2000; 
Elliott and O'Hare, 1998).
Disorganisation of the microtubule cytoskeleton during viral infection could 
also be explained by disruption of the centrosome function in infected cells 
(Ploubidou and Way, 2001). W  infection, for example, causes reduction of proteins 
at the centrosome and loss of centrosome nucléation efficiency (Ploubidou et a l,
2000). Structural modification of the centrosome has also been observed by EM in 
cells infected with HSV-1 and CMV (Bystrevskaya et a l, 1997; Gilloteaux and 
Nassiri, 2000). ASFV infection disrupts both centrosome function and assembly, 
probably by blocking the recruitment of pericentrin and y-tubulin to the centrosome 
(Fig. 6.4 to 6.6). Cytoplasmic dynein is responsible for recruiting and transporting 
pericentrin and y-tubulin to the centrosome and therefore plays a key role in 
microtubule organisation, centrosome integrity and assembly (Koonce et a l, 1999; 
Quintyne et a l, 1999; Young et al, 2000). Overexpression of the subunit 
p50/dynamitin of the dynactin complex blocks retrograde transport of several 
unrelated viruses such as W ,  HSV-1, Ad2 and Ad5, ASFV and HIV-1 (Alonso et 
a l, 2001; Heath et a l, 2001; Mabit et a l, 2002; McDonald et a l, 2002; Ploubidou et
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al, 2000). These observations suggest that these viruses use cytoplasmic dynein to be 
delivered in a retrograde manner to their replication sites. Exploitation of dynein by 
viral particles could thus impede the transport of pericentrin and y-tubulin to the 
centrosome.
Alternatively, centrosome damage, and the resulting microtubule re­
organisation, may be an active process under the control of viruses. Why viruses 
would disrupt microtubule organisation? For ASFV, the transport of particles from 
perinuclear assembly sites to the cell periphery begins at around 12 hrs (Fig. 3.1), a 
time when the mierotubule network is stabilised in infected cells (Fig. 6.4). At 16 
hpi, when large numbers of virions have reached the plasma membrane, the 
mierotubule network is less stable (Fig. 6.4) and becomes highly disrupted and 
bundled (Fig. 6.ID, white boxes). It is possible that transporting more virions to the 
cell surface is not a priority at 16 hpi. Delivering virions that are already present at 
the edge of the cell in neighbouring cells might be more important. Mierotubule re­
arrangements might be required for this cell-to-cell transport. In fact, virions were 
often found associated with microtubule-containing structures extending from the 
plasma membrane and penetrating into adjacent cells (Fig. 6.ID, white boxes). The 
formation of these mierotubule extensions would not be conceivable in the presence 
of a functional centrosome.
Mierotubule re-organisation at 16 hpi may also enhance the motility of 
infected cells. Mierotubules in late ASFV-infected eells are no longer anchored at the 
centrosome (Fig. 6.1). This is also true for mierotubules that re-polymerise after 
nocodazole washout in infected cells (Fig. 6.8). The same mierotubule arrangements 
have been reported in migrating cells: mierotubules can be released from the 
centrosome and captured by the actin cytoskeleton at the plasma membrane. These
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free minus-end microtubules are involved in lamellipodia stabilisation and enhance 
cell motility (Abal et al., 2002; Ballestrem et al., 2000). Controlling cell motility, via 
microtubule re-arrangements, would be another way for viruses to spread infection in 
vivo. Both W  and Rous sarcoma virus have been shown to induce cell movement 
(Behrens et al., 1993; Sanderson et al., 1998b) and it would be interesting to see if 
ASFV can also do so.
Lastly, re-organisation of the microtubule network at late stages of infection 
could be a way of promoting actin polymerisation at the cell periphery (see below). 
Microtubule instability can activate a signal transduction cascade that enhances actin 
polymerisation at the cell front (Waterman-Storer et al., 1999). This signalling 
pathway is triggered by the release of the small GTPase Racl, which is displaced 
from a-tubulin (Waterman-Storer et al., 1999).
8.4 Actin-based motility of ASFV
The distributions of ASFV particles and actin were analysed at late times 
post-infection by indirect immunofluorescence using different ASFV strains and cell 
lines (Fig. 7.1 to 7.4). Both wild-type and cell-culture-adapted strains induced the 
formation of long unbranched actin projections that originated from the cell surface. 
Max cells infected with the cell-culture-adapted strain Uganda produced higher 
numbers of intracellular viral particles and higher numbers of actin projections 
compared to cells infected with Malawi and Ba71v. The Max/Uganda combination 
was therefore used to forther investigate the interaction between ASFV and actin. 
ASFV particles were not only associated with long actin projections, but were also 
aligned with cortical actin fibres underneath the plasma membrane (Fig. 7.4). The
200
distribution of ASFV along cortical actin fibres and along the projections suggested 
that ASFV might move along these actin tracks.
High magnification EM analyses confirmed that ASFV particles colocalised 
with cortical microfilaments. They revealed that these microfilaments were arranged 
in parallel arrays and that they did not originate from the virions (Fig. 7.6B). The 
actin filaments present in the actin-projections were also long, unbranched and 
parallel (Fig. 7.7), reminiscent of those present in filopodia (Small et al., 2002). EM 
analyses also showed that the projection-associated virions were intracellular 
particles (Fig. 7.7), confirming immunofluorescence experiments performed on non- 
permeabilised cells (Fig. 7.5). Live cell microscopy confirmed that all the extensions 
originated from the plasma membrane and that they were all induced by a single 
particle (Fig 7.8). They also revealed that ASFV particles underwent forward and 
rearward movements along pre-existing projections (Fig 7.8). The accumulation of 
mature virions just beneath the cell surface in BFA-treated cells confirmed that the 
projections were formed de novo for the purpose of virus release (Fig. 7.10).
In summary, these experiments suggest that ASFV actin-based transport 
might involve three mechanisms: transport along cortical actin filaments, actin 
polymerisation from the plasma membrane and intra-projection movement in a bi­
directional manner. The putative mechanisms involved in ASFV actin-based 
transport are discussed below. A model for ASFV anterograde transport is given in 
figure 8.4.
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Figure 8.4. Model for ASFV anterograde transport. ASFV transport 
from assembly sites to the cell surface could involved at least four 
mechanisms: transport along microtubules by recruiting conventional 
kinesin, transport along cortical actin filaments by recruiting an un­
identified actin-based motor, actin polymerisation at the plasma 
membrane and transport along pre-existing actin-containing 
projections in a bi-directional manner.
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8.4.1 Re-arrangement and polymerisation of actin in ASFV-infected cells:
comparison with other pathogens
Live cell microscopy revealed that single ASFV particles were able to induce 
the formation of long projections that originated from the plasma membrane (Fig 
7.8). Viral particles always remained associated with the tip of these structures. 
Immunofluorescence and EM analyses have shown that these projections contained 
actin filaments (Fig. 7.1 to 7.4 and 7.7). Taken together, these studies indicate that 
ASFV particles induce the elongation of actin projections that propel them away 
from infected cells. W  also polymerises actin at the plasma membrane (Cudmore et 
al., 1995; Rietdorf et al., 2001). The resulting structure is an ‘actin tail’ that strikingly 
resembles the intracytoplasmic comet tails generated by the bacteria Rickettsia 
conorii, Listeria monocytogenes and Shigella jlexneri. Actin tails are short (3 to 5 
pm depending on cell lines) and curly (Goldberg, 2001). They may originate from 
actin stress fibres (Gouin et al., 1999). Actin at the distal end of the tail is unstable 
and depolymerises as the tail extends (Cudmore et al., 1995). In contrast, the actin 
projections produced by ASFV are straight, long (average length of 10 pm) and do 
not depolymerise at the distal end (Fig. 7.1 to 7.4 and 7.8). They originate from the 
plasma membrane and stay connected to it while elongating (Fig. 7.8).
Listeria, Shigella and W  actin tails are also structurally similar to each 
others: they are composed of short, cross-linked actin filaments (Cudmore et al., 
1995; Gouin et al., 1999). In contrast, ASFV actin projections are composed of long, 
unbranched, parallel actin filaments (Fig. 7.7), reminiscent of those present in actin 
tails generated hy Rickettsia (Gouin et al., 2004; Gouin et al., 1999).
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Immunofluorescence analyses performed with non-permeabilised cells 
suggest that ASFV particles that are associated with actin projections are intracellular 
virions (Fig. 7.5). EM analyses have confirmed these findings (Fig 7.7). Rickettsia, 
Listeria and Shigella also induce actin polymerisation from an intracellular position. 
In contrast, VV directs actin polymerisation from an extracellular position. At the 
cell surface, the outer membrane of the W  particle fuses with the plasma membrane. 
Actin polymerisation occurs on the cytosolic face of the plasma membrane, directly 
beneath the extracellular particle, and propels it away from the cell surface (Rietdorf 
et al., 2001; Ward and Moss, 2001).
Video microscopy allowed us to follow the movement of more than 150 
individual virions associated with actin projections (movies and Fig 7.8). The ASFV- 
tipped projections grow at an average rate of 3 pm/min. The maximum reported 
speed was 11.1 pm/min. These rates of movement are similar to those reported for 
W  actin-based motility, which are between 2.8 pm/min and 9-10.8 pm/min 
(Cudmore et al., 1995; Rietdorf et al., 2001). Rickettsia also moves at similar rates, 
between 4.8 and 8 pm/min (Gouin et al., 1999). Listeria and Shigella seem to move 
two- to threefold faster in the cytoplasm of infected cells, respectively at 13.2 to 22 
pm/min and 5.4 to 26 pm/min (Goldberg, 2001; Gouin et al., 1999).
Immunofluorescence analyses showed that only a sub-population of virions 
was associated with phosphotyrosine proteins at the edge of the cell (Fig 7.12). 
Video analyses have shown that ASFV particles could stay stationary at the tip of a 
projection for more than 15 minutes and that particles were associated with both 
growing and shrinking projections (Fig. 7.8). It is possible that only virions that are 
inducing the growth of a projection are associated with phosphotyrosine proteins. 
More analyses, such as blocking tyrosine phosphorylation during infection, would be
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necessary to determine whether tyrosine phosphorylation is essential for actin 
polymerisation in ASFV-infected cells. Tyrosine phosphorylation is not required for 
actin-based motility of Shigella or Listeria but plays a key role in the W  system 
(Frischknecht et al., 1999a).
Immunofluorescence analyses also showed that ASFV did not recruit GFP- 
tagged version of N-WASP, Nckl or Grb2 at the cell periphery (Fig 7.11), 
suggesting that these adaptor proteins are not involved in ASFV actin 
polymerisation. In contrast, these three proteins are recruited to the tip of VV actin 
tails and are necessary for their formation (Frischknecht et al., 1999a; Moreau et al., 
2000; Scaplehom et al., 2002). The W  protein A36R binds to Nckl, which recruits 
N-WASP, which recruits and activates Arp2/3. Arp2/3 then activates the nucléation 
of actin polymerisation and induces the continuous formation of a network of short 
and highly branched filaments, reminiscent of those present in lamellipodia. N- 
WASP is also detected in Shigella actin tails and is essential for its motility (Suzuki 
et al., 1998). The Shigella protein IscA binds directly to N-WASP. N-WASP is 
absent of Listeria and Rickettsia tails (Gouin et al., 1999). Consistent with these 
observations, the two bacteria encode their own Arp2/3 activator, ActA and RickA 
respectively (Gouin et al., 2004; Welch et al., 1998). It is interesting to note that 
Arp2/3, which generates branched actin networks, is always involved in the 
polymerisation process. The presence of Arp2/3 at the surface of Rickettsia and its 
requirement for Rickettsia motility were unexpected (Gouin et al., 2004). It has been 
proposed that Arp2/3 would be necessary to nucleate Rickettsia actin tail and that the 
tail elongation would be Arp2/3-independent (Gouin et al., 2004). The factors 
involved in Rickettsia actin tail elongation are unknown.
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Cytochalasin-D binds to the barbed ends of actin filaments and prevents 
further polymerisation. Cytochalasin-D treatment inhibits the formation of actin tails 
and subsequent release of W  (Cudmore et al., 1995). In contrast, ASFV actin 
projections occurred in cells treated with cytochalasin-D, although they were thinner 
than in control cells (Fig. 7.9). These observations confirm that the ASFV- 
projections are formed de novo by actin polymerisation. They suggest that the 
association between ASFV particles and the barbed end of actin filaments protect 
actin against the drug. ASFV might recruit proteins that irreversibly bind to the 
barbed end of actin during all the elongation process. VASP could be one of these 
proteins since it competes with capping proteins at the barbed ends and thus 
increases filament length (Bear et al., 2002). VASP also decreases branch density. 
Consistent with this, VASP is present all along the Rickettsia tail whereas it is only 
detected at the base of Listeria tails (Gouin et al., 1999).
Comparisons between ASFV, VV and bacterial actin structures are 
summarised in table 8.1. Based on the composition of actin structures, actin 
polymerising pathogens would fall into two categories: the first including Listeria, 
Shigella and W ,  the second Rickettsia and ASFV. The actin filaments that 
composed ASFV and Rickettsia actin structures are reminiscent of those present in 
filopodia (Fig.7.7) (Gouin et a l, 1999; Small et a l, 2002). It is possible that the actin 
polymerisation mechanisms are similar in the three systems. The formation of 
filopodia in vivo is not well understood. In vitro, a small number of component are 
sufficient for the assembly of filopodia: WASP-coated beads, actin, Arp2/3 complex 
and fascin (Vignjevic et a l, 2003). Filopodia would form from a pre-existing 
dendritic network and would elongate by inhibition of capping and subsequently 
cross-linked into bundles by fascin. Like filopodia, the Rickettsia actin tails contain
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fascin (Gouin et a l, 2004). It would be interesting to see whether Arp2/3, fascin and 
VASP are detectable throughout ASFV actin projections.
Table 8.1. Comparison of actin structures and actin polymerisation rates induced 
by pathogens.
Pathogen Position of 
pathogen
Actin
structure
Composition 
of the actin 
structure
Average 
polymerisation 
rate (pm/min)
W Extracellular Comet tails Short cross- 
linked filaments
2.8-10.8
ASFV Intracellular Filopodia-
like
projections
Long parallel 
filaments
3
Shigella
flexneri
Intracellular Comet tails Short cross- 
linked filaments
5.4-26
Listeria
monocytogenes
Intracellular Comet tails Short cross- 
linked filaments
13.2-22
Ricketssia
conorii
Intracellular Comet tails Long parallel 
filaments
4.8-8
Bacteria exploit actin polymerisation for their intra- and inter-cellular 
movements. Passage of Rickettsia, Shigella or Listeria into adjacent cells occurs 
when the bacterium is pushed out against the cell membrane by actin polymerisation. 
Engulfinent of the bacterium by the adjacent cell leads to the formation of a double­
membrane bound vacuole. The bacterium lyses the double-membrane and is released 
into the cytoplasm of the adjacent cell (Goldberg, 2001). W  induces actin 
polymerisation from an extracellular position and is therefore released into the 
extracellular space. It has been suggested that VV actin-based motility also promotes 
cell-to-cell spread (Cudmore et al, 1995). When the formation of actin projections 
was inhibited by BFA in ASFV infected cells (Fig. 7.10), ASFV particles 
accumulated underneath the plasma membrane, indicating that actin polymerisation 
is required for ASFV release. However, it is difficult to ascertain whether actin
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polymerisation promotes release of virions into the extracellular space and/or 
enhances cell-to-cell spread. It is interesting to note that in the ASFV system, the 
actin structures are generated by individual virions, but are further exploited by other 
viruses (Fig. 7.8). In contrast, the actin tails induced by W  and bacteria serve the 
transport of a single pathogen.
8.4.2 Viral actin-based transport: a more common mechanism than previouslv
realised?
W  actin-based motility was considered to represent a unique example of 
viral motility (Cudmore et al., 1995). Our immunofluorescence, electron microscopy 
and video analysis revealed that ASFV also utilises the actin network for its 
movement (Fig. 7.1 to 7.8), but in a different way from that used by W  (see 
discussion above and table 8.1).
Early observations of fixed cells infected with FV3 and retroviruses have 
revealed the presence of viral particles at the tip of actin-containing protrusions 
(Damsky et a l, 1977; Mortara and Koch, 1986; Mortara and Koch, 1989; Murti et 
a l, 1985). Video analyses would be necessary to confirm whether these cell-surface 
projections are induced by viral particles. It will be interesting to learn if these 
viruses also use microtubules to first reach the plasma membrane, in a manner 
similar to ASFV and VV (chapters 3 and 4) (Hollinshead et a l, 2001; Rietdorf et a l, 
2001; Ward and Moss, 2001). Actin polymerisation might also be used by viruses to 
promote their intracytoplasmic movement. This might be the case for the baculovirus 
AcMNPV. Following entry, thick actin cables stretching from the plasma membrane 
to the nucleus are observed in the cytoplasm of AcMNPV-infected cells. Single viral
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capsids are localised at the tip of these actin cables (Charlton and Volkman, 1993). 
Video analyses would confirm whether AcMNPV polymerises actin for its transport 
towards the nucleus at early stages of infection. Therefore, polymerisation of actin 
might not be restricted to W  and ASFV but a common mechanism used by viruses 
for intra- and intercellular transport.
8.4.3 Is a mvosin-like motor involved in ASFV transport along actin filaments?
Immunofluorescence and EM analyses revealed that ASFV particles were 
aligned on actin filaments at the cell cortex (Fig 7. 4). EM analyses showed that 
filaments did not occur from the particles (Fig. 7.7), indicating that the motile force 
that drives virions along actin filaments is not generated by actin polymerisation 
beneath the viral particles. Live cell microscopy revealed that ASFV particles 
underwent striking forward and rearward movements along pre-existing static actin 
projections (Fig. 7.8). Both ASFV transport along cortical actin filaments and 
movement along actin projections may be mediated by a myosin-like motor. Such a 
motor, able to drive cargo along both cortical actin filaments and filopodia-like 
structures, has not been described. ASFV could then recruit, alternatively or 
simultaneously, two members of the myosin super-family.
Myosin Va is involved in the short-range transport of vesicles in the actin- 
rich cortex of the cell (Langford, 2002). Myosin Va could therefore drive ASFV 
towards the barbed-end of cortical actin filaments. However, we were unable to 
localise endogenous myosin Va and GFP constructs corresponding to the cargo- 
binding domain of myosin Va on ASFV (data not shown).
The barbed-end motor myosin X has been proposed to mediate cargo 
transport along filopodia, in both directions (Berg and Cheney, 2002; Homma et al.,
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2001) and could therefore be involved in ASFV motility within actin-projections. 
However, GFP constructs corresponding to the tail domain and to the head, neck and 
coiled-coil domain of myosin X (Berg and Cheney, 2002) do not label actin- 
associated ASFV particles in transfected cells (data not shown). Moreover, myosin X 
rearward movement along filopodia is due to actin retrograde flow and its average 
rate is 0.9jam/min (Berg and Cheney, 2002). These rates are four-fold slower than the 
rates of ASFV rearward transport within projections (average speed: 3.69pm/min), 
reinforcing our hypothesis that this transport is not due to actin retrograde flow, but 
more likely mediated by a myosin motor.
ASFV might then recruit other members of the myosin super-family. One 
could also imagine that ASFV encodes its own myosin-like protein, in a manner 
similar to protozoan intracellular parasites such as Toxoplasma gondii and 
Plasmodium falciparum. These parasites utilise their own myosin motor to generate 
the motile force necessary to propel them inside cells (Heintzelman and 
Schwartzman, 1997; Heintzelman and Schwartzman, 1999; Heintzelman and 
Schwartzman, 2001). An ASFV putative myosin-like protein would be a structural 
protein exposed outside the viral particle and would possess, as observed for myosin, 
a Mg^^-dependent ATPase activity and an actin-binding site. A candidate in the 
ASFV genome is the B354L gene, which possess an ATPase and a Mg^^- binding 
motif (Iyer et al., 2001). The B354L gene is located next to the two genes encoding 
the main ASFV capsid protein, p73 and its chaperone, CAP80 (Yanez et al., 1995). 
All three reading frames are read in the same direction and they may originally have 
been joined and encoded as a single structural protein. Further investigations will be 
required to determine whether ASFV recruits one or more cellular members of the 
myosin super-family or whether viral particles contain a specialised motor protein
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able to drive ASFV along the barbed end of cortical actin and bi-directionally along 
actin projections.
Exploitation of microtubule motors by viruses is well documented (Smith and 
Enquist, 2001). By contrast, recruitment of members of the myosin super-family by 
viruses and subsequent movement of viruses along actin tracks has not been 
described. However, interactions between myosin II and viruses have been 
previously reported. HSV-I infection re-organises the distribution of myosin II, 
inducing its accumulation into viral assembly sites (van Leeuwen et a l, 2002). In 
vitro analyses have revealed an interaction between HSV-I tegument protein Vp22 
and myosin II. Release of HSV-I into the extracellular medium was inhibited by the 
drug butanedione monoxime, which inhibits myosin activity, suggesting that myosin 
II might play a role in HSV-1 exit (van Leeuwen et a l, 2002). Co-localisation of 
myosin II with HIV particles at the plasma membrane have been shown by 
immunofluorescence analyses (Sasaki et a l, 1995). Moreover, an inhibitor of myosin 
light chain kinase, for which myosin II is the only downstream effector known, 
blocks HIV budding (Sasaki et al, 1995). Taken together, these studies suggest that 
myosin II is involved in HSV-1 and HIV-1 transport. However, it still needs to be 
demonstrated that HSV-1 and HIV-1 are transported along actin filaments and that 
myosin II plays a direct role in this transport.
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